fluorodeoxyglucose f18 has been researched along with Carcinoma, Epidermoid in 1346 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.15) | 18.7374 |
| 1990's | 74 (5.50) | 18.2507 |
| 2000's | 388 (28.83) | 29.6817 |
| 2010's | 754 (56.02) | 24.3611 |
| 2020's | 128 (9.51) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, U; Baron, L; Barshack, I; Davidson, T; Nissan, E; Urban, D; Zabatani, A | 1 |
| Grünig, H; Huellner, MW; Kamarachev, J; Nägeli, M; Skawran, SM | 1 |
| Beppu, S; Hanai, N; Nishikawa, D; Nishio, M; Sawabe, M; Suzuki, H; Tamaki, T; Terada, H | 1 |
| Ahmed, MM; Baker, A; Fagiry, R; Ibrahim, N; Mahmood, S; Mair, M; Menon, I; Vaidhyanath, R | 1 |
| Callahan, J; Cardin, A; Cavanagh, K; Hicks, RJ; Lim, AM; McLean, LS; Rischin, D; Xie, J | 1 |
| Aryal, M; Bhambhani, C; Bhangale, A; Brenner, JC; Brummel, C; Cao, Y; Casper, K; Chinn, S; Gu, W; Haring, CT; Heft Neal, M; Lee, C; Malloy, K; McHugh, JB; Mierzwa, M; Mills, RE; Prince, ME; Schonewolf, C; Shah, J; Shuman, A; Spector, ME; Sun, Y; Swiecicki, PL; Tewari, M; Worden, FP | 1 |
| Lei, Y; Li, X; Liao, Y; Liu, J; Peng, Y; Wan, Q; Wang, P; Xia, X; Xie, X; Zhou, J | 1 |
| Chen, YH; Cheng, SC; Guenette, J; Gunasti, L; Haddad, R; Jacene, HA; Jo, VY; Lako, A; Rodig, S; Schoenfeld, JD; Shah, H; Uppaluri, R; Wang, Y | 1 |
| Hirosue, A; Kawahara, K; Kitajima, M; Minamitake, A; Murakami, R; Nakayama, H; Sakamoto, F; Sakata, J; Shiraishi, S; Yamana, K; Yoshida, R | 1 |
| Ludlow, D; Muller, RG; Weidenbecher, M | 1 |
| Li, R; Liu, Q; Liu, S; Pan, H; Song, S; Sun, D; Wang, L; Yang, H | 1 |
| Haga, A; Ikushima, H; Kudo, Y; Kudoh, K; Kudoh, T; Miyamoto, Y; Sasaki, M; Takahashi, A | 1 |
| Abdalla, AS; Khan, SA; Sheybani, ND | 1 |
| Adusumilli, P; Casanova, N; Cooper, R; Elsayed, N; Gilbert, A; Samuel, R; Scarsbrook, AF; Theophanous, S; Tolan, DJ | 1 |
| Brambilla, M; Ferrara, E; Franco, P; Guaschino, R; Krengli, M; Luciani, I; Puta, E; Sacchetti, GM; Turri, L | 1 |
| Gu, H; Li, M; Wang, Y; Wu, J; Xuan, G | 1 |
| Bakker, AS; Haj Mohammad, N; Jairam, J; Kroese, TE; Meijer, GJ; Mook, S; Ruurda, JP; van der Horst, S; van Hillegersberg, R; van Rossum, PSN | 1 |
| Chan, C; Cheng Lau, Y; Dempsey, MF; Dyab, H; Grose, D; Hendry, F; James, A; Lamb, C; Maxfield, C; Paterson, C; Rulach, R; Schipani, S; Wilson, C; Zhou, S | 1 |
| Emi, M; Hamai, Y; Hirohata, R; Ibuki, Y; Kitasaki, N; Kurokawa, T; Murakami, Y; Nagata, Y; Nishibuchi, I; Ohsawa, M; Okada, M; Yoshikawa, T | 1 |
| Hyayashi, T; Nikkuni, Y; Nishiyama, H | 1 |
| Burian, E; Callahan, N; Froelich, MF; Gassert, FG; Makowski, MR; Palla, B; Pyka, T; Rübenthaler, J; Schmid, A; von Schacky, CE; Wolff, C | 1 |
| Fang, N; Lin, S; Wang, YL; Zhang, J | 1 |
| Chen, M; Chen, WM; Lin, WC; Shia, BC; Wu, SY | 1 |
| Gao, Y; Ke, C; Kui, X; Li, F; Li, X; Liu, X; Pei, Z; Tan, F; Wan, H; Yuan, L; Zeng, J | 1 |
| Albano, D; Berruti, A; Bertagna, F; Bossi, P; Dondi, F; Farina, D; Guerini, A; Mattavelli, D; Pasinetti, N; Piazza, C; Ravanelli, M; Treglia, G | 1 |
| Chen, YY; Feng, WH; Huang, HK; Huang, TW; Kuo, YS; Lin, KH; Tsai, YM; Wu, TH | 1 |
| Haga, N; Ito, K; Kasai, Y; Masuya, D | 1 |
| Chen, MYC; Hsu, JT; Lin, NC; Tsai, KY | 1 |
| Danstrup, CS; Fisker, R; Kovacsne, A; Lyhne, NM; Zacho, HD | 1 |
| Dong, A; Wang, Y; Zhang, J | 1 |
| Dalianis, T; Hammarstedt-Nordenvall, L; Jara, SJ; Landin, D; Marklund, L; Munck-Wikland, E; Näsman, A | 1 |
| Bülbül, HM; Bülbül, O; Çapa Kaya, G; Gezer, NS; Gürel, D; Tertemiz, KC; Ulukuş, EÇ | 1 |
| Cardin, A; Dhillon, K; Dixon, B; Flatman, S; Fua, T; J R Magarey, M; Kleid, S; Manji, J; Prasad, J; Rischin, D; Tapia, M | 1 |
| d'Abadie, P; Gheysens, O; Opalinski, L; Schmitz, S; Van Eeckhout, P | 1 |
| Morand, GB | 1 |
| Cho, H; Jo, KH; Kang, WJ; Kim, J; Lee, SK; Park, K; Sohn, B; Woo, C | 1 |
| Abgral, R; Conan-Charlet, V; Dzuko Kamga, J; Leclere, JC; Tissot, V | 1 |
| Aigner, C; Darwiche, K; Hautzel, H; Hegedus, B; Hermann, K; Mardanzai, K; Nensa, F; Okumus, Ö; Plönes, T; Schuler, M; Stuschke, M; Theegarten, D | 1 |
| Abe, K; Aoki, K; Daimon, M; Iwahana, T; Kato, H; Kobayashi, Y; Ono, R | 1 |
| Doai, M; Matoba, M; Nagata, H; Nishino, Y; Ota, K; Tsuchiya, H; Tuji, H | 1 |
| Bahce, I; Comans, EFI; Dahele, MR; Daniels, HJMA; Dickhoff, C; Heineman, DJ; Radonic, T; Rauh, SP; Smesseim, I; van Boerdonk, RA | 1 |
| Al-Busani, H; Makiguchi, M; Miura, K; Namiki, T; Nishida, M; Okiyama, N; Ugajin, T; Wada, S; Yokoyama, K | 1 |
| Qiao, M; Shi, J; Song, Y; Sun, Z; Tian, S; Zhang, X | 1 |
| Bates, DDB; Ernst, R; Gangai, N; Golia Pernicka, JS; Gollub, MJ; Hope, TA; Horvat, N; Rauch, GM; Sheedy, SP | 1 |
| Feng, J; Gao, X; He, Y; Hu, Y; Ma, Y; Pan, Y; Peng, L; Xu, F; Zhu, X | 1 |
| Elhence, P; Jabbar, SA; Selvakumar, B; Soni, SC; Taywade, S | 1 |
| Röhrich, M | 1 |
| Akagi, S; Hashimoto, M; Hiraki, T; Ihara, H; Maeda, N; Noma, K; Sugiyama, S; Takao, S; Tanabe, S; Yoshio, K | 1 |
| Kirita, T; Nakayama, Y; Tamaki, S; Ueda, N; Yagyuu, T; Yamakawa, N | 1 |
| Boyle, JO; Chen, L; Cohen, MA; Cracchiolo, JR; Dunn, L; Ganly, I; Gelblum, DY; Kang, JJ; Lee, NY; McBride, SM; Michel, LS; Patel, SG; Pfister, DG; Riaz, N; Schöder, H; Sherman, EJ; Singh, B; Tsai, CJ; Wong, RJ; Yu, Y; Zakeri, K | 1 |
| Fowler, A; Holloway, L; Lee, M; Lin, P; Min, M | 1 |
| Bartolomei, M; Bianchini, C; Bonsembiante, A; Caracciolo, M; Carandina, I; Ciorba, A; Cittanti, C; Corazzi, V; Migliorelli, A; Ortolan, N; Panareo, S; Pelucchi, S; Uccelli, L; Urso, L | 1 |
| Calais, J; Czernin, J; Hotta, M; Howard, T; Maliha, PG; Mendelsohn, AH | 1 |
| Cui, Z; Feng, J; Huang, L; Li, J; Luo, Y; Ma, W; Tian, X; Xie, Y; Yuping, H; Zhang, K; Zhou, J | 1 |
| Hartel, G; Khoo, D; Liu, ZY; Punyadeera, C; Vasani, S | 1 |
| Beppu, S; Hanai, N; Kodaira, T; Nishikawa, D; Nishio, M; Sasaki, E; Sawabe, M; Suzuki, H; Tamaki, T; Terada, H | 1 |
| Daisaki, H; Enomoto, A; Ishii, K; Ito, K; Kaida, H; Kimura, T; Kitajima, K; Otsuki, N; Sato, MP; Sekine, T | 1 |
| Fukugawa, Y; Hirai, T; Matsuyama, T; Murakami, D; Orita, Y; Oya, N; Saito, T; Shiraishi, S; Toya, R; Watakabe, T | 1 |
| Bell, J; Mac Curtain, BM; Ng, ZQ; O'Mahony, A; Qian, W; Temperly, HC | 1 |
| Carré, A; Chargari, C; Classe, M; Deutsch, E; Genestie, C; Guckenberger, M; Guren, MG; La Greca Saint-Esteven, A; Lemanski, C; Malinen, E; McDermott, G; McKenna, J; Niyoteka, S; Robert, C; Rouhi, R; Scarsbrook, A; Seban, RD; Sun, R; Tanadini-Lang, S | 1 |
| Fujishima, F; Iwama, R; Koketsu, A; Kume, K; Masamune, A; Miyashita, H; Takahashi, T | 1 |
| Duvernay, J; Majoufre, C; Schlund, M | 1 |
| Li, W; Liu, Z; Zhang, R | 1 |
| Dong, Z; Fei, J; Gong, L; Li, K; Liu, W; Niu, L; Yan, R; Zheng, C; Zheng, D | 2 |
| Appelt, AL; Brown, PJ; Currie, S; Frood, R; Gilbert, A; Scarsbrook, A; Sebag-Montefiore, D; Zhong, J | 1 |
| Hata, M; Kunisaki, C; Misumi, T; Ogino, I; Watanabe, S | 1 |
| Barker, CA; Mahajan, S; Mauguen, A; Pandit-Taskar, N; Singh, B | 1 |
| Ono, K; Saito, H | 1 |
| Huynh, KN; Nguyen, BD | 1 |
| Choi, WH; Kang, JH; Kim, YS; Lee, HY; Park, JK; Sung, SW; Yoo, IR | 1 |
| Bucella, D; Buxant, F; Charaf, G; Crener, K; De Cuypere, M; Duch, J; Fastrez, M; Gebhart, G; Gennigens, C; Goffin, F; Hustinx, R; Jouret, M; Kridelka, F; Lovinfosse, P; Luyckx, M; Rovira, R; Squifflet, JL | 1 |
| Bastien, C; Campitiello, M; Gehin, W; Hennequin, L; Jaud, C; Longo, R; Plastino, F; Rozzi, A | 1 |
| Asch, DA; Goldenberg, D; Holsinger, FC; Lohia, S; Mitra, N; Myssiorek, D; Pou, AM; Roman, BR; Shea, JA; Wang, MB | 1 |
| Chen, KN | 1 |
| Harada, H; Hirai, H; Kugimoto, T; Kurabayashi, T; Kuroshima, T; Mochizuki, Y; Nakamura, S; Ohsako, T; Shimamoto, H; Tomioka, H; Tsushima, F | 1 |
| Fei, J; Guo, C; Niu, L; Wang, D; Zhang, J; Zheng, D | 1 |
| An, D; Cao, Q; Li, B; Li, Y; Li, Z; Lin, Q | 1 |
| Dong, A; Dong, H; Zhou, W | 1 |
| Andreu-Arasa, VC; Fujima, N; Meibom, SK; Mercier, GA; Sakai, O; Truong, MT | 1 |
| Chen, X; Chen, Y; Dang, H; Hou, B; Jin, Z; Shi, X; Xing, H; Xue, H; Zhang, Z; Zhu, X | 1 |
| Admard, J; Breuer, T; Clasen, K; Gatidis, S; Hilke, FJ; la Fougère, C; Leibfarth, S; Nann, D; Nikolaou, K; Ossowski, S; Riess, O; Schroeder, C; Thorwarth, D; Welz, S; Winter, RM; Zips, D | 1 |
| Aoki, S; Araya, M; Komiyama, T; Kuriyama, K; Maehata, Y; Marino, K; Matsumoto, Y; Miyakawa, A; Miyawaki, D; Nishimura, Y; Nonaka, H; Onishi, H; Saito, M; Saito, R; Sano, N; Sasaki, R; Shibamoto, Y; Shioyama, Y; Suzuki, G; Tominaga, L; Yamada, S | 1 |
| Ishikura, S; Kondo, T; Miyakawa, A; Murai, T; Ozawa, Y; Shibamoto, Y; Sugie, C; Yanagi, T | 1 |
| Arshad, H; Bogart, JA; Chowdhry, V; Degraaf, L; Farrugia, M; Gupta, V; Hahn, SS; Hicks, WL; Iovoli, A; Lacombe, MA; Mix, M; Platek, A; Platek, ME; Singh, AK; Wooten, K | 1 |
| Li, W; Li, X; Xia, Z | 1 |
| Li, W; Meng, Z | 1 |
| Appelt, A; Brown, P; Scarsbrook, A; Sebag-Montefiore, D | 1 |
| Barney, CL; Bhatt, A; Blakaj, D; Diavolitsis, V; Eckstein, JM; Gamez, M; Grecula, JC; Healy, E; Jain, A; McElroy, JP; Miller, E; Mitchell, DL; Nolan, N; Washington, I; Wobb, JL; Wright, CL | 1 |
| Campbell, F; Crosbie, R; Easton, F; Grose, D; James, A; Lamb, C; McLoone, P; Paterson, C; Poon, WY; Rizwanullah, M; Schipani, S; Thomson, M; Wilson, C | 1 |
| Boura, J; LeRose, CC; Ramirez, CA | 1 |
| Beriwal, S; Moon, CH; Nguyen, NC | 1 |
| Baba, H; Baba, Y; Harada, K; Horinouchi, T; Iwagami, S; Iwatsuki, M; Miyamoto, Y; Nagai, Y; Shiraishi, S; Sonoda, A; Tokunaga, R; Yoshida, N | 1 |
| Boellaard, R; Castelijns, JA; de Bree, R; de Graaf, P; Koopman, T; Leemans, CR; Martens, RM; Noij, DP; Vergeer, MR; Zwezerijnen, G | 1 |
| Bollam, R; Kousik, V; Krishna, G; Milap, M; Prasad, RK | 1 |
| Auerbach, MS; Calais, J; Czernin, J; French, SW; Girgis, MD; Hayrapetian, A; Schelbert, HR; Yanagawa, J | 1 |
| Bagni, O; Filippi, L; Fontana, A; Rossi, L; Spinelli, GP | 1 |
| Chakravorty, N; Chatterjee, S; Ghosh, S; Mallick, I; Maulik, S; Mukherjee, J | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Heo, HJ; Jun, S; Kang, J; Kim, BS; Kim, GH; Kim, H; Kim, YH; Pak, K | 1 |
| Eguchi, H; Fukusumi, T; Horie, M; Inohara, H; Isohashi, F; Komukai, S; Ogawa, K; Suzuki, M; Takai, E; Takemoto, N; Tanaka, H; Tatsumi, M; Yachida, S | 1 |
| Ge, H; Liu, S; Pan, H; Song, S; Wang, C; Xia, L; Yang, Z; Zhou, Z | 1 |
| Brown, P; Currie, S; Frood, R; McDermott, G; Nelstrop, H; Prestwich, R; Scarsbrook, AF; Vaidyanathan, S; Zhong, J | 1 |
| Guo, H; Li, W; Meng, Z; Zhou, H | 1 |
| Cheng, J; Qi, M; Ren, C; Song, S; Sun, Y; Zhang, J; Zhang, Y | 1 |
| Chicco, A; Cong, E; Ho Shon, I; Lee, MT; Lin, M; Lin, P; Oar, AJ; Yap, J | 1 |
| Bradford, C; Casper, KA; Chapman, CH; Chinn, SB; Chotchutipan, T; Eisbruch, A; Ibrahim, M; Malloy, KM; McLean, SA; Mierzwa, ML; Miller, JE; Prince, MEP; Rosen, BS; Rosko, AJ; Schonewolf, CA; Shah, JL; Shuman, AG; Spector, ME; Stucken, CL; Sun, Y; Swiecicki, PL; Wilkie, JR; Worden, FP | 1 |
| Abecasis, N; Brandão, F; Cabral, F; Casaca, R; Cruz, A; Fonseca, R; Monteiro, C; Pedro, C; Pinto, I; Ramos, P; Ratão, P; Salgado, L | 1 |
| Bohr, C; Grosse, J; Hackenberg, B; Hautmann, MG; Jung, EM; Künzel, J; Mehanna, H; Michaelides, I; Rennert, J; Seebauer, CT; Ugele, I | 1 |
| Ishibashi, K; Kato, I; Kimura, M; Nagao, T; Sone, Y; Umemura, M | 1 |
| Gani, C; Gatidis, S; la Fougère, C; Nikolaou, K; Pfannenberg, C; Reinert, CP; Sekler, J | 1 |
| Albrecht-Beste, E; Alslev, L; Bjerggaard Jensen, J; Bouchelouche, K; Cardoso Costa, J; Frahm Nielsen, T; Grønkaer Toft, B; Høyer, S; Ipsen, P; Jakobsen, JK; Predbjørn Krarup, K | 1 |
| Chen, B; Gao, S; Ji, B; Liu, D; Wang, X; Zhang, H | 1 |
| Chargari, C; Deandreis, D; Genestie, C; Gouy, S; Grimaldi, S; Ilenko, A; Leary, A; Maulard, A; Morice, P; Pautier, P; Seebacher, V; Terroir, M | 1 |
| Hara, A; Kato, H; Kawaguchi, M; Matsuo, M; Matsuyama, K; Miyazaki, T; Seishima, M; Suzui, N; Tomita, H | 1 |
| Bommakanti, K; Coffey, C | 1 |
| Arora, S; Bhoriwal, S; Das, P; Deo, S; Kumar, N; Kumar, R; Kumar, S; Pramanik, R; Sharma, A | 1 |
| Benali, K; Delabie, P; Evrard, D; Ou, P; Piekarski, E; Rouzet, F; Zouhry, I | 1 |
| Furukawa, M; Hanai, N; Sato, Y; Shimode, Y; Terada, H | 1 |
| Song, T; Sun, J; Wang, J; Zhao, B | 1 |
| Ohta, K; Yoshimura, H | 1 |
| Chen, CC; Chuang, CY; Li, C; Lin, JW; Yeh, HL | 1 |
| Fan, Q; Su, M; Tian, R; Wang, R | 1 |
| Marcus, C; Subramaniam, RM | 1 |
| Fujimoto, K; Hoshikawa, H; Ihara-Nishishita, A; Kobata, T; Kudomi, N; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Yamamoto, Y | 1 |
| Balogh, P; Jan, H; Kastler, A; Miquel, ME; Nowosinska, E; Parsai, A; Subhan, S; Thaha, M; Zerizer, I | 1 |
| Dong, A; Gao, J; Wang, Y; Zhang, J | 1 |
| Chen, H; Hao, B; Meng, T; Pang, Y; Shang, Q | 1 |
| Fujita, H; Imai, K; Kemuriyama, K; Maeda, E; Minamiya, Y; Motoyama, S; Nagaki, Y; Sasaki, Y; Sato, Y; Wakita, A | 1 |
| Agazzi, GM; Albano, D; Bertagna, F; Bosio, P; Farina, D; Giubbini, R; Grammatica, A; Lancini, D; Maroldi, R; Nicolai, P; Piazza, C; Ravanelli, M; Squassina, G; Zigliani, A | 1 |
| Guo, CB; Liu, XJ; Peng, X; Yu, GY; Yu, Y; Zhang, WB | 1 |
| Dijkema, T; Doornaert, PA; Hoebers, FJ; Kaanders, JH; Kreike, B; Kunze-Busch, MC; Oyen, WJ; Raaijmakers, CP; Terhaard, CH; van den Bosch, S; Vergeer, MR; Wijers, OB | 1 |
| de Patoul, N; Denis, JM; Differding, S; Grégoire, V; Hermand, N; Lee, JA; Nuyts, S; Sterpin, E; Vanstraelen, B | 1 |
| Fang, N; Liu, LL; Wang, YL; Wu, ZJ; Zeng, L | 1 |
| Al-Mamgani, A; de Boer, J; de Ridder, M; Hamming-Vrieze, O; Jasperse, B; Klop, M; Smit, L; van den Brekel, M; Vogel, W | 1 |
| Fan, B; Fan, P; Fu, Z; Hu, M; Kong, L; Ma, L; Sun, X; Wang, S; Yu, J; Zhao, S; Zheng, J | 1 |
| Alongi, P; Broggi, S; Dell Oca, I; Di Muzio, NG; Fallanca, F; Fiorino, C; Gianolli, L; Incerti, E; Kirienko, M; Mapelli, P; Picchio, M; Vanoli, EG | 1 |
| Abe, O; Nakagawa, K; Yamashita, H | 1 |
| Kakugawa, Y; Matsuda, T; Saito, Y; Sekiguchi, M; Shimada, N; Terauchi, T | 1 |
| Grosu, HB; Kalhor, N; Miller, R; Mudambi, L; Vial, MR | 1 |
| Bol, A; Di Perri, D; Geets, X; Hanin, FX; Janssens, G; Labar, D; Lee, JA; Robert, A; Sterpin, E | 1 |
| Castelijns, JA; de Bree, R; de Graaf, P; de Jong, MC; Hoekstra, OS; Jagesar, VA; Noij, DP | 1 |
| Bilbao, P; Cacicedo, J; de Zarate, RO; Del Hoyo, O; Escudero, J; Fernandez, I; Gomez-Iturriaga, A; Gomez-Suarez, J; Martinez-Indart, L; Navarro, A; Perez, JF; Pijoan, JI; Rades, D | 1 |
| Abe, H; Ahn, JM; Chen, M; Choe, JH; Choi, H; Endo, H; Goodwin, J; Helke, KL; Inoue, M; Jenkins, DMR; Jeong, JY; Kim, JW; Lee, SY; Minna, JD; Neugent, ML; Robinson, MW; Ruthenborg, RJ; Shackelford, DB; Singh, PK; Takeda, N; Wake, M; Xuan, Z; Yoo, H | 1 |
| Chang, YC; Chao, YK; Hou, MM; Hsieh, CE; Hsieh, CH; Hung, TM; Lin, CR; Pai, PC; Su, PJ; Tseng, CK; Wu, YY; Yang, CK; Yap, WK | 1 |
| Hiroshima, K; Kamata, T; Kou, E; Masunaga, A; Oide, T; Sekine, Y | 1 |
| Abraham, T; Bello, JA; Cho, JK; Gulko, E; Lee, AY; Lin, J; Moadel, RM; Neimark, M; Ow, TJ; Schiff, BA; Schlecht, NF; Shifteh, K; Smith, RV; Tassler, AB; Ustun, B; Valdivia, A | 1 |
| Kitajima, K; Komori, T; Minamikawa, T; Nibu, KI; Sasaki, R; Takahashi, Y; Yonezawa, N | 1 |
| Ehrenfeld, M; Müller-Lisse, U; Obermeier, K; Otto, S; Probst, FA; Probst, M; Rominger, A; Troeltzsch, M | 1 |
| Aktas, Z; Demirag, F; Ozturk, A; Tari, P; Yilmaz, A | 1 |
| Bernd, K; Gasparri, ML; Genoud, S; Mueller, MD; Papadia, A | 1 |
| Doki, Y; Hatazawa, J; Makino, T; Mori, M; Takiguchi, S; Tanaka, K; Tatsumi, M; Yamasaki, M | 1 |
| Kan, Y; Wang, W; Yang, J; Yuan, L | 1 |
| Goel, R; Khan, S; Moore, W; Sher, D; Subramaniam, RM; Sumer, B | 1 |
| Asaka, T; Hirata, K; Kitagawa, Y; Kuge, Y; Ohga, N; Okamoto, S; Sato, J; Shiga, T; Shindoh, M; Tamaki, N; Watanabe, S | 1 |
| Carp, L; Helsen, N; Roothans, D; Stroobants, S; Van Den Heuvel, B; Van den Weyngaert, D; Van den Wyngaert, T | 1 |
| Becker, CD; Becker, M; Burkhardt, K; Caparrotti, F; Combescure, C; Delattre, BMA; Dulguerov, N; Dulguerov, P; Katirtzidou, E; Pusztaszeri, M; Rager, O; Ratib, O; Varoquaux, AD; Zaidi, H | 1 |
| de Bree, R; de Keizer, B; Ferlito, A; Forastiere, AA; Haigentz, M; Hartl, DM; Nixon, IJ; Rinaldo, A; Rodrigo, JP; Saba, NF; Suárez, C; Vermorken, JB; Wolf, GT | 1 |
| Bogowicz, M; Guckenberger, M; Riesterer, O; Stark, LS; Studer, G; Tanadini-Lang, S; Unkelbach, J | 1 |
| Berwouts, D; Bonte, K; Boterberg, T; De Neve, W; Deron, P; Duprez, F; Goethals, I; Huvenne, W; Madani, I; Olteanu, AL; Vercauteren, T | 1 |
| Belderbos, JSA; Das, M; De Ruysscher, D; Even, AJG; Jochems, A; La Fontaine, MD; Lambin, P; Mottaghy, FM; Reymen, B; van Elmpt, W | 1 |
| Carp, L; De Bree, R; Debruyne, PR; Hakim, S; Helsen, N; Hoekstra, OS; Hutsebaut, I; Lenssen, O; Maes, ALM; Martens, MJ; Meersschout, SAE; Stroobants, S; Van den Weyngaert, D; Van den Wyngaert, T; van Dinther, J; Van Laer, CG; Vermorken, JB | 1 |
| Bukawa, H; Hasegawa, S; Ishibashi-Kanno, N; Uchida, F; Yamagata, K; Yanagawa, T | 1 |
| Goel, R; Subramaniam, RM; Wachsmann, JW | 1 |
| Dong, A; Wang, Y; Yang, B; Zhao, Q; Zuo, C | 1 |
| Dong, X; Duan, Q; Jiang, R; Shen, Y; Xue, Y; Zhang, G; Zhu, W | 1 |
| Khan, S; Son, H | 1 |
| Chen, L; Fu, C; Li, A; Tan, Z; Xu, X | 1 |
| Imai, K; Kawakita, Y; Konno, H; Liu, J; Minamiya, Y; Mizusawa, KT; Motoyama, S; Nagaki, Y; Saito, H; Sasaki, T; Sato, Y; Wakita, A | 1 |
| Choi, YJ; Jang, JY; Ki, YK; Kim, H; Kim, IJ; Kim, SJ; Kim, WT; Pak, KJ; Seol, YM; Wang, SG; Yi, KI | 1 |
| Asaka, T; Hirata, K; Kitagawa, Y; Ohga, N; Sato, J; Satoh, A; Shiga, T; Tamaki, N; Watanabe, S | 1 |
| Inoue, T; Kaneta, T; Kobayashi, T; Kubota, A; Miyagi, Y; Mizoguchi, N; Narimatsu, H; Nonaka, T; Suzuki-Shibata, S; Yamamoto, Y; Yoshida, T | 1 |
| Aleman, BMP; Grootscholten, C; Lalezari, F; Steinberg, JD; van Dieren, JM; van Sandick, JW; Vegt, E; Voncken, FEM | 1 |
| Antonucci, MU; Day, TA; Hansen, RM | 1 |
| Ammari, S; Bidault, F; Dercle, L; Hartl, D; Mokrane, FZ; Rozenblum-Beddok, L; Seban, RD; Yeh, R | 1 |
| Arcadipane, F; Fiandra, C; Franco, P; Giglioli, FR; Ragona, R; Ricardi, U; Trino, E | 1 |
| Bogowicz, M; Guckenberger, M; Konukoglu, E; Lambin, P; Leijenaar, RTH; Pruschy, M; Riesterer, O; Studer, G; Tanadini-Lang, S; Unkelbach, J | 1 |
| Asmussen, JT; Bjørndal, K; Diaz, A; Døssing, H; Gerke, O; Godballe, C; Gyldenkerne, N; Høilund-Carlsen, PF; Johansen, J; Nielsen, AL; Rohde, M; Sørensen, JA; Thomassen, A | 1 |
| Bhide, SA; Dunlop, A; Harrington, KJ; Koh, DM; Leach, MO; Mcquaid, D; Murray, I; Newbold, KL; Nutting, CM; Oyen, WJ; Panek, R; Riddell, A; Welsh, LC; Wong, KH | 1 |
| Asamoah, P; Gross, M; Viglianti, BL; Wale, DJ; Wong, KK | 1 |
| Grégoire, V; Lee, JA; Thorwarth, D | 1 |
| Chen, M; Chen, X; Rong, L; Sun, Q; Sun, Y; Wu, Q; Xu, H; Zhu, D | 1 |
| Chang, YC; Chao, YK; Chen, CC; Hsieh, CH; Hung, TM; Shih, MC; Yap, WK | 1 |
| Cuna, E; Eickhoff, J; Jeraj, R; Perlman, S; Scarpelli, M | 1 |
| Chen, Y; Huang, Z; Qi, C; Xia, Y; Zhang, S | 1 |
| Bockisch, A; Herrmann, K; Hoffmann, TK; Nagarajah, J; Poeppel, TD; Ruhlmann, V; Sauerwein, W; Umutlu, L; Veit, J | 1 |
| Bradley, KM; Dwivedi, K; Prabhu, IS | 1 |
| Chen, RY; Chen, SW; Hsieh, TC; Kao, CH; Lin, YC; Shen, WC; Yen, KY | 1 |
| Anderson, C; Bayon, R; Buatti, J; Clamon, G; Ginader, T; Hoover, A; Marquardt, M; Pagedar, N; Parkhurst, J | 1 |
| Ellmann, A; Morkel, M; Simonds, H; Warwick, J | 1 |
| Ge, D; Gu, J; He, J; Huang, Y; Jin, X; Lu, C; Shi, S; Xu, F; Ye, L; Zeng, Z | 1 |
| Cayci, Z; Khaja, S; Li, F; Ozturk, K; Rischall, M; Ustun, C | 1 |
| Hyun, SH; Koh, YW; Lee, SJ; Park, SY | 1 |
| Luo, R; Shi, H; Xiu, Y; Yin, H; Zhang, H | 1 |
| Chang, YC; Chao, A; Chou, HH; Lai, CH; Liu, FY; Su, TP; Wang, CC; Yen, TC | 1 |
| Carp, L; Helsen, N; Stroobants, S; Van den Wyngaert, T | 1 |
| Chang, JT; Cheng, NM; Fang, YD; Lee, LY; Liao, CT; Ng, SH; Tsan, DL; Wang, HM; Yang, LY; Yen, TC | 1 |
| Bires, P; Lederleitner, D; Masarykova, A; Pobijakova, M; Povinec, P; Scepanovic, D | 1 |
| Berwouts, D; De Gersem, W; De Kerf, G; De Neve, W; De Ost, B; Duprez, F; Goethals, I; Olteanu, AML; Rottey, S; Schatteman, J; Van Gestel, D; Vercauteren, T | 1 |
| Gatidis, S; la Fougère, C; Nikolaou, K; Schmidt, H; Schwenzer, NF; Thorwarth, D; Weiss, J; Welz, S; Winter, RM; Zips, D; Zwirner, K | 1 |
| Alshehri, S; Gantet, P; Herbault-Barres, B; Hitzel, A; Julian, A; Lopez, R; Payoux, P | 1 |
| Bourhis, J; Castelli, J; Depeursinge, A; Herrera, FG; Ozsahin, M; Prior, JO; Scher, N | 1 |
| Arisaka, Y; Asao, T; Bao, P; Erkhem-Ochir, B; Higuchi, T; Kaira, K; Kasahara, N; Kosaka, T; Kuwano, H; Mogi, A; Nishiyama, M; Ohtaki, Y; Oyama, T; Shimizu, K; Sunaga, N; Tsushima, Y; Yajima, T; Yokobori, T | 1 |
| Asai, S; Fujioka, T; Harada, H; Michi, Y; Nakamura, S; Tateishi, U; Toriihara, A; Yamaga, E; Yoshimura, R | 1 |
| Aymar, N; Gimenez, M; Jimenez-Jimenez, E; Mateos, P; Ortiz, I; Pardo, J; Roncero, R; Sabater, S; Salinas, J | 1 |
| Chin, AL; Diehn, M; Gensheimer, MF; Guo, HH; Kumar, KA; Loo, BW; Maxim, PG; Neal, JW; Wakelee, H | 1 |
| Choi, JW; Han, M; Kim, SY; Lee, D; Lee, SJ | 1 |
| Doi, H; Fujita, M; Fujiwara, M; Katsuura, T; Kitajima, K; Noguchi, K; Tamaki, Y; Terada, T; Tsuchitani, T; Uwa, N; Yamakado, K; Yoshida, R | 1 |
| Feingold, D; Gaertner, WB; Glasgow, SC; Herzig, DO; Steele, SR; Stewart, DB | 1 |
| Pal, R; Qiu, S; Vargas, G; Villarreal, P | 1 |
| Ahn, BC; Chong, GO; Hong, CM; Jeong, JH; Jeong, SY; Lee, CH; Lee, J; Lee, SW; Lee, YH; Park, SH; Son, SH | 1 |
| Adkins, DR; Chin, RI; Dehdashti, F; DeWees, TA; Floberg, JM; Garsa, AA; Gay, HA; Nussenbaum, B; Oppelt, PJ; Thorstad, WL | 1 |
| Cui, C; Feng, W; Guo, X; Huang, J; Li, X; Liang, Z; Liu, M; Ma, Y; Wu, Z; Zhang, F | 1 |
| de Bree, R; de Keizer, B | 1 |
| Behzadi, B; Doroudinia, A; Karam, MB; Koma, AY; Mehrian, P | 1 |
| Drew, ZJ | 1 |
| Chen, C; Cui, F; Su, M; Tian, R | 1 |
| Abele, J; Biron, V; Cooper, T; Harris, J; Isaac, A; O' Connell, DA; Puttagunta, L; Seikaly, H; Sivarajah, S; Zhang, H | 1 |
| Jun, S; Park, JG; Seo, Y | 1 |
| Ankrah, AO; Kaoma, CA; Lawal, IO; Maes, A; Mokgoro, NP; Mokoala, KMG; Popoola, GO; Sathekge, MM; Van de Wiele, C | 1 |
| Brismar, TB; Herlin, G; Lundell, L; Nilsson, M; Rouvelas, I; Zhang, YH | 1 |
| Huss, S; Rahbar, K; Schülke, C; Stegger, L; Wenning, C | 1 |
| Moreno, AJ; Wang, B | 1 |
| Biddinger, P; Figueroa, R; Groves, MW; Pucar, D; Williams, HT | 1 |
| Guo, Q; Li, B; Sun, H; Wang, X; Zhang, S | 1 |
| Higashiyama, S; Hosono, M; Iguchi, H; Kawabe, J; Miki, Y; Oishi, M; Okazaki, E; Shiomi, S; Teranishi, Y | 1 |
| Chotchutipan, T; Eisbruch, A; El Naqa, I; Hawkins, PG; Lee, JY; Mierzwa, ML; Rosen, BS; Saripalli, AL; Thakkar, D | 1 |
| Huber, GF; Huellner, MW; Meerwein, CM; Morand, GB; Pizzuto, DA; Stolzmann, P; Vital, D | 1 |
| Eisele, DW; Fakhry, C; Gourin, CG; Motz, KM; Mydlarz, WK; Quon, H; Rooper, LM; Ryan, JF; Tan, M | 1 |
| Aznar, MC; Chu, KY; Cooke, R; Hawkins, MA; Jacobs, C; Muirhead, R; Ng, SM; Sabbagh, A; Strauss, VY; Virdee, PS | 1 |
| Çermik, TF; Dağ, S; Ergul, N; Yilmaz, B | 1 |
| Doi, H; Fujiwara, M; Ishikura, R; Kamikonya, N; Kitajima, K; Noguchi, K; Tanooka, M; Terada, T; Yamakado, K | 1 |
| Chen, CJ; Chiu, NT; Ho, KW; Hsu, CC; Huang, YC; Li, SH; Lin, WC; Lu, HI; Wang, YM | 1 |
| Dabbagh, VR; Harsini, S; Qodsi Rad, MA; Sadeghi, R; Treglia, G | 1 |
| Cattan, P; Costantini, A; Hammoudi, N; Hennequin, C; Quéro, L; Valverde, A; Vercellino, L | 1 |
| Aoki, Y; Emi, M; Furukawa, T; Hamai, Y; Hihara, J; Ibuki, Y; Murakami, Y; Nagata, Y; Nishibuchi, I; Okada, M | 1 |
| Chen, PY; Chen, S; Chinnaiyan, P; Krauss, DJ; Wilson, GD; Yan, D | 1 |
| Brotherston, D; Caldwell, CB; Conrad, T; Karam, I; Kiss, A; Le, T; Lee, J; Mendez, LC; Poon, I; Smith, B | 1 |
| Andriana, P; Higuchi, T; Hirasawa, H; Kim, M; Kurihara, J; Nakajima, T; Tokue, A; Tsushima, Y; Yokoo, S | 1 |
| Guren, MG; Hernes, E; Klotz, D; Malinen, E; Rekstad, BL; Rusten, E; Undseth, C | 1 |
| Flavell, RR; Ha, P; Raghavan, K; Small, EJ; Wen, KW | 1 |
| Ishikawa, Y; Jingu, K; Kadoya, N; Matsushita, H; Takahashi, N; Takeda, K; Umezawa, R; Yamamoto, T | 1 |
| Koh, YW; Lee, D; Lee, SJ | 1 |
| Handra-Luca, A | 1 |
| Abgral, R; Bourhis, D; Corre, JB; Delcroix, O; Gobel, Y; Guezennec, C; Orlhac, F; Robin, P; Salaün, PY; Schick, U | 1 |
| Bone, TM; Byrd, JK; Groves, MW; Leto, CJ; Liebman, RM; Sharbel, D; Wang, CW | 1 |
| Omami, G | 1 |
| Bauer, C; Beichel, RR; Brown, B; Buatti, JM; Casavant, T; Graham, MM; Smith, BJ; Sunderland, JJ; Ulrich, EJ | 1 |
| Liu, Y | 1 |
| Doll, C; Duimering, A; Fairchild, A; Ghosh, S; Joseph, K; MacEwan, R; Mulder, K; Nijjar, T; Nijjar, Y; Riauka, T; Schiller, D; Severin, D; Tankel, K; Usmani, N; Warkentin, H; Wong, C | 1 |
| Barker, CA; Mahajan, S; Pandit-Taskar, N; Singh, B | 1 |
| Nguyen, BD; Ocal, TI; Seetharam, M | 1 |
| Anbai, A; Hashimoto, M; Hatakeyama, K; Kumagai, S; Okuyama, E; Takagi, N; Wada, Y | 1 |
| Eyck, BM; Lagarde, SM; Nieboer, D; Noordman, BJ; Onstenk, BD; Spaander, MCW; Valkema, R; van Lanschot, JJB; Wijnhoven, BPL | 1 |
| Burzyńska-Śliwowska, J; Gugnacki, P; Jurgilewicz, DH; Mojsak, M; Samołyk-Kogaczewska, N; Sierko, E; Szczecina, K; Szumowski, P; Wojtukiewicz, MZ; Zuzda, K | 1 |
| Ahn, BC; Chong, GO; Hong, CM; Jeong, JH; Jeong, SY; Lee, J; Lee, SW; Lee, YH; Park, SH | 1 |
| Bellefqih, S; Dejust, S; El Farsaoui, K; Lalire, P; Morland, D | 1 |
| Aerts, J; Biesma, B; Dingemans, AC; Groen, HJM; Hoekstra, O; Klinkenberg, TJ; Kloosterziel, C; Pieterman, R; Schramel, FMNH; Smit, EF; Smit, HJM; van den Borne, B; van der Heijden, EHFM; van der Noort, V; van Tinteren, H; Verhagen, A | 1 |
| Cheon, M; Choi, JY; Hyun, SH; Kim, H; Kim, J; Lee, KS; Shim, YM; Yoo, J; Zo, JI | 1 |
| Fatima, N; Tahseen, R; Zaman, A; Zaman, MU; Zaman, S; Zaman, U | 1 |
| Haga, N; Inoue, S; Ito, K; Kasai, Y; Kume, S; Masuya, D; Miyoshi, K; Monden, K; Okada, N; Ootsuka, K; Suzuki, Y; Takata, N; Tanaka, Y | 1 |
| Capp, A; Gallagher, S; Holder, C; Hruby, G; Jones, MP; Kumar, M; Martin, J; Metser, U; Oldmeadow, C; Rutherford, N; Sridharan, S | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Huber, GF; Kastrinidis, N; Kuhn, FP | 1 |
| Becker, CD; Becker, M; Dulguerov, P; Lovblad, KO; Masterson, K; Rager, O; Ratib, O; Varoquaux, A | 1 |
| Achmad, A; Arisaka, Y; Higuchi, T; Kim, M; Miyashita, G; Miyazaki, H; Negishi, A; Tokue, A; Tominaga, H; Tsushima, Y; Yokoo, S | 1 |
| Cheng, CY; Ho, CL; Huang, WS; Lin, YH; Su, TF | 1 |
| Cho, KJ; Joo, YH; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 3 |
| Grigsby, PW; Mutch, DG; Powell, MA; Schwarz, JK; Zighelboim, I | 1 |
| Abgral, R; Le Roux, PY; Marianowski, R; Nowak, E; Querellou, S; Rousset, J; Salaün, PY; Tissot, V; Turzo, A; Valette, G | 1 |
| Achong, DM | 1 |
| Alafate, A; Fujiwara, T; Gobara, H; Hiraki, T; Ishii, H; Kaji, M; Kanazawa, S; Kato, K; Miyoshi, S; Okumura, Y; Sato, S; Shinya, T | 1 |
| Habu, M; Kaneuji, T; Kitamura, C; Kito, S; Kodama, M; Koga, H; Kokuryo, S; Matsumoto-Takeda, S; Matsuo, K; Miyamoto, I; Morimoto, Y; Nishino, T; Nogami, S; Oda, M; Seta, Y; Tanaka, T; Tominaga, K; Wakasugi-Sato, N; Yamamoto, N; Yamashita, Y; Yoshiga, D; Yoshioka, I; Zhang, M | 1 |
| Fujikawa, A; Kosuda, S; Kyoto, Y; Nakamori, T; Nakamori, Y; Naoi, Y | 1 |
| Bussu, F; Castaldi, P; Leccisotti, L; Miccichè, F; Rufini, V | 1 |
| Hanai, N; Hasegawa, Y; Hirakawa, H; Hosoi, H; Kawakita, D; Masui, T; Nishio, M; Ozawa, T; Terada, A | 1 |
| de Bree, R; Ferlito, A; Rinaldo, A; Takes, RP; Zbären, P | 1 |
| Cappoen, N; Duprez, T; Gillain, A; Hamoir, M; Hanin, FX; Lhommel, R; Lonneux, M; Machiels, JP; Magremanne, M; Michoux, N; Reychler, H; Rommel, D; Schmitz, S; Weynand, B | 1 |
| Bardet, S; Benyoucef, A; Bridji, B; Di Fiore, F; Diana, C; Faure, G; Houzard, C; Itti, E; Jalali, K; M'vondo, CM; Ménard, JF; Meyer, ME; Michel, P; Mornex, F; Olivier, P; Palie, O; Rio, E; Rousseau, C; Vera, P | 1 |
| Hayashi, T; Ishii, T; Kikuchi, T; Kobayashi, Y; Minami, T; Nishimoto, M; Nozawa, M; Shimizu, N; Tsuji, H; Uemura, H; Yamamoto, Y; Yoshimura, K | 1 |
| Chen, EC; Jiang, W; Li, MH; Liu, P; Ma, JB; Song, YP; Yu, JM | 1 |
| Corral, C; de Guevara, DL; Fariña, C; Fuentes, A; Pefaur, R | 1 |
| Perez-Bouza, A; Rauch, M; Strunk, H | 1 |
| Kraft, SL; LaRue, SM; Randall, EK; Yoshikawa, H | 1 |
| Agrawal, A; Karapinar, U; Naiboglu, B; Ozer, E; Ozer, HG; Schuller, DE | 1 |
| Guler, OC; Onal, C; Oymak, E; Parlak, C; Reyhan, M | 1 |
| Higuchi, T; Kaira, K; Kanai, Y; Kim, M; Miyashita, G; Negishi, A; Nobusawa, A; Oriuchi, N; Oyama, T; Tsushima, Y; Yokoo, S | 1 |
| Chen, L; Chen, M; Li, X; Ma, H; Sun, X; Xie, P; Xing, L; Xu, W; Xu, X; Yu, J; Zhang, H; Zhang, L | 1 |
| Allen, C; Anayama, T; Driscoll, B; Dunne, M; Jaffray, D; Keshavjee, S; Nakajima, T; Vines, D; Yasufuku, K; Zheng, J | 1 |
| Dong, A; Lu, J; Wang, Y; Zuo, C | 1 |
| Antke, C; Antoch, G; Boeck, I; Buchbender, C; Handschel, J; Heusch, P; Heusner, TA; Macht, S; Rieser, E; Scherer, A; Sproll, C; Terjung, J | 1 |
| Adams, G; Burmeister, B; Foote, M; Panizza, B; Porceddu, SV; Pryor, DI; Rowan, A | 1 |
| Zafereo, ME | 1 |
| Ganeshan, D; Hanlon, R; Lewis-Jones, H; Prowse, PM; Prowse, SJ; Shaw, R; Wieshmann, H | 1 |
| Farjah, F; Lou, F; Rizk, NP; Rusch, VW; Sima, C | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 2 |
| Chan, SC; Chang, JT; Huang, SF; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Lupinacci, RM; Menegaux, F; Simon, JM; Spano, JP | 1 |
| de Wet, C; Deonarine, P; Han, S; Poon, FW | 1 |
| Busk, M; Horsman, MR; Iversen, AB; Jakobsen, S; Ji, X; Lee, DY; Mortensen, LS; Nordsmark, M; Overgaard, J; Raleigh, JR | 1 |
| Hanamoto, A; Hatazawa, J; Inohara, H; Nakahara, S; Shimosegawa, E; Takenaka, Y; Ymamamoto, Y; Yoshii, T | 1 |
| Alber, M; Kaanders, JH; Mönnich, D; Oyen, WJ; Thorwarth, D; Troost, EG; Zips, D | 1 |
| Chang, CY; Lin, KH; Liu, RS; Shih, WJ; Wang, SJ; Yang, BH | 1 |
| Afify, AM; Farwell, DG; Ferrara, KW; Haynam, EM; Mahakian, LM; Poirier, B; Seo, JW; Shaye, D; Tinling, SP; Zhang, H | 1 |
| Doki, Y; Kurokawa, Y; Miyata, H; Mori, M; Murakami, K; Nakajima, K; Takahashi, T; Takiguchi, S; Yamasaki, M | 1 |
| Chang, JT; Cheng, NM; Fang, YH; Huang, CG; Liao, CT; Lin, CY; Ng, SH; Tsan, DL; Wang, HM; Yen, TC | 1 |
| Choi, JY; Huh, SJ; Kim, BT; Lee, JE; Nam, H; Oh, D; Park, W | 1 |
| Hosokawa, M; Itoh, K; Kikkawa, T; Kinoshita, Y; Kusumi, T; Nishida, Y; Sakashita, K; Sasaki, S; Takenouchi, T; Uemura, S; Yamada, H | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Nam, SY; Roh, JL; Ryu, IS | 1 |
| Ekmekcioglu, O; Elicin, O; Halac, M; Uzel, EK; Uzel, OE | 1 |
| Becker, CD; Becker, M; Delattre, BM; Dulguerov, N; Dulguerov, P; Poncet, A; Rager, O; Ratib, O; Varoquaux, A; Zaidi, H | 1 |
| Behrendt, FF; Gray, BD; Kiessling, F; Lederle, W; Mottaghy, FM; Pak, KY; Palmowski, K; Palmowski, M; Rix, A | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, JW; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 2 |
| Alluri, KC; Koch, W; Quon, H; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Bjurberg, M; Brun, E | 1 |
| Chen, W; D'Souza, WD; Kim, G; Kligerman, S; Lu, W; Suntharalingam, M; Tan, S; Zhang, H | 1 |
| Abgral, R; Bourhis, D; Keromnes, N; Le Roux, PY; Marianowski, R; Palard, X; Robin, P; Rousset, J; Salaün, PY; Valette, G | 1 |
| Doki, Y; Hatazawa, J; Miyata, H; Mori, M; Morii, E; Murakami, K; Nakajima, K; Takahashi, T; Takiguchi, S; Tanaka, K; Yamasaki, M; Yukinori, K | 1 |
| Cervino, AR; Chondrogiannis, S; Colletti, PM; Evangelista, L; Maffione, AM; Marzola, MC; Muzzio, PC; Rubello, D | 1 |
| Hida, Y; Hirano, S; Kaga, K; Matsui, Y; Muto, J; Nakada-Kubota, R; Ohtaka, K; Okamoto, S; Shiga, T; Tamaki, N | 1 |
| Kitai, R; Ohba, S; Sano, K; Yoshimura, H | 1 |
| Geiger, GA; Grover, S; Kim, MB; Langer, CJ; Plastaras, JP; Pryma, DA; Rengan, R; Simone, CB; Xanthopoulos, EP | 1 |
| Ho, TY; Lee, LY; Liao, CT; Lin, CY; Tseng, JR; Wang, HM; Yen, TC | 1 |
| Chen, SW; Ding, HJ; Hsieh, TC; Kao, CH; Liang, JA; Lin, CY; Yen, KY | 1 |
| Jeong, Y; Jung, HY; Kim, HR; Kim, JH; Kim, SB; Kim, YH; Lee, GH; Park, SI; Ryu, JS; Yoon, DH | 1 |
| Kessing, R | 1 |
| Chan, SC; Chao, YK; Chen, SH; Yen, TC | 1 |
| Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, H; Zhang, WJ; Zhao, SJ; Zheng, R | 1 |
| Fujishiro, T; Kono, T; Matsubara, H; Ohira, G; Okazumi, S; Shuto, K; Tochigi, T; Tohma, T | 1 |
| Akutsu, Y; Fujishiro, T; Gunji, H; Hanaoka, T; Hoshino, I; Imanishi, S; Kono, T; Matsubara, H; Murakami, K; Narushima, K; Ohira, G; Okazumi, S; Shiratori, T; Shuto, K; Tochigi, T; Tohma, T; Uesato, M | 1 |
| Fukuchi, M; Higuchi, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Sakai, M; Sohda, M; Suzuki, S; Tanaka, N; Tsushima, Y; Yokobori, T | 1 |
| Darling, G; Guindi, M; Knox, J; Metser, U; Moshonov, H; Rashidi, F; Wong, R | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Park, JP; Roh, JL | 1 |
| Fujimoto, Y; Hasegawa, Y; Hiramatsu, M; Itoh, Y; Kato, K; Naganawa, S; Nakashima, T; Suzuki, H | 1 |
| Ball, DL; Binns, DS; Brennan, S; Campeau, MP; Fisher, RJ; Hicks, RJ; Lin, MY; MacManus, M; Solomon, B; Wu, M | 1 |
| Cooley, T; Mercier, G; Subramaniam, RM; Truong, MT; Yu, J | 1 |
| Ela Bella, AJ; Fan, W; Fu, JH; Lin, P; Luo, KJ; Rong, TH; Yang, H; Zhang, YR | 1 |
| Dong, A; Wang, Y; Wen, W; Zhai, Z; Zuo, C | 1 |
| Dai, MM; Li, YM; Lin, Q; Luo, ZM; Sun, L; Wang, LC; Wu, H; Zhao, L; Zheng, H | 1 |
| Hayashida, K; Itoh, K; Kikuchi, M; Koyasu, S; Nakamoto, Y; Suzuki, K; Togashi, K | 1 |
| Aebersold, DM; Cihoric, N; Klaeser, B; Krüger, K; Lössl, K; Tapia, C | 1 |
| Borms, M; Cocquyt, V; D'Asseler, Y; Kruse, V; Maes, A; Mees, G; Van De Wiele, C | 1 |
| Choi, JY; Choi, YS; Hyun, SH; Kim, BT; Kim, HS; Lee, KH; Moon, SH; Shim, YM; Zo, JI | 1 |
| Almquist, H; Brun, E; Kjellén, E; Sjövall, J; Wahlberg, P | 1 |
| Beuthien-Baumann, B; Gudziol, V; Kitzler, HH; Kotzerke, J; Laniado, M; Maus, J; Platzek, I; Popp, M; Schneider, M; Schramm, G; van den Hoff, J | 1 |
| Boerhout, EJ; Castelijns, JA; Comans, EF; de Bree, R; de Graaf, P; Hoekstra, OS; Noij, DP; Oprea-Lager, D; Pieters-van den Bos, IC; Reinhard, R | 1 |
| Ameshima, S; Anzai, M; Araya, T; Demura, Y; Ishizaki, T; Ishizuka, T; Kasahara, K; Matsuoka, H; Morikawa, M; Nishi, K; Nishitsuji, M; Sumida, Y; Tsuchida, T; Umeda, Y | 1 |
| Lu, P; Sun, Y; Yu, L | 2 |
| Aznar, MC; Bentzen, SM; Fischer, BM; Friborg, J; Håkansson, K; Kristensen, CA; Persson, GF; Rasmussen, JH; Specht, L; Vogelius, IR | 1 |
| Baltazart, B; Castetbon, V; de Monès, E; Digue, L; Fernandez, P | 1 |
| Deasy, JO; Jeong, J; Lee, NY; Oh, JH; Setton, JS | 1 |
| Xi, K; Xi, S; Xie, X | 1 |
| Asaka, T; Hata, H; Kitagawa, Y; Kuge, Y; Miyakoshi, M; Okamoto, S; Sato, J; Shiga, T; Shindoh, M; Tamaki, N; Yamazaki, Y | 1 |
| Harada, H; Hino, M; Imai, Y; Itoh, K; Kanazawa, Y; Kikuchi, M; Kishimoto, I; Koyasu, S; Naito, Y; Shinohara, S; Tona, R; Usami, Y | 1 |
| Baba, H; Baba, Y; Ida, S; Ishimoto, T; Iwagami, S; Iwatsuki, M; Miyamoto, Y; Nagai, Y; Sakamoto, Y; Watanabe, M; Yamao, T | 1 |
| Arya, S; Deshmukh, A; Rane, P | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, HS; Nam, SY; Roh, JL | 1 |
| Babacan, NA; Erselcan, T; Hasbek, Z; Kacan, T; Salk, I; Turgut, B; Yucel, B | 1 |
| Groen, H; Hollema, H; Pavlov, K; Plukker, JT; Pruim, J; Pultrum, BB; Schreurs, LM; Smit, JK | 1 |
| Hasegawa, M; Imai, Y; Kirita, T; Kuniyasu, H; Kurihara, M; Sasahira, T; Shimomura, H; Shirone, N; Tamaki, S; Yamakawa, N; Yamanaka, Y | 1 |
| Ciarallo, A; Kang, H; Kiess, AP; Koch, W; Marcus, C; Mena, E; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Abele, J; Allegretto, M; Bedard, E; Hunt, I; Maquire, C; Patel, A; Perry, T | 1 |
| Doki, Y; Fujiwara, Y; Higuchi, I; Miyata, H; Takiguchi, S; Yamasaki, M; Yano, M; Yasuda, T | 1 |
| Hoermann, K; Klohr, S; Li, CY; Sadick, H; Sadick, M; Schoenberg, SO; Weiss, C | 1 |
| An, YS; Jo, KS; Kim, CH; Kwon, SH; Lee, DH; Lee, SJ; Shin, YS; Yoon, JK | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Kim, DH; Lee, J; Lee, SW; Song, BI | 1 |
| Differding, S; Geets, X; Grégoire, V; Janssens, G; Lee, JA; Sterpin, E | 1 |
| Aznar, MC; Bentzen, SM; Berthelsen, AK; Due, AK; Korreman, SS; Kristensen, CA; Loft, A; Specht, L; Vogelius, IR | 1 |
| Cho, KJ; Choi, SH; Hong, HR; Jin, S; Kim, JS; Kim, SY; Koo, HJ; Nam, SY; Roh, JL | 1 |
| Aung, W; Endo, H; Fujibayashi, Y; Furukawa, T; Hasegawa, S; Inoue, M; Jin, ZH; Saga, T; Yoshii, Y; Yuan, Q; Zhang, MR | 1 |
| Amini, B; Jorgensen, JL; Kumar, R; Salem, U; Zhang, L | 1 |
| Cai, L; Chen, Y; Huang, Z; Wu, J | 1 |
| Dyrvig, AK; Gerke, O; Godballe, C; Høilund-Carlsen, PF; Johansen, J; Nielsen, AL; Rohde, M; Sørensen, JA | 1 |
| Di Fiore, F; Dubray, B; Gouel, P; Hapdey, S; Lemarignier, C; Marre, C; Michel, P; Modzelewski, R; Vera, P | 1 |
| Chen, SW; Chien, CR; Hsieh, TC; Kao, CH; Liang, JA; Wang, YC; Yang, SN; Yen, KY | 1 |
| Arias, F; Asín, G; Barrado, M; Caicedo, C; Chicata, V; Eito, C; Errasti, M; García-Bragado, F; García-Velloso, MJ; Hernández, I; Quilez, I; Saenz, J; Uzcanga, M; Viudez, A | 1 |
| Adkins, D; Dehdashti, F; Ley, J; Michel, L; Siegel, BA; Siegel, MJ; Trinkaus, K; Wildes, TM | 1 |
| Cho, KJ; Choi, SH; Kang, BC; Kim, JS; Kim, SB; Kim, SY; Lee, SW; Nam, SY; Roh, JL | 1 |
| Chen, X; Chen, Y; Ji-An, L; Li, F | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Kim, SY; Nam, IC; Park, JO; Yoo, IR | 1 |
| Anelli, V; Covello, R; Kayal, R; Manciocco, V; Marucci, L; Mercante, G; Pellini, R; Pichi, B; Sanguineti, G; Sciuto, R; Sperduti, I; Spriano, G; Turri-Zanoni, M; Vidiri, A | 1 |
| An, H; Chen, H; Li, Y; Lin, Q; Sun, L; Wu, H; Zhao, L | 1 |
| Abgral, R; Keromnes, N; Le Roux, PY; Marianowski, R; Palard, X; Potard, G; Robin, P; Rousset, J; Salaun, PY; Valette, G | 1 |
| Bussink, J; de Geus-Oei, LF; Kaanders, JH; Looijen-Salamon, MG; Meijer, TW; Oyen, WJ; Schuurbiers, OC; Span, PN; van der Drift, MA; van der Heijden, EH; Visser, EP | 1 |
| Giraud, P; Servagi-Vernat, S | 1 |
| Kang, WJ; Kim, J; Koh, YW; Lee, JH; Shin, NY; Sohn, B | 2 |
| Chen, MK; Hong, SF; Lai, YS; Lee, KW | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Kim, SY; Lee, YS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Hata, M; Inoue, T; Katahira-Suzuki, R; Omura-Minamisawa, M; Taguchi, T; Takano, S; Tateishi, U | 1 |
| Berry, MF; D'Amico, TA; Englum, BR; Erhunmwunsee, L; Onaitis, MW | 1 |
| Boerman, OC; Bussink, J; Franssen, GM; Kaanders, JH; Lok, J; van Dijk, LK | 1 |
| Alluri, KC; Chung, CH; Koch, W; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| García Vicente, AM; Honguero Martínez, AF; Jiménez Londoño, GA; León Atance, P; Soriano Castrejón, AM; Udias, JM; van Gómez López, O | 1 |
| Burger, IA; Dinkelborg, L; Friebe, M; Graham, K; Haerle, SK; Hany, TF; Horn-Tutic, M; Kowal, K; Luurtsema, G; Maas, B; Pruim, J; Schaefer, NG; Schibli, R; Stephens, A; von Schulthess, GK; Wiegers, J; Zitzmann-Kolbe, S | 1 |
| Cheze Le Rest, C; Fayad, H; Fernandez, P; Lamare, F; Le Pogam, A; Pradier, O; Valette, G; Visvikis, D | 1 |
| Dong, Y; Liu, Y; Qian, W; Wang, X; Wang, Y; Wu, S; Zhang, J | 1 |
| Huang, ZQ; Li, J; Li, X; Liu, QW; Tan, HH; Tan, R; Yao, SZ | 1 |
| Baschnagel, AM; Chunta, J; Fortier, LE; Galoforo, S; Huang, J; Marples, B; Oliver Wong, CY; Pruetz, BL; Thibodeau, BJ; Wilson, GD; Yan, D | 1 |
| Abele, JT; Harris, JR; Jeffery, DT; O'Connell, DA; Seikaly, H; Zhang, H | 1 |
| Clausen, MM; Engelholm, SA; Hansen, AE; Hollensen, C; Kjær, A; Kristensen, AT; Lundemann, M; McEvoy, FJ; Munck Af Rosenschöld, P; Pommer, T | 1 |
| Cho, JH; Cho, KJ; Chun, BJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Yoo, IeR | 1 |
| Ameye, L; Awada, A; Flamen, P; Garcia, C; Lalami, Y; Paesmans, M | 1 |
| Chang, JT; Cheng, NM; Fang, YH; Hsu, CH; Lee, LY; Liao, CT; Ng, SH; Tsan, DL; Wang, HM; Yang, LY; Yen, TC | 1 |
| Bhuta, S; Huang, YT; Ravi Kumar, AS | 1 |
| Bloemena, E; Boellaard, R; Braakhuis, BJ; Brakenhoff, RH; de Bree, R; Doornaert, PA; Hakim, S; Hoekstra, OS; Leemans, CR; Schouten, CS; Witte, BI | 1 |
| Ishiwata, K; Ito, K; Kubota, K; Minamimoto, R; Miyata, Y; Morooka, M; Okasaki, M; Toyohara, J; Yokoyama, J | 1 |
| Apostolova, I; Baumann, M; Brenner, W; Buchert, R; Hentschel, M; Hofheinz, F; Kotzerke, J; Lougovski, A; Steffen, IG; van den Hoff, J; Wedel, F; Zöphel, K | 1 |
| Benyoucef, A; Doyeux, K; Dubray, B; Edet-Sanson, A; Gardin, I; Michel, P; Nkhali, L; Thureau, S; Vera, P | 1 |
| Eskola, O; Grénman, R; Grönroos, TJ; Kronqvist, P; Laine, J; Lehtiö, K; Minn, H; Söderström, KO; Solin, O; Viljanen, T | 1 |
| Gallet, P; Gavid, M; Martin, C; Prades, JM; Prevot-Bitot, N; Timoschenko, A | 1 |
| Bourhis, J; Callaway, S; Elicin, O; Herrera, FG; Ozsahin, M; Prior, JO | 1 |
| Atallah, I; Berta, E; Boyer, E; Karkas, A; Reyt, E; Righini, CA | 1 |
| Lauridsen, JK; Rohde, M; Thomassen, A | 1 |
| Aleknavičius, E; Burneckis, A; Daisne, JF; Grybauskas, M | 1 |
| Achmad, A; Arisaka, Y; Higuchi, T; Kim, M; Tsushima, Y; Yokoo, H; Yokoo, S | 1 |
| Brandau, S; Franklin, C; Hermann, S; Jure-Kunkel, M; Kerem, A; Lang, S; Öztürk, E; Schäfers, M; Vahle, AK; Wildner, M | 1 |
| Cho, KJ; Choi, SH; Kang, BC; Kim, JS; Kim, SB; Kim, SY; Lee, SW; Nam, SY; Oh, JS; Roh, JL | 1 |
| Doki, Y; Fujiwara, Y; Miyata, H; Takiguchi, S; Yamasaki, M; Yano, M; Yasuda, T | 1 |
| Chang, KP; Fan, KH; Fang, KH; Ho, TY; Huang, SF; Kang, CJ; Lee, LY; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yang, LY; Yen, TC | 1 |
| Chan, SC; Chang, CJ; Chang, JT; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Jeon, TY; Kim, HJ; Kim, YW; Lee, BJ; Lee, JC | 1 |
| Harada, H; Kikuchi, M; Kishimoto, I; Shinohara, S; Suehiro, A | 1 |
| Fukumura, T; Hoshikawa, H; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Samukawa, Y; Yamamoto, Y | 1 |
| Chen, Y; Guo, L; Hu, X; Huang, J; Ji, C; Ling, C; Xu, H; Zhang, B; Zhu, W | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR; Peters, TT; Senft, A; Witte, BI | 1 |
| Burmeister, BH; Burmeister, E; Chua, B; Foote, MC; Panizza, B; Porceddu, SV; Pryor, D; Sjövall, J | 1 |
| Machida, Y; Motono, N; Sagawa, M; Sakuma, T; Tanaka, M; Ueno, M; Usuda, K | 1 |
| Hu, C; Hu, S; Pan, H; Shi, Q; Shi, W; Yang, Z; Yao, Z; Zhang, Y; Zhu, B | 1 |
| Dulamea, AO; Ionescu, V | 1 |
| Cai, XW; Feng, W; Fu, XL; Liu, Q; Yao, ZF; Yu, W; Zhang, Q; Zhang, YJ; Zhu, ZF | 1 |
| Fu, XL; Liu, Q; Yu, W; Zhang, YJ; Zhu, ZF | 1 |
| Lu, Y | 1 |
| Beitler, JJ; Corey, A; El-Deiry, MW; Galt, J; Higgins, K; Hudgins, PA; Kendi, AT; Magliocca, K; Nickleach, DC; Saba, NF; Schuster, DM; Wadsworth, JT | 1 |
| Chen, SW; Hsieh, TC; Kao, CH; Lin, YC; Wang, YC; Yang, SN; Yen, KY | 1 |
| Frey, S; Hoermann, K; Piniol, R; Sadick, H; Sadick, M; Schoenberg, SO; Weiss, C | 1 |
| Geng, J; Li, X; Nie, F; Zhang, B | 1 |
| Andersen, FL; Aznar, MC; Fischer, BM; Hansen, AE; Højgaard, L; Kjaer, A; Löfgren, J; Loft, A; Rasmussen, JH; Specht, L; Vogelius, IR | 1 |
| Baumann, S; Browning, CM; Craft, JF; Renker, M; Schoepf, UJ | 1 |
| Hruby, G; Jones, M; Martin, J; Rutherford, N; Solomon, M | 1 |
| Cheng, JC; Cheng, MF; Lee, JM; Liu, CJ; Tzen, KY; Yen, RF | 1 |
| Anderson, CM; Buatti, JM; Button, A; Chang, T; Graham, MM; Marquardt, MD; Menda, Y; Pagedar, NA; Smith, BJ; Sun, W | 1 |
| Inoue, T; Komatsu, M; Nishimura, G; Oridate, N; Sano, D; Shiono, O; Taguchi, T; Takahashi, M; Yabuki, K | 1 |
| Bal, C; Behera, A; Chakraborty, PS; Kumar, R; Mukherjee, A | 1 |
| Dong, X; Li, W; Sun, X; Wan, H; Wu, P; Xing, L; Yu, J | 1 |
| Alberts, FM; Bloemena, E; Castelijns, JA; Comans, EF; de Bree, R; de Graaf, P; Hoekstra, OS; Leemans, CR; Sanchez, E; Schouten, CS; Witte, BI | 1 |
| Akutsu, Y; Hoshino, I; Kono, T; Matsubara, H; Murakami, K; Narushima, K; Okazumi, S; Shutou, K; Tochigi, T; Toma, T; Uesato, M | 1 |
| Boellaard, R; de Bree, R; Hoekstra, OS; Leemans, CR; Meeuwis, J; Witte, BI | 1 |
| Chikamatsu, K; Kaira, K; Sakakura, K; Toyoda, M; Tsushima, Y; Yokobori, Y | 1 |
| Bluemel, C; Kircher, S; Lapa, C; Linz, C; Müller-Richter, UD | 1 |
| Hagiwara, N; Matsutani, T; Miyashita, M; Nomura, T; Uchida, E; Wachi, E; Yamashita, N | 1 |
| Bentzen, SM; Bowen, SR; Bradshaw, TJ; Chappell, RJ; Deveau, MA; Forrest, LJ; Jeraj, R; Kubicek, L; White, P | 1 |
| Coleman, A; Collins, M; Corry, J; D'Costa, I; De Abreu Lourenco, R; Fua, T; Lau, E; Liu, C; Rischin, D; Shah, K; Te Marvelde, L | 1 |
| Komatsu, M; Mori, M; Nishimura, G; Oridate, N; Taguchi, T; Takahashi, M; Yabuki, K | 1 |
| Fujiwara, K; Harada, H; Hino, M; Itoh, K; Kikuchi, M; Kishimoto, I; Naito, Y; Shinohara, S; Suehiro, A; Tona, R | 1 |
| Corey, A; El-Deiry, MW; Galt, J; Hudgins, PA; Kendi, AT; Magliocca, KR; Nickleach, DC; Saba, NF; Schuster, DM; Switchenko, JM; Wadsworth, JT | 1 |
| Marcus, C; Sheikhbahaei, S; Subramaniam, RM | 1 |
| Kondo, T; Matoba, M; Oota, K; Shimode, Y; Tonami, H; Tuji, H | 2 |
| Barragán, AM; Differding, S; Janssens, G; Lee, JA; Sterpin, E | 1 |
| Clavero R, JM; Furnaro L, F; Ladrón de Guevara H, D; Lazo P, D; Pardo B, C; Pefaur D, R; Piottante B, A; Rodríguez D, P; Yévenes A, S | 1 |
| Carlson, ER; Heidel, RE; Schaefferkoetter, JD | 1 |
| Dong, M; Liu, K; Ma, S; Wang, Y; Yao, Y; Zhou, J | 1 |
| Barber, PV; Booton, R; Califano, R; Crosbie, PA; Evison, M; Martin, J; Summers, Y | 1 |
| Gao, K; Li, XY; Liang, Y; Wu, N; Zhang, LF; Zhou, LN | 1 |
| Andratschke, N; Bundschuh, RA; Essler, M; Mayer, B; Papp, L; Pyka, T; Specht, HM; Zsótér, N | 1 |
| Hoshikawa, M; Kimura, H; Kurimoto, N; Marushima, H; Nakamura, H; Saji, H; Tagaya, R; Takagi, M | 1 |
| Branstetter, BF; Hughes, MA; Kim, S; Leung, AS; Rath, TJ | 1 |
| Bristow, RE; Eskander, RN; Grove, N; Zheng, M | 1 |
| Akdoğan, V; Canpolat, T; Erkan, AN; Özlüoğlu, LN; Reyhan, M; Yaşar, M; Yılmaz, İ; Yılmazer, C | 1 |
| Chang, TC; Chang, YC; Hong, JH; Kao, WH; Lai, CH; Lin, SY; Ng, KK; Tsai, CS | 1 |
| Alvarez, J; Bilbao, P; Cacicedo, J; Del Hoyo, O; Dolado, A; Espinosa, JM; Fernandez, I; Gaafar, A; Gómez-Suarez, J; Hortelano, E; Pijoan, JI; Sancho, A | 1 |
| Lin, R; Su, M; Wei, H; Zhang, X; Zhao, L; Zou, C | 1 |
| Imataki, O; Kida, J; Shiroshita, K; Uchida, S; Uemura, M | 1 |
| An, DZ; Han, D; Li, BS; Sun, JL; Wang, ZT; Zhang, DK; Zhao, Q | 1 |
| Besenyi, Z; Csenki, M; Cserháti, A; Dobi, Á; Együd, Z; Gaál, S; Hideghéty, K; Lengyel, Z; Maráz, A; Mózes, P; Pávics, L; Rusz, O; Szántó, E; Varga, Z; Zag, L | 1 |
| Choi, SH; Kim, JS; Kim, JW; Kim, SY; Nam, SY; Oh, JS; Roh, JL | 1 |
| Differding, S; Grégoire, V; Hanin, FX; Janssens, G; Lee, JA; Sterpin, E | 1 |
| Prestwich, RJ; Ramasamy, S; Scarsbrook, AF; Sen, M; Slevin, F; Subesinghe, M | 1 |
| Bray, V; Chicco, A; Forstner, D; Fowler, A; Lee, MT; Lin, M; Lin, P; Min, M; Shon, IH; Tieu, MT | 1 |
| Chen, Z; Dai, R; Liang, Y; Mu, W; Shen, W; Tian, J; Wu, N; Yang, F | 1 |
| Galoforo, S; Grills, IS; Kane, JL; Krueger, SA; Marples, B; Wilson, GD; Wobb, J | 1 |
| Cosman, P; Das, A; Devadas, M; Lin, M; Merrett, N; Mittal, A; Wilson, R; Ziazaris, W | 1 |
| Cho, KJ; Choi, SH; Choi, YJ; Kim, JS; Kim, SY; Lee, JH; Lee, JR; Nam, SY; Roh, JL | 1 |
| Ishihara, T; Kitajima, K; Kiyota, N; Minamikawa, T; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Cimen, F; Demirag, F; Gokcek, A; Ozmen, O; Tatci, E; Unsal, E; Yazici, S | 1 |
| Hoebers, FJ; Lambin, P; Mottaghy, FM; Öllers, MC; Troost, EG; van Elmpt, W; Zegers, CM | 1 |
| Antoch, G; Bergmann, C; Buchbender, C; Forsting, M; Heusch, P; Ruhlmann, M; Ruhlmann, V; Schaarschmidt, BM; Schlamann, M; Wetter, A | 1 |
| Emmadi, R; Lu, Y; Patel, D; VanDreel, A | 1 |
| Bentzen, SM; Cullen, K; Fischer, BM; Ioffe, O; Rasmussen, GB; Rasmussen, JH; Schumaker, L; Specht, L; Therkildsen, MH; Vogelius, IR | 1 |
| De Leeuw, AA; Fokdal, LU; Gormsen, LC; Jürgenliemk-Schulz, IM; Kroon, PS; Lindegaard, JC; Ramlov, A; Tanderup, K | 1 |
| Bosari, S; Castellani, M; Del Gobbo, A; Ferrero, S; Franco, R; Gaudioso, G; Nosotti, M; Palleschi, A; Pellegrinelli, A; Vaira, V; Zito Marino, F | 1 |
| Arai, Y; Chiba, Y; Hata, M; Komatsu, M; Nishimura, G; Oridate, N; Sano, D; Shiono, O; Taguchi, T; Takahashi, H; Takahashi, M; Yabuki, K | 2 |
| Demir, Y; Şengöz, T; Sürücü, E | 1 |
| Chang, JT; Cheng, NM; Fang, YH; Lee, LY; Liao, CT; Ng, SH; Tsan, DL; Wang, HM; Yang, LY; Yen, TC | 1 |
| Claxton, Z; Fagan, AJ; Harmon, M; Johnston, C; Keogan, M; Malik, V; Meaney, JF; Muldoon, C; O'Toole, D; Ravi, N; Reynolds, JV | 1 |
| Castetbon, V; de Clermont-Galleran, H; de Monès, E; Digue, L; Fernandez, P; Ghafouri, A; Haaser, T; Sagardoy, T | 1 |
| Damhuis, RA; Derks, JL; Dingemans, AM; Hendriks, LE; Hochstenbag, MM; Houben, RM; Postmus, PE; Smit, EF; Troost, EG | 1 |
| Jung, HS; Kim, DJ; Lee, JW; Park, CK; Park, SY; Yun, MJ | 1 |
| Baschnagel, AM; Dilworth, JT; Eskandari, M; Pruetz, BL; Williams, L; Wilson, GD; Wobb, JL; Wu, D | 1 |
| Ito, R; Ito, S; Iwano, S; Kato, K; Kishimoto, M; Naganawa, S | 1 |
| Aznar, MC; Bentzen, SM; Christensen, CB; Fischer, BM; Friborg, J; Kristensen, CA; Loft, A; Rasmussen, JH; Specht, L; Vogelius, IR | 1 |
| de Bree, R; Hoekstra, OS; Leemans, CR; Senft, A; Witte, BI | 1 |
| Cao, J; Li, D; Ma, C; Yin, Y | 1 |
| Acuff, S; de Geus-Oei, LF; Grootjans, W; Hamill, JJ; Meeuwis, AP; Osborne, DR; van der Vos, CS; Visser, EP | 1 |
| Abu-Rustum, NR; Burger, IA; Goldman, DA; Gonen, M; Hricak, H; Kollmeier, MA; Micco, M; Park, KJ; Sala, E; Vargas, HA; Yakar, D | 1 |
| Andersen, LJ; Brunø, AH; Carl, J; Sand, HM | 1 |
| Altorki, NK; Ameye, L; Berghmans, T; Borst, GR; de Jong, WK; Eschmann, S; Flamen, P; Garcia, C; Govindan, R; Higashi, K; Komaki, R; Lafitte, JJ; Meert, AP; Paesmans, M; Patz, EF; Rami-Porta, R; Sculier, JP; Van Baardwijk, A; Vansteenkiste, J; Wong, CY | 1 |
| Choi, WH; Kim, TJ; Kim, YK; Lee, KY; O, JH; Yoo, IeR | 1 |
| Acar, T; Ersöz, G; Kocaçelebi, K; Savaş, R | 1 |
| Adam, AC; Guntinas-Lichius, O; Huebbers, CU; Klussmann, JP; Preuss, SF; Schiffer, T; Schilder, S; Schmidt, M; Wiesner, RJ | 1 |
| Glatz, S; Guckenberger, M; Hemmatazad, H; Huber, G; Ikenberg, K; Klöck, S; Lang, S; Nesteruk, M; Pruschy, M; Riesterer, O; Stieb, S; Studer, G; Veit-Haibach, P | 1 |
| Ata, Ö; Çolpan, B; Kara Gedik, G; Öztürk, K; Sarı, O; Yavaş, G | 1 |
| Agrawal, N; Chan, JY; Mydlarz, WK; Qualliotine, JR; Wang, H; Zhou, X | 1 |
| Barron, BJ; Brandon, DC; Corey, AS; Halkar, RK; Harrison, CE; Karagulle Kendi, AT; Plaxton, NA | 1 |
| Lee, SJ; Park, SY; Yoon, JK | 1 |
| Abdulrezzak, U; Dolanbay, M; Kutuk, MS; Ozcelik, B; Serin, IS; Uludag, S | 1 |
| Doki, Y; Kurokawa, Y; Makino, T; Miyata, H; Miyazaki, Y; Mori, M; Takahashi, T; Takiguchi, S; Tatsumi, M; Yamasaki, M | 1 |
| Bousquet, F; Cathelinaud, O; Fakhry, N; Giovanni, A; Morvan, JB; Rivière, D; Vatin, L; Verdalle, P | 1 |
| Bayman, E; Bird, D; Carey, B; Karakaya, E; McDermott, G; Prestwich, RJ; Ramasamy, S; Roberts, N; Scarsbrook, AF; Sen, M; Speight, R; Subesinghe, M; Sykes, J; Wilson, DJ | 1 |
| Bitencourt, AG; Chojniak, R; Kowalski, LP; Lima, EN; Martins, EB; Nicolau, UR | 1 |
| Álvarez, A; Calzado, MA; Caro, T; Lara-Chica, M; Medina, M; Moreno, P; Muñoz, E; Salvatierra, Á; Soler-Torronteras, R | 1 |
| Kiess, A; Marashdeh, W; Sheikhbahaei, S; Solnes, L; Subramaniam, RM; Taghipour, M | 1 |
| Eriksson, O; Mortensen, AC; Nestor, M; Selvaraju, RK; Spiegelberg, D; Stenerlöw, B | 1 |
| Choi, JW; Han, M; Kim, SY; Lee, SJ | 1 |
| Ashrafinia, S; Jackson, A; Marcus, C; Rahmim, A; Schmidtlein, CR; Sheikhbahaei, S; Soltani, M; Subramaniam, RM | 1 |
| Buvat, I; Chouahnia, K; Martinod, E; Orlhac, F; Soussan, M | 1 |
| Itoh, T; Kanda, T; Kitajima, K; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Anwar, B; George, MM; Homer, JJ; Mani, N; Nash, L | 1 |
| Baba, H; Baba, Y; Harada, K; Higashi, T; Ida, S; Imamura, Y; Ishimoto, T; Iwagami, S; Izumi, D; Kosumi, K; Miyamoto, Y; Miyata, T; Sakamoto, Y; Shiraishi, S; Taki, K; Tokunaga, R; Watanabe, M; Yamashita, Y; Yoshida, N | 1 |
| Eriksson, O; Haylock, AK; Mortensen, AC; Nestor, MV; Nilvebrant, J; Selvaraju, RK; Spiegelberg, D; Tolmachev, V | 1 |
| Bal, N; Erhamamcı, S; Reyhan, M | 1 |
| Barrington, S; Bird, T; Guerrero Urbano, T; Jeannon, JP; Lei, M; Lyons, A; Oakley, R; Simo, R; Thavaraj, S | 1 |
| de Galiza Barbosa, F; Haerle, SK; Hany, TF; Huber, GF; Hüllner, MW; Pietsch, C; Schmid, DT; Studer, G; Veit-Haibach, P | 1 |
| Capitain, O; Couturier, O; Gustin, P; Hatt, M; Lacombe, M; Marquis, A; Ménager, É; Paumier, A; Peyraga, G; Rio, E; Septans, AL; Trémolières, P; Vénara, A; Visvikis, D | 1 |
| Hirota, M; Inoue, T; Iwai, T; Kioi, M; Koike, I; Koizumi, T; Mitsudo, K; Oguri, S; Shimizu, M; Taguri, M; Tohnai, I | 1 |
| Califano, J; Fakhry, C; Marcus, C; Subramaniam, RM; Taghipour, M | 1 |
| Cheon, GJ; Chung, HH; Ha, S; Kang, SY; Kim, JW; Park, NH; Song, YS | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR; Senft, A | 1 |
| Chang, S; Kim, SJ; Koo, PJ; Kwak, JJ | 1 |
| Colletti, PM; Giammarile, F; Grassetto, G; Manca, G; Perkins, AC; Rubello, D; Vanzi, E; Volterrani, D; Wong, KK | 1 |
| Bray, V; Chicco, A; Forstner, D; Fowler, A; Lee, M; Lin, M; Lin, P; Min, M; Shon, IH; Tieu, MT | 1 |
| Chen, L; Li, WF; Liu, Q; Ma, J; Mao, YP; Peng, H; Sun, Y; Zhang, Y; Zhou, GQ | 1 |
| Gariani, J; Martin, SP; Tabouret Viaud, C | 1 |
| Hara, K; Honjo, H; Kuwano, H; Miyazaki, T; Ozawa, D; Sakai, M; Sohda, M; Suzuki, S; Tanaka, N; Yokobori, T | 1 |
| Chan, SC; Chang, JT; Fan, KH; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yang, LY; Yen, TC | 1 |
| Bomanji, JB; Brown, J; Capitanio, A; Carroll, B; Falzon, M; Fraioli, F; George, PJ; Groves, AM; Janes, SM; Kayani, I; Navani, N; Smith, LJ; Thakrar, RM | 1 |
| Eo, JS; Hong, JH; Jung, US; Kim, S; Lee, JK; Min, KJ; So, KA | 1 |
| Chino, Y; Kimura, H; Kurokawa, T; Okazawa, H; Rahman, T; Shinagawa, A; Tsuchida, T; Tsujikawa, T; Yamamoto, M; Yoshida, Y | 1 |
| Amegnizin, JL; Durand, P; Kerrou, K; Ohnona, J | 1 |
| Aznar, MC; Bentzen, SM; Fischer, BM; Friborg, J; Håkansson, K; Kristensen, CA; Loft, A; Rasmussen, JH; Specht, L; Vogelius, IR | 1 |
| Agrawal, N; Kang, H; Richmon, J; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Wray, R | 1 |
| Hotta, K; Kaji, M; Kiura, K; Kubo, T; Minami, D; Ninomiya, T; Oda, N; Ohashi, K; Sato, A; Tabata, M; Takigawa, N; Tanimoto, M | 1 |
| Berwouts, D; De Gersem, W; De Neve, W; Duprez, F; Madani, I; Olteanu, LA; Speleers, B; Vercauteren, T | 1 |
| Fujiwara, M; Fukamizu, H; Suzuki, T; Takiguchi, T; Tokura, Y | 1 |
| Chang, JS; Choi, EC; Keum, KC; Kim, KH; Kim, SH; Lee, CG; Lee, J; Yun, M | 1 |
| Callahan, J; Hirshoren, N; Lau, E; Olayos, E | 1 |
| Huang, H; Ren, H; Ren, X; Song, X; Xu, W; You, J; Zhang, X; Zhao, N | 1 |
| Chiu, KW; Khong, PL; Law, SY; Tong, DK; Vardhanabhuti, V; Yuan, H | 1 |
| Burkill, GJ; Connor, SE; Evans, RM; Raman, VV | 1 |
| Chang, CJ; Chang, WY; Chang, YC; Chao, A; Chou, HH; Hong, JH; Huang, SH; Huang, YE; Lai, CH; Lin, G; Liu, FY; Peng, NJ; Wang, CC; Yang, LY; Yen, TC | 1 |
| Andrzejewski, P; Baltzer, P; Georg, D; Georg, P; Grimm, C; Helbich, TH; Karanikas, G; Mitterhauser, M; Pinker, K; Poetter, R; Polanec, SH; Polterauer, S; Sturdza, A; Wadsak, W | 1 |
| Chin, BB; Oldan, JD | 1 |
| Abele, JT; Dziegielewski, PT; Harris, JR; Nguyen, NT; O'Connell, DA; Seikaly, H; Zhang, H | 1 |
| Abe, T; Hirose, Y; Ishibashi, M; Kage, M; Kaida, H; Kawahara, A; Kurata, S; Matono, S; Tanaka, T | 1 |
| Corey, A; El-Deiry, MW; Galt, JR; Hudgins, PA; Kendi, AT; Magliocca, KR; Saba, NF; Schuster, DM; Switchenko, J; Wadsworth, JT | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, IS | 1 |
| Boehm, A; Gawlitza, M; Höhn, AK; Kahn, T; Meyer, HJ; Purz, S; Sabri, O; Stumpp, P; Surov, A | 1 |
| Emi, M; Furukawa, T; Hamai, Y; Hihara, J; Kurokawa, T; Okada, M; Yamakita, I | 1 |
| Kajiwara, M; Moriyama, H; Yonehara, S | 1 |
| Cease, K; Chen, G; Chopra, V; Gross, M; Raghunathan, R; Ramnath, N; Troeschel, S; Zhao, L | 1 |
| Ferraro, R; Marcus, C; Rahmim, A; Sheikhbahaei, S; Subramaniam, RM; Wray, R; Zan, E | 1 |
| Emi, M; Furukawa, T; Hamai, Y; Hihara, J; Ibuki, Y; Okada, M; Yamakita, I | 1 |
| Deák, P; Fábián, G; Kahán, Z; Kovács, L; Mózes, P; Nagy, O; Pál, M; Reisz, Z; Rovó, L; Rusz, O; Szilágyi, É; Tiszlavicz, L; Tomisa, B; Varga, Z | 1 |
| Achenbach, HJ; Amthauer, H; Apostolova, I; Furth, C; Genseke, P; Kalinski, T; Riedel, S; Rogasch, JM; Schreiber, J; Schultz, M; Steffen, IG; Steinkrüger, FL; Wertzel, H | 1 |
| Arya, S; Mahajan, A; Paul, PP | 1 |
| De Carvalho Bittencourt, M; Dolivet, G; Faure, GC; Mastronicola, R; Tu, Q; Wu, X | 1 |
| Bae, JS; Jeon, HS; Ki, YK; Kim, DH; Kim, KH; Kim, WT; Lee, JH; Lee, JY; Nam, JH; Park, D; Suh, DS | 1 |
| Chi, KK; Kader, I; Leavers, B; Shashinder, S; Sundaresan, P; Wylie, B | 1 |
| Abdulelah, H; Al-Hussaini, M; Al-Ibraheem, A; AlSharif, A | 1 |
| Kang, DY; Lee, JW; Lee, SM; Lee, SY; Na, JO | 1 |
| Alberini, JL; Cacheux, W; Fayard, J; Gauthé, M; Lièvre, A; Richard-Molard, M | 1 |
| de Melo, NS; Dos Anjos, DA; Dos Anjos, RF; Figueiredo, PTS; Leite, AF; Vieira, DL | 1 |
| Baumann, M; Bergmann, R; Beuthien-Baumann, B; Brüchner, K; Jentsch, C; Kotzerke, J; Krause, M; Löck, S; Mosch, B; Steinbach, J; Thames, H; Troost, EGC; Yaromina, A; Zips, D | 1 |
| Baek, KH; Cho, JK; Choi, JY; Choi, N; Hyun, SH; Jeong, HS; Kim, MJ; Lee, SH | 1 |
| Arnett, ALH; Haddock, MG; Hallemeier, CL; James, SE; Macintosh, EM; Merrell, KW; Nathan, MA; Neben Wittich, MA; Ravi, K; Shen, KR | 1 |
| Bittner, MI; Bucher, S; Grosu, AL; Hentschel, M; Kayser, G; Meyer, PT; Mix, M; Rücker, G; Weber, WA; Werner, M; Wiedenmann, N | 1 |
| Guler, OC; Onal, C; Torun, N; Yildirim, BA | 1 |
| Bogsrud, TV; Dale, E; Moan, JM; Osnes, TA | 1 |
| Cong, L; Gao, T; Hu, L; Wang, S | 1 |
| Ahnesjö, A; Grönlund, E; Johansson, S; Montelius, A | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; René Leemans, C; Senft, A; Yildirim, G | 1 |
| Fujima, N; Hirata, K; Homma, A; Kudo, K; Sakashita, T; Shiga, T; Shirato, H | 1 |
| Jeon, JH; Kim, MS; Lee, GK; Lee, JM; Moon, DH; Yang, HC; Zo, JI | 1 |
| Akutsu, Y; Fujishiro, T; Gunji, H; Hanaoka, T; Hayano, K; Kono, T; Matsubara, H; Narushima, K; Ohira, G; Okazumi, S; Shuto, K; Tochigi, T; Tohma, T | 1 |
| Agarwal, KK; Bal, CS; Kumar, R; Parida, GK; Sahoo, MK; Thakar, A; Tripathi, M | 1 |
| Bray, V; Forstner, D; Fowler, A; Holloway, L; Lee, M; Lin, P; Min, M | 1 |
| Calcagni, ML; Castelluccia, A; Mantini, G; Massaccesi, M; Mattoli, MV; Scolozzi, V | 1 |
| Alnaji, R; Attwood, K; Du, W; Gabriel, E; Hochwald, S; Kukar, M | 1 |
| Chundury, A; Dehdashti, F; DeWees, T; Grigsby, PW; Hassanzadeh, C; Hui, C; Mullen, D; Mutch, DG; Powell, MA; Rao, YJ; Schwarz, JK; Siegel, BA | 1 |
| Kruse, MJ; Mena, E; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M | 1 |
| Liu, C; Ma, Y; Xin, J; Xu, W; Yu, S | 1 |
| Dong, X; Huang, Y; Li, W; Sun, L; Sun, X; Wan, H; Xing, L; Yu, J; Zhao, X; Zhu, W | 1 |
| Kamijo, A; Kanazawa, M; Kawaguchi, AT; Murayama, C; Naito, K; Tsukada, H | 1 |
| Alhilahi, LM; Branstetter, BF; Fakhran, S; Hughes, MA; Rath, TJ; Seungwon, KW; Yankevich, U | 1 |
| Arigami, T; Kita, Y; Maemura, K; Natsugoe, S; Okumura, H; Omoto, I; Owaki, T; Sasaki, K; Uchikado, Y; Uenosono, Y | 1 |
| Jha, AK; Mena, E; Rahmim, A; Sheikhbahaei, S; Solnes, L; Subramaniam, RM; Taghipour, M | 1 |
| Appold, S; Bandurska-Luque, A; Baumann, M; Gudziol, V; Haase, R; Kotzerke, J; Krause, M; Leger, S; Löck, S; Richter, C; Schreiber, A; Zips, D; Zöphel, K; Zschaeck, S | 1 |
| Fu, Z; Li, Q; Li, Z; Liu, M; Zhang, J | 1 |
| Choi, JW; Han, M; Hyun, SH; Kim, JH; Lee, D; Lee, SJ | 1 |
| Deng, S; Huang, Y; Li, J; Sang, S; Zhang, B; Zhang, W | 1 |
| Fu, Z; Han, A; Kong, FM; Li, D; Li, H; Mu, D; Song, P; Yang, G; Yu, J; Zhang, B; Zhang, W; Zhong, X | 1 |
| Krohn, KA; Yeuh, B | 1 |
| Balan, A; Mirsadraee, S; Naik, K; Salahudeen, HM; Scarsbrook, AF | 1 |
| Tikkakoski, T | 1 |
| Hirai, T; Katsuragawa, S; Kawanaka, K; Murakami, R; Nishimura, R; Oya, N; Shiraishi, S; Tashiro, K; Tomiguchi, S; Toya, R; Uozumi, H; Yamashita, Y | 1 |
| Durnick, DK; Peller, PJ; Subramaniam, RM | 1 |
| Chan, SC; Chang, JT; Chin, SC; Huang, SF; Ko, SF; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Fu, Z; Guo, H; Hu, Q; Wang, W; Yu, J; Yuan, S; Zhong, X | 1 |
| Doki, Y; Fujiwara, Y; Fukunaga, H; Hatazawa, J; Higuchi, I; Miyata, H; Monden, M; Takiguchi, S; Tatsumi, M; Yano, M; Yasuda, T | 1 |
| Decker, PA; Meyers, BF; Putnam, JB; Veeramachaneni, NK; Zoole, JB | 1 |
| Krabbe, CA; Pruim, J; Rödiger, LA; Roodenburg, JL; van der Laan, BF | 1 |
| Carrozzi, L; Comin, C; Falaschi, F; Grazzini, M; Innocenti, F; Lopes Pegna, A; Maria Carozzi, F; Mascalchi, M; Paci, E; Picozzi, G; Ronchi, C; Spinelli, C | 1 |
| Jordan, CD; Salskov, A; Schmidt, R; Turcotte, E; Vallières, E; Vesselle, H; Wiens, L; Wood, DE | 1 |
| Brusa, M; Carnino, R; Cistaro, A; Colombini, E; Ferraris, MM; Gandolfo, S; Giovanella, L; Pentenero, M; Pezzuto, C; Spriano, G; Valentini, MC | 1 |
| Hasegawa, Y; Hyodo, I; Nakashima, T; Nishio, M; Suzuki, H; Tamaki, T; Terada, A | 1 |
| Chang, JT; Chen, IH; Cheng, AJ; Hsueh, C; Huang, SF; Lee, LY; Liao, CT; Lin, CH; Ng, SH; See, LC; Wang, HM; Yen, TC | 1 |
| Gönen, M; Greco, C; Humm, JL; Larson, SM; Lee, NY; Nehmeh, SA; Raphael, B; Schöder, H; Stambuk, HE | 1 |
| Enomoto, K; Hatazawa, J; Higuchi, I; Inohara, H; Inoue, T; Osaki, Y; Tomiyama, Y; Yoshii, T | 1 |
| Ahn, HY; Chang, SK; Hwang, HS; Kim, JH; Lee, IJ; Rho, YS; Yoon, DY | 1 |
| Obando, JA; Samii, JM; Yasrebi, M | 1 |
| He, C; Hu, JB; Sun, XN; Xu, J | 1 |
| Azar, RR; Chen, J; Early, DS; Edmundowicz, SA; Govindan, R; Keswani, RN; Kohlmeier, C; Meyers, BF; Sharma, A | 1 |
| Hasegawa, Y; Hyodo, I; Nakashima, T; Nishio, M; Ogawa, T; Suzuki, H; Suzuki, M; Tamaki, T; Terada, A | 1 |
| Henderson, R; Ho, L; Modarresifar, H | 1 |
| Goya, T; Honda, Y; Horio, H; Iyama, K; Kaji, M; Koizumi, K; Nakashima, R; Nomori, H; Sakaguchi, K; Shibata, H; Suzuki, T; Takanami, I; Uno, K | 1 |
| Alberini, JL; Banal, A; Floiras, JL; Gardner, M; Halimi, P; Hans, S; Housset, M; Labib, A; Plantet, MM; Valinta, D; Wartski, M | 1 |
| Doki, Y; Fujiwara, Y; Hatazawa, J; Higuchi, I; Makino, T; Miyata, H; Monden, M; Takiguchi, S; Yamasaki, M; Yasuda, T | 1 |
| Abgral, R; Bizais, Y; Kraeber-Bodéré, F; Le Duc-Pennec, A; Le Roux, PY; Marianovski, R; Potard, G; Pradier, O; Querellou, S; Salaun, PY | 1 |
| Ariji, E; Ariji, Y; Fuwa, N; Kodaira, T; Nakamura, T; Satoh, Y; Tachibana, H | 1 |
| Bollschweiler, E; Dietlein, M; Eschner, W; Hölscher, A; Kobe, C; Mönig, SP; Schicha, H; Schmidt, M; Vallboehmer, D; Vallböhmer, D | 1 |
| Bol, A; Christian, N; De Bast, M; Grégoire, V; Jordan, B; Lee, JA | 1 |
| Chang, JT; Chen, IH; Cheng, AJ; Hsueh, C; Huang, SF; Lee, LY; Liao, CT; Lin, CH; Ng, SH; Wang, HM; Yen, TC | 2 |
| Andrel, J; Anne, PR; Hyslop, T; Intenzo, CM; Keane, W; Lavarino, J; Machtay, M; Natwa, M | 1 |
| Goyal, P; Hsu, JM; Kellman, RM | 1 |
| Fong, Y; Gulec, SA; Hall, M; Pennington, K | 1 |
| Brix, WK; Jones, DR; Kozower, BD; Lau, CL; Smith, PW; Swenson, BR; Taylor, MD; Theodosakis, N; Wick, MR | 1 |
| Fukumoto, D; Harada, N; Kakiuchi, T; Kamijo, A; Kawaguchi, AT; Murayama, C; Tsukada, H | 1 |
| Duan, Y; Lu, PO; Wang, WZ; Yu, LJ | 1 |
| Hu, M; Kong, L; Li, MH; Liu, NB; Yang, GR; Yu, JM | 1 |
| Cheng, Z; He, J; Lin, L; Liu, L; Mao, YS; Zheng, R | 1 |
| Chang, FC; Chang, SY; Chu, PY; Huang, JL; Liu, RS; Tai, SK; Tsai, TL; Wang, YF | 1 |
| Bradford, CR; Bui, C; Chepeha, DB; Eisbruch, A; Frey, KA; Karamchandani, R; Lee, JS; Miller, TH; Mukherji, SK; Oxford, LE; Sacco, AG; Teknos, TN; Urba, SG; Wolf, GT; Worden, FM | 1 |
| Batty, V; Wong, WL | 1 |
| Agarwala, SS; Argiris, A; Branstetter, BF; Childs, EE; Couture, LA; Egloff, AM; Gooding, WE; Grandis, JR; Johnson, JT; Johnson, R; Koppikar, P; Lai, SY; Lui, VW; Mills, G; Mountz, JM; Muthukrishnan, A; Myers, EN; Seethala, RR; Shin, DM; Thomas, SM | 1 |
| Baldetorp, B; Bendahl, PO; Borg, A; Brun, E; Henriksson, E; Kjellén, E; Mertens, F; Ohlsson, T; Rennstam, K; Wahlberg, P; Wennerberg, J | 1 |
| Bumpous, JM | 1 |
| Drummond, E; Fay, M; Heriot, AG; Hicks, RJ; Hogg, A; Leong, T; MacKay, J; Milner, A; Ng, M; Ngan, SY; Winton, Ed | 1 |
| Baba, H; Baba, Y; Hayashi, N; Hiyoshi, Y; Imamura, Y; Nagai, Y; Toyama, E; Watanabe, M; Yoshida, N | 1 |
| Futatsubashi, M; Kanno, T; Naitou, K; Ouchi, Y; Tanizaki, Y; Torizuka, T; Ueda, Y | 1 |
| Cheng, KJ; Fan, J; Li, LF; Ling, L; Wang, SQ; Wu, QL; Zhao, K; Zhou, SH | 1 |
| Ang, KK; Cannon, BA; Chao, KS; Chronowski, GM; Frank, SJ; Garden, AS; Ginsberg, LE; Lee, JJ; Lippman, SM; Macapinlac, HA; Moeller, BJ; Morrison, WH; Rana, V; Rosenthal, DI; Schwartz, DL; Sturgis, EM; Weber, RS; Williams, MD | 2 |
| Fields, R; McWhorter, A; Mercante, DE; Nuss, D; Pou, AM; Rabalais, AG; Walvekar, R; Wood, C | 1 |
| Hsieh, CC; Hsu, PK; Hsu, WH; Huang, CS; Lin, KH; Wang, SJ; Wu, YC | 1 |
| Fury, M; Kraus, D; Lee, N; Schöder, H | 1 |
| Huang, SS; Tu, DG; Wang, KB | 1 |
| Fukuyama, R; Hasegawa, Y; Nakashima, T; Nishio, M; Suzuki, H; Tamaki, T; Tatematsu, M | 1 |
| Andrade, RS; Argiris, A; Branstetter, BF; Burton, S; Deeb, EL; Ferris, RL; Gooding, WE; Grandis, JR; Heron, DE; Johnson, JT; Karamouzis, M; Lai, SY; Mountz, JM | 1 |
| Chang, TC; Hong, JH; Hsueh, S; Lai, CH; Lee, SP; Ng, KK; Tsai, CS; Yen, TC | 1 |
| Dehdashti, F; Grigsby, PW; Huettner, PC; Kidd, EA; Rader, JS; Siegel, BA; Spencer, CR | 1 |
| De Keyzer, F; Dirix, P; Hermans, R; Nuyts, S; Stroobants, S; Vandecaveye, V | 1 |
| Bjurberg, M; Brun, A; Brun, E; Ekblad, L; Henriksson, E; Kjellén, E; Ohlsson, T | 1 |
| Baglin, AC; Le Stanc, E; Tainturier, C; Vilain, D | 1 |
| Genden, EM; Kao, J; Kostakoglu, L; Mocherla, B; Packer, S; Park, EE; Som, PM; Vu, HL | 1 |
| Baek, CH; Choi, JY; Chung, MK; Hyun, SH; Jeong, HS; Kim, HJ; Ko, YH; Park, GY; So, YK; Son, YI | 1 |
| Aoyama, H; Homma, A; Nishioka, T; Onimaru, R; Shirato, H; Suzuki, K; Tamaki, N; Tsuchiya, K; Yasuda, M | 1 |
| Krabbe, CA; Pruim, J; Roodenburg, JL; van der Wal, JE; van der Werff-Regelink, G | 1 |
| Haerle, SK; Hany, TF; Sidler, D; Stoeckli, SJ; Strobel, K | 1 |
| Bellò, M; Beltramo, G; Cassoni, P; Castellano, I; Contu, V; Mistrangelo, M; Morino, M; Munoz, F; Mussa, A; Pelosi, E; Racca, P; Ricardi, U | 1 |
| Abe, T; Fujita, H; Hayabuchi, N; Ishibashi, M; Kaibara, H; Kaida, H; Kobayashi, M; Kurata, S; Nakashima, T; Tanaka, N; Uchida, M; Uchiyama, Y | 1 |
| Dooms, C; Stroobants, S; Vansteenkiste, J; Verbeken, E | 1 |
| Baumann, M; Bergmann, R; Beuthien-Baumann, B; Bruechner, K; Hessel, F; Hofheinz, F; Mosch, B; Santiago, A; van den Hoff, J; Yaromina, A | 1 |
| Carson, KJ; Cosgrove, VP; Eakin, RL; Hanna, GG; Hounsell, AR; Jarritt, PH; Lynch, T; McAleese, J; O'Sullivan, JM; Stewart, DP; Young, VA; Zatari, A | 1 |
| Buchmann, I; Freier, K; Haberkorn, U; Hofele, C; Thiele, OC | 1 |
| Chang, JY; Fu, XL; Jiang, GL; Shen, L; Xiang, JQ; Yu, W; Zhang, YJ | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR | 1 |
| Bauduceau, O; Bonardel, G; Chargari, C; Dechaud, C; Fayolle, M; Foehrenbach, H; Gontier, E; Soret, M | 1 |
| Fan, W; Hu, YY; Liang, PY; Lin, XP; Sun, XR; Zhang, X | 1 |
| Lurain, JR; Nemcek, A; Rademaker, A; Schink, JC; Singh, DK; Small, W; Spies, S; Vern, TZ | 1 |
| Fowler, AR; Leong, PM; Lin, M | 1 |
| Beukema, JC; Busz, DM; Langendijk, JA; Muijs, CT; Plukker, JT; Pruim, J; Schreurs, LM; van der Borden, AJ; Van der Jagt, EJ | 1 |
| Bol, A; Castadot, P; Geets, X; Grégoire, V; Lee, JA | 1 |
| Doki, Y; Fujiwara, Y; Kawabata, R; Makino, T; Miyata, H; Mori, M; Nakajima, K; Nishida, T; Nushijima, Y; Takeno, A; Takiguchi, S; Yamasaki, M | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Kim, BT; Kim, K; Lee, JY; Lee, KH; Lee, SJ; Shim, YM | 1 |
| Bold, B; Ishida, R; Okada, N; Omura, K; Piao, Y; Shibuya, H; Tayier, A | 1 |
| Fujita, M; Hosokawa, M; Itoh, K; Shimizu, S; Shirato, H; Takahashi, H | 1 |
| Chu, HR; Hwang, HS; Kim, JH; Rho, YS; Yoon, DY | 1 |
| Barret, O; de Clermont-Gallerande, H; De-Mones-Del-Pujol, E; Demeaux, H; Fernandez, P; Henriques de Figueiredo, B; Kantor, G; Lagarde, P; Richaud, P | 1 |
| Kim, BS; Kim, IJ; Kim, SJ; Kim, YK; Nam, HY; Park, K; Rho, HJ | 1 |
| Hirata, T; Kitamura, H; Nakamura, H; Nishikawa, J | 1 |
| Fu, Z; Han, D; He, W; Huo, Z; Kong, L; Liu, X; Lu, J; Mu, D; Sun, X; Yin, Y; Yu, J; Yu, Y; Zhang, B; Zhang, G; Zhao, S; Zhong, X | 1 |
| Demura, Y; Fujibayashi, Y; Kiyono, Y; Kudo, T; Lohith, TG; Okazawa, H; Umeda, Y | 1 |
| Balink, H; de Visscher, JG; Dijkstra, PU; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF | 1 |
| Mercier, G; Peller, P; Sakai, O; Subramaniam, RM; Truong, M | 1 |
| Feng, R; Kong, L; Li, MH; Shi, F; Yang, GR; Yu, JM | 1 |
| Bendahl, PO; Bjurberg, M; Brun, E; Kjellén, E; Ohlsson, T | 1 |
| Heriot, A; Leong, T; Ngan, SY; Wang, ML | 1 |
| Agool, A; Brouwers, AH; Dijkstra, PU; Krabbe, CA; Phan, TT; Pruim, J; Roodenburg, JL; Scholtens, AM | 1 |
| Grigsby, PW; Huettner, P; Miller, TR; Rader, J; Showalter, TN | 1 |
| De La Mota, J; Espaillat-Rijo, L; Hernandez, E; Micaily, B; Thomas, MB | 1 |
| Clark, JR; Iyer, NG; Singham, S; Zhu, J | 1 |
| Blackman, G; Bomanji, J; Boulos, PB; Ell, PJ; Engledow, AH; Groves, A; Skipworth, JR; Warren, SJ | 1 |
| Guo, W; Li, SJ; Liao, JX; Ren, GX | 1 |
| Li, X; Lu, X; Zhang, B | 1 |
| Gong, H; Huang, W; Lu, Y; Xie, D; Yu, J | 1 |
| de Bree, R; Hoekstra, OS; Leemans, CR; Senft, A; Uyl-de Groot, CA | 1 |
| Bridji, B; Calais, G; Digue, L; Duvillard, C; Grégoire, V; Hamoir, M; Lonneux, M; Maingon, P; Reychler, H; Toubeau, M | 1 |
| Malone, J; Robbins, KT | 1 |
| Büchler, P; Friess, H; Kranzfelder, M; Lange, K | 1 |
| Chung, DH; Goo, JM; Jang, BG; Kang, CH; Kang, KW; Kim, YT; Lee, CH; Lee, HJ; Lee, HY; Park, CM | 1 |
| Cabrera, AR; Chen, L; Han, A; Han, D; Li, Y; Ma, L; Ma, Y; Mu, D; Sun, X; Teng, X; Yu, J; Yue, J; Zhao, S; Zhao, X; Zheng, F; Zheng, J | 1 |
| Fen, YL; He, XH; Xian, WJ; Ye, QL; Yuan, BH; Yuan, JW | 1 |
| Baron, M; Chastan, M; Diologent, B; Hitzel, A; Manrique, A; Sanson, AE; Vera, P | 1 |
| Hijioka, H; Ikeda, R; Ishida, T; Miyawaki, A; Nakamura, N; Nozoe, E; Ushiyama, M | 1 |
| Doki, Y; Fujiwara, Y; Hatazawa, J; Higuchi, I; Makino, T; Miyata, H; Mori, M; Nakajima, K; Takiguchi, S; Yamasaki, M | 1 |
| Davison, JM; Grillone, GA; Imsande, HM; Ozonoff, A; Subramaniam, RM | 1 |
| Higashi, T; Hiraoka, M; Matsuo, Y; Mizowaki, T; Nagata, Y; Nakamoto, Y; Narabayashi, M; Norihisa, Y; Saga, T; Shibuya, K; Takayama, K; Togashi, K | 1 |
| Argiris, A; Branstetter, BF; Ferris, RL; Gibson, MK; Grandis, JR; Heron, DE; Johnson, JT; Kim, SW; Lai, SY; Passero, VA; Shuai, Y | 1 |
| Fuwa, N; Inokuchi, H; Kodaira, T; Mizoguchi, N; Nakahara, R; Nakamura, T; Tachibana, H; Takada, A; Tamaki, T; Tomita, N | 1 |
| Bisdas, S; Bisdas, T; Chambron-Pinho, N; Ernemann, U; Hammerstingl, R; Mack, MG; Middendorp, M; Seitz, O; Vogl, TJ | 1 |
| Chang, JT; Chen, IH; Cheng, AJ; Hsueh, C; Huang, SF; Lee, LY; Liao, CT; Lin, CH; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Gambhir, SS; Iagaru, A; Mittra, ES | 1 |
| Hwang, SH; Kim, IJ; Kim, SJ; Lee, CH; Lee, EY; Lee, MK; Lee, SY | 1 |
| Adachi, T; Fujiwara, K; Hori, SY; Imai, Y; Kikuchi, M; Naito, Y; Nakamoto, Y; Shinohara, S; Tona, Y; Usami, Y; Yamazaki, H | 1 |
| Fajnwak, P; Farghaly, HR; Nguyen, NC; Osman, MM | 1 |
| Hiramatsu, Y; Hongo, A; Kanazawa, S; Kodama, J; Nakamura, K; Okumura, Y | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Haberland, U; Koch, A; Shakirin, G; Tokalov, S; Wolf, G; Zöphel, K | 1 |
| Cohen, EE; de Souza, JA | 1 |
| Paleri, V; Zammit-Maempel, I | 1 |
| Endo, K; Fukuchi, M; Inose, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Oriuchi, N; Sakai, M; Sano, A; Sohda, M; Suzuki, S; Tanaka, N | 1 |
| Agarwal, JP; Dinshaw, KA; Ghosh-Laskar, S; Gupta, T; Jain, S; Purandare, N; Rangarajan, V | 1 |
| Bettenworth, D; Domagk, D; Domschke, W; Fuchs, M; Reuter, S; Schnöckel, U; Weckesser, M; Wessling, J | 1 |
| Devic, S; Faria, S; Lehnert, S; Lisbona, R; Menard, S; Tomic, N | 1 |
| Chu, K; Fischbein, NJ; Graves, EE; La, TH; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Quon, A | 1 |
| Arisaka, Y; Endo, K; Hanaoka, H; Higuchi, T; Ishikita, T; Miyakubo, M; Miyashita, G; Morita, S; Nakasone, Y; Negishi, A; Oriuchi, N; Tominaga, H; Yokoo, S | 1 |
| Ahmad, N; Haerle, SK; Schmid, DT; Soltermann, A; Stoeckli, SJ; Strobel, K | 1 |
| Cho, KJ; Cho, Y; Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JH; Lee, SW; Nam, SY; Roh, JL; Song, SY; Yoon, DH | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Huber, GF; Schmid, DT | 1 |
| Alvfors, C; Bergman, A; Bergqvist, M; Bergström, S; Dahg, P; Ekman, S; Frödin, JE; Harmenberg, J; Hedlund, A; Ståhl, B | 1 |
| Ajani, JA; Bhutani, MS; Hofstetter, WL; Lee, JH; Liao, Z; Macapinlac, HA; Murthy, SB; Patnana, SV; Rohren, E; Swisher, SG; Wang, X; Xiao, L | 1 |
| Aikawa, H; Higashi, K; Machida, Y; Sagawa, M; Sakuma, T; Tanaka, M; Ueda, Y; Ueno, M; Usuda, K; Zhao, XT | 1 |
| Araki, O; Chida, M; Fukushima, Y; Honma, K; Inoue, T; Tamura, M; Tatewaki, M; Umezu, H | 1 |
| Ferris, RL; Hagan, JL; Rabalais, A; Tauzin, M; Walvekar, RR; Wood, CG | 1 |
| Dubois, F; Dumollard, JM; Martin, C; Prades, JM; Prevot, N; Richard, C; Timoshenko, AP | 1 |
| Horiuchi, C; Nishimura, G; Taguchi, T; Tsukuda, M; Yabuki, K | 1 |
| de Bree, R | 1 |
| Aznar, M; Bender, E; Bentzen, SM; Berthelsen, AK; Due, AK; Korreman, S; Kristensen, CA; Specht, L; Tomé, W; Vogelius, I | 1 |
| Al-Nahhas, A; Barwick, T; Howard, DJ; Patel, NH; Salem, S; Win, Z; Zerizer, I | 1 |
| Ahmad, N; Buck, A; Fischer, DR; Haerle, SK; Huber, GF; Schmid, DT | 1 |
| Dehdashti, F; Grigsby, PW; Olsen, JR; Schwarz, JK; Siegel, BA; Zighelboim, I | 1 |
| Bae, SH; Chang, SK; Choi, CS; Gu, DH; Lim, KJ; Park, CH; Seo, YL; Yoon, DY; Yun, EJ | 1 |
| Aristophanous, M; Berbeco, RI; Chen, AB; Killoran, JH; Yap, JT | 1 |
| Blauwgeers, H; Boersma, L; Burgers, S; Gilhuijs, K; Klomp, H; Knegjens, J; Rossi, M; Siedschlag, C; Stroom, J; van Baardwijk, A; van Loon, J; van Suylen, RJ; Vogel, W | 1 |
| Brizel, DM; Hawk, TC; Higgins, KA; Hoang, JK; Roach, MC; Turkington, TG | 1 |
| Jia, C; Lou, G; Lu, P; Tian, M; Wang, W; Wang, X; Yu, L | 1 |
| De Potter, A; Deron, P; Goethals, I; Peeters, M; Van de Wiele, C; Vangestel, C; Vermeersch, H | 1 |
| Chida, M; Honma, K; Inoue, T; Murakami, K | 1 |
| Ishikawa, A; Kito, S; Koga, H; Matsumoto-Takeda, S; Matsuo, K; Miyamoto, I; Morimoto, Y; Oda, M; Seta, Y; Shiiba, S; Takahashi, T; Tanaka, T; Wakasugi-Sato, N; Yamamoto, N; Yamashita, Y; Yamauchi, K | 1 |
| de Bree, R; Heuveling, DA; van Dongen, GA | 1 |
| Bove, P; Colella, G; Pagliarulo, V; Tozzi, U | 1 |
| Abdelsalam, M; Abouzied, M; Amin, T; Bazarbashi, S; Darwish, A; Rahal, M; Soudy, H | 1 |
| Hsieh, TC; Kao, CH; Sun, SS; Wu, YC; Yen, KY | 1 |
| Abdelmalik, AG; Fajnwaks, P; Nguyen, NC; Osman, MM | 1 |
| Carson, KJ; Hanna, GG; Hounsell, AR; O'Sullivan, JM; Senan, S; Van Sörnsen De Koste, JR | 1 |
| Fu, Z; Li, M; Sun, X; Xie, P; Yu, J; Zhao, H | 1 |
| Bouchelouche, K; Gerke, O; Holt, P; Jensen, TK; Marcussen, N; Riehmann, M; Svolgaard, B | 1 |
| Bergman, JJ; Boellaard, R; Bonenkamp, HJ; Bossuyt, PM; Busch, OR; Cuesta, MA; Hoekstra, OS; Hulshof, MC; Nieuwenhuijzen, GA; Omloo, JM; Plukker, JT; Pruim, J; Sloof, GW; Ten Kate, FJ; Tilanus, HW; van Berge Henegouwen, MI; van Dekken, H; van der Gaast, A; van Heijl, M; van Lanschot, JJ | 1 |
| Fury, MG; Jansen, JF; Koutcher, JA; Lee, NY; Patel, SG; Pfister, DG; Schöder, H; Shah, JP; Shukla-Dave, A; Stambuk, HE; Wang, Y | 1 |
| Daşu, A; Johansson, S; Sörensen, J; Sun, A; Turesson, I | 1 |
| Brizel, DM; Chino, J; Higgins, KA; Hoang, JK; Roach, MC; Turkington, TG; Yoo, DS | 1 |
| Cacheux, W; Farkhondeh, F; Girodet, J; Paulmier, B; Petras, S; Servois, V | 1 |
| Hong, SH; Kang, EJ; Kim, DW; Kim, SH; Lee, KN | 1 |
| Bannier, M; Bats, AS; Brenot-Rossi, I; Ferron, G; Gauthier, H; Ghazzar, N; Houvenaeghel, G; Leblanc, E; Lecuru, F; Lumbroso, S; Morice, P; Narducci, F; Querleu, D; Uzan, C; Zerdoud, S | 1 |
| Liao, CT; Liu, FY; Yen, TC | 1 |
| Chachoua, A; Friedman, K; Probst, S; Seltzer, A; Spieler, B | 1 |
| Allen, AM; Aristophanous, M; Berbeco, RI; Chen, AB; Killoran, JH; Larson, E; Sher, DJ; Yap, JT | 1 |
| Gokce, M; Kilicgun, A; Saydam, O; Tanriverdi, O | 1 |
| Belova, EA; Karelin, MI; Karlov, PA; Mus, VF; Shkol'nik, MI | 1 |
| Brown, JA; Coleman, T; Collins, M; Lightfoot, AJ; Rosevear, HM; Williams, H | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JH; Lee, SW; Nam, SY; Roh, JL; Yi, JS | 1 |
| Kong, FM; Ma, L; Meng, X; Mu, D; Sun, X; Xing, L; Yang, G; Yu, J; Zhang, B; Zhao, S | 1 |
| Chen, JH; Hsieh, TC; Kao, CH; Liang, JA; Shum, WY; Su, CC; Yeh, JJ | 1 |
| Chang, JY; Fu, XL; Shen, L; Xiang, JQ; Yu, W; Zhang, YJ | 1 |
| Cho, KJ; Choi, SH; Doo, H; Kim, JS; Kim, SY; Lee, H; Lee, JH; Nam, SY; Roh, JL | 1 |
| Brenner, W; Buchert, R; Diekmann, F; Froeling, V; Nogami, M; Schreiter, N | 1 |
| Beadsmoore, C; Geropantas, K; Loo, SW; Martin, WM; Montgomery, PQ; Roques, TW | 1 |
| Lindskog, DM; Nikkhou, K; Talusan, P | 1 |
| Ahn, SJ; Chung, WK; Jeong, JU; Jeong, SY; Nah, BS; Nam, TK; Song, JY; Yoon, MS | 1 |
| Fockens, P; Groen, H; Janssens, AC; Plukker, JT; Pruim, J; Schreurs, LM; Sloof, GW; Steyerberg, EW; van Berge Henegouwen, MI; van Dullemen, HM; van Lanschot, JJ | 1 |
| Enomoto, A; Hamada, S; Nakahara, H; Tsuji, H; Uchihashi, T | 1 |
| Fujibayashi, Y; Hata, H; Kitagawa, Y; Kotsuji, M; Nakamura, M; Okazawa, H; Sano, K; Yamazaki, Y; Yonekura, Y | 1 |
| Au, DH; Ghaus, SJ; Gould, MK; Provenzale, D; Schultz, EM; Wagner, TH; Wallace, RB; Xu, X | 1 |
| Cline, KJ; Darling, GE; Driedger, AA; Evans, WK; Gu, CS; Gulenchyn, KY; Inculet, RI; Julian, JA; Kuruvilla, MS; Levine, MN; Maziak, DE; Ung, YC | 1 |
| Haerle, SK; Haile, SR; Hany, TF; Schuknecht, B; Stoeckli, SJ; Strobel, K | 1 |
| Abgral, R; Cavarec, MB; Le Duc-Pennec, A; Le Roux, PY; Marianovski, R; Nowak, E; Potard, G; Querellou, S; Salaün, PY; Valette, G | 1 |
| Chiang, IP; Hsieh, CY; Hsieh, TC; Hsu, CN; Kao, CH; Sun, SS; Wu, YC; Yang, CF | 1 |
| Hihara, J; Ikeda, T; Mimura, T; Misumi, K; Miyata, Y; Okada, M; Tsutani, Y | 1 |
| Chang, CC; Chien, CY; Fang, FM; Huang, SH; Huang, YC; Hung, BT; Lin, WC; Lui, CC; Tu, MC; Wang, PW | 1 |
| Ishibashi, T; Ishikawa, K; Kadoya, M; Kaji, M; Kato, T; Tamaki, N | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Schmid, DT; Stoeckli, SJ | 1 |
| Chisholm, KM; Daly, ME; Graves, EE; Iagaru, A; Kaplan, MJ; Kong, C; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Truong, D; Wiegner, EA | 1 |
| Horiuchi, C; Komatsu, M; Matsuda, H; Mori, M; Niho, T; Nishimura, G; Sakuma, N; Shibata, K; Sugisaki, S; Taguchi, T; Takahashi, M; Tsukuda, M | 1 |
| Chang, KH; Choi, SH; Han, MH; Jang, JY; Kim, JH; Kim, KG; Kim, YJ; Paeng, JC; Pagsisihan, JR; Sohn, CH; Yun, TJ | 1 |
| Busk, M; Horsman, MR; Jakobsen, S; Mueller-Klieser, W; Overgaard, J; Steiniche, T; Walenta, S | 1 |
| Cheng, EC; Ma, JB; Song, YP; Yu, JM; Zhang, XQ; Zhou, W | 1 |
| Bonte, KM; Deron, PB; Van de Wiele, C; Vermeersch, HF | 1 |
| Abe, T; Hayashi, Y; Ito, Y; Koyama, K; Sato, M | 1 |
| Citak, N; Gurses, A; Kök, A; Melek, H; Metin, M; Pekcolaklar, A; Sayar, A | 1 |
| Belgers, HJ; Blom, RL; Oostenbrug, LE; Schreurs, WM; Sosef, MN; Vliegen, RF | 1 |
| Barth, T; Muehling, B; Oberhuber, A; Orend, KH; Schelzig, H; Wehrmann, C | 1 |
| Doki, Y; Fujiwara, Y; Hatazawa, J; Higuchi, I; Miyata, H; Takiguchi, S; Yamasaki, M; Yano, M; Yasuda, T | 1 |
| Bazan, J; Diehn, M; Donington, JS; Graves, EE; Hara, WY; Hoang, CD; Kozak, MM; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Quon, A; Schipper, ML; Shrager, JB; Wakelee, HA; Whyte, RI; Zhou, L | 1 |
| Abdul-Karim, FW; Faulhaber, P; Kunos, C; Radivoyevitch, T | 1 |
| Day, FL; Heriot, A; Hicks, RJ; Hogg, A; Leong, T; Link, E; Lynch, C; Michael, M; Moodie, K; Ngan, S; Winton, Ed | 1 |
| Guvenc-Tuncturk, S; Kuschner, WG; Paintal, HS; Sahni, V | 1 |
| Balink, H; de Visscher, JG; Dol, J; Krabbe, CA; Roodenburg, JL | 1 |
| Ng, DC; Tan, AE | 1 |
| Chera, BS; Fried, D; Hackman, T; Hayes, N; Khandani, A; Rosenman, J; Shores, C; Weissler, M | 1 |
| Chan, SC; Chang, CJ; Chang, JT; Liao, CT; Lin, CY; Lin, SY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Chiu, CH; Chou, TY; Lee, YC; Lin, KH; Tsai, CM; Wu, YC; Yeh, YC | 1 |
| de Koning, HJ; Groen, HJ; Lammers, JW; Mali, W; Nackaerts, K; Oudkerk, M; Thunnissen, FB; van Klaveren, RJ; van't Westeinde, SC; Vernhout, R; Weenink, C | 1 |
| Furukawa, M; Kiura, K; Miyoshi, S; Oto, T; Toyooka, S; Yamane, M | 1 |
| Beaulieu, S; Bélair, M; Boucher, L; Cohade, C; Coulombe, G; Delouya, G; Després, P; Filion, EJ; Hinse, M; Houle, A; Igidbashian, L; Martel, C; Nguyen-Tan, PF | 1 |
| Fujiwara, T; Fujiwara, Y; Hiraki, T; Kaji, M; Kanazawa, S; Mitani, M; Naomoto, Y; Noma, K; Okumura, Y; Sakurama, K; Shirakawa, Y; Takaoka, M; Tanabe, S; Yamatsuji, T | 1 |
| Feng, R; Han, A; Kong, L; Ma, Y; Sun, X; Yang, Y; Yang, Z; Yu, J; Zheng, J | 1 |
| Abe, K; Hatakenaka, M; Honda, H; Nakamura, K; Nakashima, T; Nonoshita, T; Ohga, S; Ohnishi, K; Shioyama, Y; Yoshitake, T; Yoshiura, T | 1 |
| Davison, JM; Devaiah, AK; Imsande, HM; Mercier, GA; Ozonoff, AJ; Subramaniam, RM; Truong, MT | 1 |
| Bergman, JJ; Bossuyt, PM; Hulshof, MC; Mearadji, BM; Omloo, JM; Phoa, SS; Richel, DJ; Sloof, GW; Stoker, J; Ten Kate, FJ; van Berge Henegouwen, MI; van Heijl, M; van Lanschot, JJ | 1 |
| Fu, Z; Han, D; Mu, D; Xu, G; Yang, W; Yu, J; Zhang, B; Zhao, S; Zhong, X | 1 |
| Bomanji, J; Hashemi, M; Iordanidou, L; Markar, SR; Mitchell, I; Read, S; Stoker, D; Vyas, S; Winslet, M | 1 |
| Büchler, M; Ott, K; Sisic, L | 1 |
| Dehdashti, F; Grigsby, PW; Schwarz, JK; Siegel, BA | 1 |
| Corry, J; Hicks, RJ; Lau, E; Mak, D; Rischin, D | 1 |
| Arens, AI; Kaanders, JH; Oyen, WJ; Schinagl, D; Troost, EG | 1 |
| Gornik, G; Weber, W | 1 |
| Ahmad, N; Crook, DW; Haerle, SK; Hany, TF; Huber, GF; Schmid, DT; Soyka, MB | 1 |
| Cho, KJ; Choi, SH; Han, MW; Kim, JS; Kim, SY; Lee, HJ; Nam, SY; Roh, JL | 1 |
| Cheng, J; Pan, L; Yao, Z; Zhang, Y; Zhou, M | 1 |
| Corry, J; Ferlito, A; Grégoire, V; Hamoir, M; Hanin, FX; Machiels, JP; Rinaldo, A; Robbins, KT; Schmitz, S; Silver, CE; Strojan, P; Takes, RP; Thariat, J; Weynand, B | 1 |
| Beswick, DM; Branstetter, BF; Ferris, RL; Gooding, WE; Maxwell, JH; Zhang, I | 1 |
| Aubard, Y; Fermeaux, V; Genet, D; Leobon, S; Marin, B; Maubon, A; Monteil, J; Renaudie, J; Roux, S; Tubiana-Mathieu, N | 1 |
| Akdemir, UO; Baykara, M; Benekli, M; Buyukberber, S; Cakir, T; Coskun, U; Demirci, U; Kapucu, O; Ozkan, S | 1 |
| Belgers, HJ; Blom, RL; Oostenbrug, LE; Schreurs, WM; Sosef, MN; Stohr, I; Vliegen, RF | 1 |
| Ansquer, C; Bouchot, O; Marconnet, L; Rigaud, J; Souillac, I | 1 |
| Farrell, R; Gharpurhy, A; Gollub, F; Goodchild, K; Lemon, C; Saunders, M; Sonoda, LI; Wellsted, D; Wong, WL | 1 |
| Kawano, T; Kishimoto, S; Makino, T; Nakaminato, S; Shibuya, H; Toriihara, A | 1 |
| Agrawal, A; Meacham, R; Naiboğlu, B; Ozer, E; Ryoo, C; Schuller, DE | 1 |
| Huang, YT; Ravi Kumar, AS | 1 |
| Codreanu, I; Dasanu, CA; Divgi, C; Weinstein, GS | 1 |
| Hoh, CK; Jensen, LG; Lau, SK; Liang, Y; Mell, LK; Rose, BS; Yashar, CM | 1 |
| Colevas, AD; Fischbein, NJ; Graves, EE; Iagaru, AH; Khong, B; Kong, C; La, TH; Le, QT; Loo, BW; Murphy, JD; Tang, C | 1 |
| Arai, Y; Komatsu, M; Matsuda, H; Nishimura, G; Sakuma, N; Sano, D; Taguchi, T; Takahashi, H; Takahashi, M | 1 |
| Abdoli, M; El Naqa, IM; Fuentes, CL; Zaidi, H | 1 |
| Arguis, P; Boada, M; Cabañas, M; Gómez-Caro, A; Lomeña, F; Molins, L; Ramirez, J; Sanchez, M | 1 |
| Ahn, YC; Baek, CH; Choi, JY; Kim, BT; Lee, HJ; Lee, KH; Moon, SH; Park, K; Son, YI | 1 |
| Fujibayashi, Y; Fujieda, S; Kimura, Y; Kiyono, Y; Kositwattanarerk, A; Kudo, T; Maruyama, R; Mori, T; Oh, M; Okazawa, H | 1 |
| Amin, M; Chunta, JL; Grills, IS; Huang, J; Lee, DY; Marples, B; Martinez, AA; Wilson, GD; Wong, CY; Yan, D | 1 |
| Gorospe, L; Jover-Díaz, R; Vicente-Bártulos, A | 1 |
| Chang, DT; Graves, E; Jayachandran, P; Koong, AC; Krakow, TE; La, T; Loo, BW; Pai, RK; Quon, A | 1 |
| Choi, YJ; Huh, CY; Ki, KD; Kim, GY; Lee, JM; Lee, SK; Lim, SJ; Seol, HJ; Tong, SY | 1 |
| Fujiwara, K; Harada, H; Kanazawa, Y; Kikuchi, M; Kishimoto, I; Kurihara, R; Naito, Y; Nakamoto, Y; Shinohara, S; Yamazaki, H | 1 |
| Chera, BS; Cullip, T; Fried, D; Khandani, AH; Lawrence, M; Rosenman, J | 1 |
| Harris, J; Hu, J; Kurien, G; Seikaly, H | 1 |
| Almadori, G; Autorino, R; Bussu, F; Castaldi, P; De Corso, E; Dinapoli, N; Galli, J; Giordano, A; Lago, M; Miccichè, F; Paludetti, G; Rufini, V; Valentini, V | 1 |
| Gholami, H; Horenblas, S; Kakhki, VR; Sadeghi, R; Zakavi, SR | 1 |
| I, HS; Kim, IJ; Kim, K; Kim, SJ | 1 |
| Fujita, H; Hattori, S; Hayabuchi, N; Hayakawa, M; Hirose, Y; Ishibashi, M; Kage, M; Kaida, H; Kawahara, A; Kobayashi, M; Kurata, S; Uchida, M | 1 |
| Fukukura, Y; Kajiya, Y; Kamiyama, T; Koriyama, C; Matsuzaki, T; Nakajo, M; Nishimoto, K; Nomoto, M; Tani, A; Yonekura, R | 1 |
| Higashiyama, S; Kawabe, J; Kotani, K; Shiomi, S; Yoshida, A | 1 |
| Buonerba, C; D'Aniello, C; Damiano, V; De Placido, S; Di Lorenzo, G; Di Trolio, R; Federico, P; Mainolfi, C; Matano, E; Palmieri, G; Raimondo, L; Rescigno, P | 1 |
| Abe, K; Chikui, T; Goto, Y; Hirano, M; Jinno, T; Kawano, S; Kiyosue, T; Matsubara, R; Nagata, T; Nakamura, S; Oobu, K | 1 |
| Ding, XP; Li, BS; Li, HS; Sun, HF; Wang, DQ; Wang, ZT; Yi, Y; Zhang, J | 1 |
| Han, A; Hu, M; Wang, X; Xue, J; Zheng, J | 1 |
| Dehdashti, F; Grigsby, PW; Kidd, EA; Siegel, BA; Thomas, M | 1 |
| Colavolpe, C; Dessi, P; Fakhry, N; Giovanni, A; Michel, J; Varoquaux, A | 1 |
| Huh, SH; Jin, SM; Lee, SH; Park, CH; Rho, YS; Yoon, DY | 1 |
| Bonomo, L; Calcagni, ML; Giordano, A; Leccisotti, L; Maggi, F; Rufini, V; Taralli, S; Treglia, G | 1 |
| Baccega, M; Bellò, M; Cassoni, P; Cravero, F; Filippini, C; Fora, G; Lesca, A; Milanesi, E; Mistrangelo, M; Morino, M; Munoz, FH; Pelosi, E; Racca, P; Ricardi, U; Skanjeti, A | 1 |
| Chowdhury, FU; Gilbert, A; Prestwich, RJ; Scarsbrook, AF; Sen, M; Subesinghe, M | 1 |
| Abgral, R; Barberot, C; Chinellato, S; Garetier, M; Le Bivic, T; Potard, G; Rousset, J; Salaun, PY; Valette, G | 1 |
| Chopra, S; Engineer, R; Mahantshetty, UM; Merchant, N; Purandare, N; Rangarajan, V; Shrivastava, SK; Thakur, M; Upasani, MN | 1 |
| Cannon, B; Dong, L; Schwartz, DL | 1 |
| Cincibuch, J; Formanek, R; Koranda, P; Myslivecek, M; Neoral, C; Vomackova, K; Vrba, R; Zapletalova, J | 1 |
| Belohlavek, O; Chrobok, V; Dolezel, M; Dusek, L; Jarkovsky, J; Kandrnal, V; Kolarova, I; Michalek, R; Odrazka, K; Petruzelka, L; Vanasek, J | 1 |
| Harada, H; Kurabayashi, T; Mochizuki, Y; Nakamura, S; Omura, K; Shibuya, H | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yi, JS | 1 |
| Kitamura, N; Kwang-Lee, K; Sasabe, E; Uchida, M; Yamada, T; Yamamoto, T; Yoshimura, T | 1 |
| Azadi, J; Durand, DJ; Subhawong, A | 1 |
| Monteiro, E; Pereira, G; Silva, JC | 1 |
| Campbell, PD; Carlson, ER; Long, M; McCoy, JM; Schaefferkoetter, J; Townsend, D | 1 |
| Axelrod, R; Champ, C; Fogh, SE; Intenzo, C; Keane, WM; Kubicek, GJ; Machtay, MM | 1 |
| Cheng, J; Cohen, SJ; Keller, L; Klayton, T; Konski, A; Li, T; Meropol, NJ; Scott, W; Xu-Welliver, M; Yu, JQ | 1 |
| Bond, J; Counts, S; Dusing, R; Girod, D; More, Y; Tsue, T | 1 |
| Frumovitz, M; Jhingran, A; Klopp, AH; Macapinlac, HA; Nick, AM; Ramirez, PT; Ramondetta, LM | 1 |
| Bae, DS; Choe, YS; Choi, JY; Kim, BT; Lee, KH; Moon, SH; Park, SB; Yoo, J | 1 |
| Kong, L; Li, M; Qu, W; Sun, X; Xing, L; Yu, J; Yue, J; Zhu, WQ | 1 |
| Jujo, T; Oide, T; Sakao, S; Tatsumi, K | 1 |
| Dong, MJ; Lin, LL; Liu, JH; Lu, ZJ; Luo, XM; Yan, SX; Yang, SY; Zhao, K; Zhou, SH | 1 |
| Hamamoto, Y; Kataoka, M; Kozuki, T; Nakajima, N; Nogami, N; Sawada, S; Shinkai, T; Shinohara, S; Suehisa, H; Sugawara, Y; Yamashita, M | 1 |
| Adams, E; Beveridge, S; Clark, CH; Jordan, T; Nisbet, A; Rickard, D; Teoh, M; Whitaker, S; Wood, K | 1 |
| Chen, SW; Chien, CR; Hsieh, TC; Hsu, SM; Kao, CH; Liang, JA; Pan, T; Wang, YC; Yang, SN; Yen, KY; Yu, CY | 1 |
| Chang, JT; Cheng, NM; Hsu, CL; Huang, CG; Liao, CT; Lin, CY; Ng, SH; Tsan, DL; Wang, HM; Yen, TC | 1 |
| Ahlzén, HS; Arnér, ES; Cheng, Q; Grafström, J; Johansson, K; Linder, S; Lu, L; Olofsson, MH; Samén, E; Stone-Elander, S; Thorell, JO | 1 |
| Hoshikawa, H; Kishino, T; Mori, N; Nishiyama, Y; Yamamoto, Y | 1 |
| Dai, MM; Li, YM; Lin, Q; Luo, ZM; Sun, L; Wang, LC; Wu, H; Yang, RS; Zhao, L | 1 |
| Eaton, A; Fury, M; Lee, NY; Lim, R; Ohri, N; Rao, S; Schöder, H; Setton, J; Wong, R | 1 |
| Abgral, R; Gouders, D; Keromnes, N; Le Roux, PY; Leleu, C; Mollon, D; Nowak, E; Querellou, S; Rousset, J; Salaün, PY; Valette, G | 1 |
| Hsieh, TC; Kao, CH; Sun, SS; Wu, YC; Yang, CF | 1 |
| Chan, DS; Ellis-Owen, R; Fielding, P; Lewis, WG; Reid, TD; Roberts, SA | 1 |
| Honda, E; Ishimaru, N; Kubo, M; Miyamoto, Y; Otsuka, H; Sugawara, C; Takahashi, A | 1 |
| Chen, JH; Wang, CC | 1 |
| Bartel, TB; Chen, C; Lowe, VJ; Nagarkar, V; Shafirstein, G; Siegel, E; Singh, B; Stack, BC; Thacker, S; Ye, J | 1 |
| Burmeister, BH; Porceddu, SV; Pryor, DI; Scuffham, PA; Thomas, PA; Whitty, JA | 1 |
| Chen, SW; Ding, HJ; Kao, CH; Liang, JA; Shum, WY; Yen, KY | 1 |
| Choi, SH; Kim, JS; Kim, SY; Nam, SY; Park, GC; Roh, JL | 1 |
| Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
| Abelson, JA; Bazan, JG; Diehn, M; Graves, EE; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Quon, A; Trakul, N | 1 |
| Krajewski, KM; Ramaiya, N; Saboo, SS; Shinagare, AB; Zukotynski, K | 1 |
| Banks, KP; Clemenshaw, MN; Craun, JB; Moren, RW | 1 |
| Caldito, GC; Ekshyyan, O; Nathan, CA; Sibley, D; Sunderland, J; Vascoe, C | 1 |
| Dehdashti, F; DeWees, T; Esthappan, J; Grigsby, PW; Narra, VR; Olsen, JR; Schwarz, JK; Siegel, BA | 1 |
| Fukui, T; Fukumoto, K; Ishikawa, Y; Kato, K; Kawaguchi, K; Matsuo, K; Taniguchi, T; Yokoi, K | 1 |
| Abd El-Hafez, YG; Khalil, HF; Liao, CT; Moustafa, HM; Yen, TC | 1 |
| Beuthien-Baumann, B; Gudziol, V; Kotzerke, J; Langner, J; Laniado, M; Platzek, I; Schneider, M; Schramm, G; van den Hoff, J | 1 |
| Bogsrud, TV; Eilertsen, K; Evensen, JF; Glomset, OK; Løndalen, AM; Skretting, A | 1 |
| Dong, X; Fu, Z; Li, D; Sun, X; Wan, H; Wu, P; Xing, L; Yin, Y; Yu, J | 1 |
| Li, M; Liu, Q; Peng, Z; Sun, J; Yao, S | 1 |
| Kruse, V; Maes, A; Sathekge, M; Smeets, P; Van de Wiele, C | 1 |
| Aygun, N; Walden, MJ | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, MJ; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Chowdhury, FU; Godfrey, EM; Radhakrishna, G | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, HJ; Lee, JH; Nam, SY; Park, GC; Roh, JL | 1 |
| Han, YM; Hwang, DH; Hwang, HS; Kang, IW; Ko, Y; Lee, ES; Lee, GK | 1 |
| Humbert Vidan, L; Koopman, M; Newbold, K; Partridge, M; Powell, C | 1 |
| Calles, L; García-Espantaleón, M; Iglesias, E; Jiménez, JS; Mucientes, J; Pereira, A; Perez-Medina, T; Rodríguez, B | 1 |
| Chen, W; D'Souza, WD; Feigenberg, S; Kim, G; Kligerman, S; Lu, M; Lu, W; Suntharalingam, M; Tan, S | 1 |
| Cho, KJ; Joo, YH; Kim, MS; Nam, IC; Park, JO; Yoo, IR | 1 |
| Ishigami, S; Kajiya, Y; Kita, Y; Matsumoto, M; Mori, S; Natsugoe, S; Okumura, H; Omoto, I; Owaki, T; Sasaki, K; Setoyama, T; Tanoue, K; Uchikado, Y; Ueno, S | 1 |
| Dierckx, RA; Halmos, GB; Langedijk, JA; Pruim, J; Roodenburg, JL; van der Laan, BF; Wedman, J | 1 |
| Capitain, O; Cellier, P; Denis, F; Girault, S; Hamy, A; Mahé, MA; Mesgouez-Nebout, N; Paumier, A; Poirier, AL; Rousseau, D | 1 |
| Ansquer, C; Bodere, F; Bouchot, O; Branchereau, J; Hitier-Berthault, M; Renaudin, K; Rigaud, J | 1 |
| Akdemir, UO; Atasever, T; Benekli, M; Buyukberber, S; Cetin, B; Coskun, U; Senturk, S; Tufan, G; Turan, N | 1 |
| Asakawa, I; Hasegawa, M; Inoue, K; Kajitani, C; Katayama, E; Kirita, T; Okamoto, H; Shirone, N; Tamamoto, T; Uto, F | 1 |
| Anderson, NJ; Chang, JH; Gan, HK; Gong, SJ; Gunawardana, DH; Khoo, V; Lee, ST; Lim Joon, D; O'Keefe, G; Sachinidis, J; Scott, AM; Wada, M | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Baumann, M; Zöphel, K | 1 |
| Dong, L; Eifel, PJ; Fontanilla, HP; Iyer, RB; Jhingran, A; Kelly, P; Klopp, A; Levenback, CF; Takiar, V; Zhang, Y | 1 |
| Fabre, A; Hegarty, C; Purcell, YM; Sharaf, O; Skehan, SJ | 1 |
| Fujimoto, Y; Hasegawa, Y; Hiramatsu, M; Itoh, Y; Kato, K; Maruo, T; Naganawa, S; Nakashima, T; Suzuki, H | 1 |
| Findikcioglu, A; Onal, C; Oymak, E; Reyhan, M | 1 |
| Chen, HH; Chen, IH; Fan, KH; Huang, SF; Kang, CJ; Liao, CT; Lin, CY; Wang, HM; Yen, TC | 1 |
| Brizel, DM; Choudhury, KR; Das, SK; Hoang, JK; Yoo, DS | 1 |
| de Bree, R; Hoekstra, OS | 1 |
| Akhurst, T; Berlangieri, S; Chan, JG; Hannah, A; McKay, WJ; Price, D; Schelleman, T; Scott, AM; Sizeland, A; Smith, GJ; Tochon-Danguy, H | 1 |
| Asaka, M; Kato, T; Katoh, C; Kondo, S; Kuge, Y; Nambu, T; Nobuta, A; Tamaki, N; Tsukamoto, E | 1 |
| Angelard, B; Kerrou, K; Lacau St Guily, J; Montravers, F; Périé, S; Talbot, JN; Tassart, M | 1 |
| Endo, K; Fukuchi, M; Kato, H; Kuwano, H; Manda, R; Masuda, N; Miyazaki, T; Nakajima, M; Oriuchi, N; Tsukada, K; Yoshikawa, M | 1 |
| Bares, R; Bartusek, G; Dittmann, H; Dohmen, BM; Kehlbach, R; Pritzkow, M; Sarbia, M | 1 |
| Himeno, S; Makuuchi, H; Shimada, H; Tajima, T; Yasuda, S | 1 |
| Buchwald, C; Eigtved, A; Hansen, HS; Johansen, J; Theilgaard, SA | 1 |
| Chen, YR; Gu, MX; Li, WX; Pan, Y | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Di Martino, E; Gagel, B; Hausmann, R; Krombach, GA; Nowak, B; Tietze, L; Westhofen, M; Zimny, M | 1 |
| Brinkbaeumer, K; Dresel, S; Hahn, K; Hautmann, H; Kellner, W; Moisseev, A; Poellinger, B; Schmid, RA; Weiss, M | 1 |
| Bartenstein, P; Benz, P; Förster, GJ; Kunkel, M; Kutzner, J; Reichert, TE; Wagner, W | 1 |
| Alavi, A; Ponzo, F; Woodfield, C; Zhuang, H | 1 |
| Couper, GW; Park, KG | 1 |
| Bartenstein, P; Benz, P; Jeong, JH; Kunkel, M; Lehr, HA; Reichert, TE; Wagner, W; Whiteside, TL; Wieand, S | 1 |
| Hyde, NC; Keshtgar, MR; Prvulovich, E | 1 |
| Dehdashti, F; Grigsby, PW; Miller, TR; Pinkus, E | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y; Yoshida, M | 1 |
| Biesma, B; Hoekstra, CJ; Hoekstra, OS; Schramel, FJ; Smit, EF; Stroobants, SG; van Tinteren, H; van Zandwijk, N; Vansteenkiste, J | 1 |
| Dehdashti, F; Grigsby, PW; Mutch, DG; Siegel, BA | 1 |
| Adachi, S; Hamanaka, A; Kadoh, T; Kono, M; Kotani, Y; Monzawa, S; Ohbayashi, K; Sakamoto, S; Senda, M; Sugimura, K; Takada, Y; Uotani, K | 1 |
| Choi, CW; Choi, SC; Kim, MH; Lee, KH; Ryu, SY | 1 |
| Goerres, GW; Mosna-Firlejczyk, K; Stoeckli, SJ | 1 |
| Alavi, A; Bhargava, P; Zhuang, H | 1 |
| Dehdashti, F; Grigsby, PW; Lewis, JS; Mintun, MA; Siegel, BA; Welch, MJ | 1 |
| Buell, U; Cremerius, U; Hochstenbag, M; Lamers, R; Reinartz, P; ten Velde, G; Zimny, M | 1 |
| Endo, K; Higuchi, T; Inoue, T; Khan, N; Oriuchi, N; Sato, N; Tian, M; Zhang, H | 1 |
| Ell, P; Hyde, NC; Newman, L; Prvulovich, E; Visvikis, D; Waddington, WA | 1 |
| Dehdashti, F; Grigsby, PW; Herzog, TJ; Siegel, BA; Singh, AK | 1 |
| Kim, BT; Kim, K; Kim, TS; Lee, KS; Shim, YM; Yoon, YC | 1 |
| Bandhauer, F; Goerres, GW; Huguenin, P; Schmid, DT; Schmid, S; Stoeckli, SJ; von Schulthess, GK | 1 |
| Eyrich, GK; Goerres, GW; Grätz, KW; Schmid, DT; von Schulthess, GK | 1 |
| Balkay, L; Galuska, L; Goda, K; Juhász, I; Krasznai, Z; Márián, T; Mikecz, P; Nagy, H; Szabó, G; Szincsák, N; Trón, L | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Eyrich, GK; Grätz, K; Hugenin, P; Sigg, MB; Steinert, H; Stoeckli, S | 1 |
| Nguyen, BD | 1 |
| Endo, K; Mogi, K; Nakasone, Y; Tian, M; Zhang, H | 1 |
| Mukherji, SK; Wolf, GT | 1 |
| Ham, H; Loose, D; Otte, A; Van de Wiele, C; Vermeersch, H | 1 |
| Groen, H; Heeren, PA; Jager, PL; Plukker, JT; van Dullemen, HM; van Westreenen, HL | 1 |
| Bartenstein, P; Benz, P; Förster, GJ; Jeong, JH; Kunkel, M; Reichert, TE; Wagner, W; Whiteside, TL | 1 |
| Bartenstein, P; Grünwald, F; Junginger, T; Kneist, W; Oberholzer, K; Schreckenberger, M | 1 |
| Anzai, Y; Coltrera, M; Eary, J; Krohn, K; Rajendran, J; Schwartz, DL; Yueh, B | 1 |
| Bartenstein, P; Helisch, A; Kunkel, M; Reichert, TE; Wagner, W | 1 |
| Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Hoekstra, OS; Leemans, CR | 1 |
| Saunders, M; Wong, WL | 2 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sano, K; Yonekura, Y | 1 |
| Liu, XB; Sun, YE; Tian, JH; Wang, K; Wang, T; Yao, SL | 1 |
| Chen, JT; Chen, WJ; Hsueh, S; Lai, CH; Lai, CR; Lin, WJ; Ma, SY; Ng, KK; See, LC; Yah-Huei, CW; Yen, TC | 1 |
| Goldsmith, SJ; Kostakoglu, L | 1 |
| Dietz, A; Dollner, R; Harms, W; Henze, M; Jungehülsing, M; Rudat, V | 1 |
| Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van der Laan, BF | 1 |
| Cappellari, JO; Geisinger, K; Greven, KM; Keyes, JW; McGuirt, WF; Rogers, JW; Watson, NE; Williams, DW | 1 |
| Dong, JC; Guan, YH; He, SL | 1 |
| Becker, K; Beer, A; Brücher, BL; Fink, U; Lordick, F; Schwaiger, M; Siewert, JR; Stein, HJ; Weber, WA; Wieder, HA; Zimmermann, F | 1 |
| Gonen, M; Kraus, D; Larson, SM; Schöder, H; Yeung, HW | 1 |
| Chan, SC; Chang, JT; Liu, SH; Ng, SH; Yen, TC | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 1 |
| Buck, AK; Glatting, G; Halter, G; Hetzel, M; Liewald, F; Neumaier, B; Reske, SN; Schirrmeister, H; Sunder-Plassmann, L; Wurziger, I | 1 |
| Eyrich, GK; Goerres, GW; Schmid, DT | 1 |
| Gillessen, S; Joerger, M; Klaeser, B; Kluckert, JT; Schmid, HP; Warzinek, T | 1 |
| Aksoy, E; Buck, AK; Glatting, G; Halter, G; Hetzel, M; Liewald, F; Mühling, B; Neumaier, B; Nüssle-Kügele, K; Reske, SN; Schirrmeister, H; Sunder-Plassmann, L | 1 |
| Daisne, JF; Geets, X; Gregoire, V; Hamoir, M; Lonneux, M | 1 |
| Bongaerts, F; Heeren, PA; Jager, PL; Plukker, JT; Sluiter, W; van Dullemen, H | 1 |
| Flamen, P | 1 |
| Chang, WC; Hung, YC; Kao, CH; Lin, CC; Shen, YY | 1 |
| Dietlein, M; Eschner, W; Jungehülsing, M; Schicha, H; Schmalenbach, M; Schmidt, M; Schröder, U; Stennert, E; Theissen, P | 1 |
| Buatti, JM; Dornfeld, KJ; Funk, GF; Graham, MM; Graham, SM; Hoffman, HT; Menda, Y; Skwarchuk, M; Smith, RB; Yao, M | 1 |
| Daisne, JF; Duprez, T; Grégoire, V; Hamoir, M; Lonneux, M; Reychler, H; Weynand, B | 1 |
| Conessa, C; Foehrenbach, H; Hervé, S; Poncet, JL | 1 |
| Ball, DL; Binns, D; Hicks, RJ; Hogg, A; Mac Manus, MP; Matthews, JP; Peters, LJ; Rischin, D | 1 |
| Ajani, JA; Correa, AM; Cox, JD; Erasmus, J; Hong, D; Komaki, RR; Lee, HK; Macapinlac, H; Maish, M; Putnam, JB; Rice, DC; Roth, JA; Smythe, WR; Swisher, SG; Thai, L; Vaporciyan, AA; Walsh, GL; Wu, TT | 1 |
| Burrell, SC; Case, MA; Haddad, RI; McCollum, AD; Norris, CM; Posner, MR; Tishler, RB; Van den Abbeele, AD | 1 |
| Corry, J; Hicks, RJ; Hogg, A; Matthews, JP; Peters, LJ; Porceddu, S; Rischin, D; Ware, RE | 1 |
| Ajani, JA; Bresalier, R; Correa, AM; Erasmus, JJ; Komaki, R; Macapinlac, H; Maish, M; Munden, RF; Putnam, JB; Rice, D; Roth, JA; Smythe, WR; Swisher, SG; Vaporciyan, AA; Walsh, GL; Wu, TT | 1 |
| Büll, U; Coenen, HH; Dimartino, E; Eble, MJ; Gagel, B; Hamacher, K; Maneschi, P; Pinkawa, M; Reinartz, P; Stanzel, S; Westhofen, M; Zimny, M | 1 |
| Conrad, GR; Holzhauer, M; Sinha, P | 1 |
| Mackie, GC; Yarram, SG | 1 |
| Liu, FY; Shang, JB; Wang, QS; Zhang, XL | 1 |
| Baldetorp, B; Brun, E; Fallenius, G; Kjellén, E; Tennvall, J; Wennerberg, J | 1 |
| Choe, YS; Choi, JY; Choi, Y; Jang, HJ; Kim, BT; Kim, K; Lee, KH; Lee, KS; Shim, YM | 1 |
| Georg, T; Graeter, TP; Hellwig, D; Kirsch, CM; Schäfers, HJ; Ukena, D | 1 |
| Agarwala, SS; Andrade, RS; Avril, N; Flickinger, J; Heron, DE; Johnson, J; Kalnicki, S; Wu, A | 1 |
| Lowe, JE; Lyburn, ID; Wong, WL | 1 |
| Boardman, CH; Fey, GL; Lopatina, OA; Spottswood, SE | 1 |
| Hain, SF | 1 |
| Groen, H; Heeren, PA; Jager, PL; Plukker, JT; van der Jagt, EJ; van Dullemen, HM; van Westreenen, HL | 1 |
| Corry, J; Hicks, RJ; Jarmolowski, E; Peters, LJ; Porceddu, SV; Rischin, D; Ware, R; Weih, L | 1 |
| Anzai, Y; Coltrera, MD; Eary, J; Ford, E; Haynor, D; Kinahan, P; Krohn, K; Laramore, GE; Leblanc, M; Lewellyn, B; Mattes, D; Meyer, J; Phillips, M; Rajendran, J; Schwartz, DL; Virgin, J; Yueh, B | 1 |
| Buatti, JM; Dornfeld, KJ; Funk, GF; Graham, MM; Hoffman, HT; Smith, RB; Yao, M | 1 |
| Barrio, J; Czernin, J; Halpern, BS; Mellinghoff, IK; Phelps, ME; Rozengurt, N; Safaei, A; Satyamurthy, N; Sawyers, CL; Silverman, DH; Stout, D; Tran, C; Waldherr, C; Weber, WA | 1 |
| Dehdashti, F; Grigsby, PW; Herzog, TJ; Mutch, DG; Rader, J; Siegel, BA; Zoberi, I | 1 |
| Hayashi, T; Higashiyama, S; Kawabe, J; Kawamura, E; Kotani, J; Oe, A; Osugi, H; Shiomi, S; Torii, K | 1 |
| Farag, I; Hain, SF; Jones, J; McGurk, M | 1 |
| Kraus, DH; Kutler, DI; Wong, RJ | 1 |
| Chan, SC; Chang, JT; Chang, YC; Fu, YK; Lin, CY; Lin, KJ; Lin, WJ; Ng, SH; Yen, TC | 1 |
| Adler, L; Doss, M; Freedman, G; Haluszka, O; Hanlon, A; Konski, A; Milestone, B | 1 |
| Davis, LW; Halkar, R; Howell, R; Koshy, M; Paulino, AC; Schuster, D | 1 |
| Anzai, Y; Coltrera, MD; Eary, J; Ford, EC; Haynor, D; Kinahan, P; Krohn, K; Laramore, GE; Leblanc, M; Lewellen, B; Mattes, D; Meyer, J; Phillips, M; Rajendran, J; Schwartz, DL; Virgin, J; Yueh, B | 1 |
| Bares, R; Claussen, C; Claussen, CD; Dammann, F; Eschmann, S; Hoffman, J; Horger, M; Mueller-Berg, M; Schlemmer, H | 1 |
| Ahn, SD; Choi, EK; Choi, SH; Im, KC; Kim, JH; Kim, JS; Kim, SB; Kim, SY; Lee, BJ; Lee, SW; Moon, DH; Nam, SY; Oh, SJ; Ryu, JS; Shin, SS; Yi, BY | 1 |
| Buatti, JM; Funk, GF; Graham, MM; Hoffman, HT; Smith, RB; Yao, M | 1 |
| Fee, WE; Le, QT; Pinto, HA; Ryan, WR | 1 |
| Davis, LW; Howell, R; Koshy, M; Paulino, AC; Schuster, D | 1 |
| Cho, SB; Chung, KY; Chung, WG; Lee, JD; Lee, MG; Yun, M | 1 |
| Chan, SC; Chang, JT; Chang, YC; Chen, TM; Kang, CJ; Liao, CT; Lin, KJ; Ng, SH; See, LC; Wang, HM; Wu, YF; Yen, TC | 1 |
| Hirabayashi, H; Maeda, J; Matsuda, H; Ohta, M | 1 |
| Ahn, YC; Bae, DS; Choi, JY; Huh, SJ; Kim, BG; Kim, BH; Lee, J; Lim, DH; Park, W; Park, YJ | 1 |
| Chan, SC; Chang, JT; Chang, YC; Chen, IH; Chen, TM; Kang, CJ; Liao, CT; Lin, CY; Lin, KJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Bhatnagar, AK; Heron, DE; Schaitkin, B | 1 |
| Cumming, P; Horsman, MR; Keiding, S; Munk, OL; Sørensen, M | 1 |
| Chan, SC; Chang, JT; Ko, SF; Liao, CT; Ng, SH; Wang, HM; Wong, HF; Yen, TC | 1 |
| Huber, M; Mirzaei, S; Mostbeck, G; Oschatz, E; Prosch, H; Strasser, G | 1 |
| Goshen, E; Oksman, Y; Rotenberg, G; Talmi, YP; Yahalom, R; Zwas, ST | 1 |
| Endo, K; Higuchi, T; Mogi, K; Nakajima, N; Nakasone, Y; Oriuchi, N; Takata, K; Tian, M; Zhang, H | 1 |
| Buatti, JM; Chang, K; Dornfeld, KJ; Funk, GF; Graham, MM; Graham, SM; Hoffman, HT; Menda, Y; Smith, RB; Tan, H; Yao, M | 1 |
| Daisne, JF; Geets, X; Gregoire, V | 1 |
| Ichinose, A; Jingu, K; Kaneta, T; Nemoto, K; Ogawa, Y; Takai, Y; Yamada, S | 1 |
| Graham, MM; Menda, Y | 1 |
| Grosu, AL; Nieder, C | 1 |
| Hoskin, P; Short, S; Wong, W | 1 |
| Bonardel, G; Foehrenbach, H; Gontier, E; Guigay, J; L'Her, P; Mantzarides, M; Salles, Y; Vaylet, F | 1 |
| Ferlito, A; Genden, EM; Gourin, CG; Kowalski, LP; Leemans, CR; Lefebvre, JL; Lowry, J; Medina, JE; Pellitteri, PK; Rinaldo, A; Robbins, KT; Shah, JP; Shaha, AR; Suárez, C; Weber, RS; Wei, WI | 1 |
| Cavalcanti, MG; Chojniak, R; Dos Santos, DT; Pereira Lima, EN | 1 |
| Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Golding, RP; Hoekstra, OS; Leemans, CR; Senft, A | 1 |
| Gor, DM; Langer, JE; Loevner, LA | 1 |
| Grigsby, PW; Hope, AJ; Saha, P | 1 |
| Bartenstein, P; Benz, P; Buchholz, HG; Helisch, A; Jeong, JH; Kunkel, M; Reichert, TE; Wagner, W; Whiteside, TL | 1 |
| Branstetter, BF; Johnson, JT; Nayak, JV; Zimmer, LA | 1 |
| Hayashi, T; Higashiyama, S; Kawabe, J; Kawamura, E; Kotani, J; Kurooka, H; Oe, A; Sakamoto, H; Shiomi, S; Torii, K; Wanibuchi, H | 1 |
| Arens, A; de Jong, J; Kremer, B; Lambin, P; Thimister, P; van Baardwijk, A; Verseput, G | 1 |
| Campa, J; Finn, R; Forster, G; Humm, J; Larson, S; Ling, C; Polycarpe-Holman, D; Zanzonico, P | 1 |
| Bar-Shalom, R; Daitzchman, M; Doweck, I; Golz, A; Gordin, A; Israel, O; Keidar, Z; Kuten, A; Yefremov, N | 1 |
| Bradford, CR; Mukherji, SK | 1 |
| Dietl, B; Kölbl, O; Kühnel, T; Marienhagen, J; Schaefer, C | 1 |
| Daisne, JF; Duprez, T; Geets, X; Grégoire, V; Lonneux, M; Tomsej, M | 1 |
| Grigsby, PW; Lin, LL; Miller, TR; Mutic, S; Yang, Z | 1 |
| Blackstock, AW; Clark, P; Farmer, MR; Geisinger, KR; Ho, C; Levine, EA; Lovato, J; Melin, SA; Mishra, G; Oaks, T | 1 |
| Kraus, DH; Kutler, DI; Schoder, H; Wong, RJ | 1 |
| Boellaard, R; Börjesson, PK; Castelijns, JA; Comans, EF; de Bree, R; Jauw, YW; Kummer, JA; Lammertsma, AA; Leemans, CR; Roos, JC; van Dongen, GA; Vosjan, MJ | 1 |
| Biswal, S; Do, B; Gambhir, SS; Kalinyak, J; Mari, C; Quon, A | 1 |
| Chen, AY; Halkar, R; Hudgins, PA; Schuster, D; Vilaseca, I | 1 |
| Pickles, J; Price, T | 1 |
| Marres, HA; Merkx, MA; Oyen, WJ; Postema, EJ; van den Hoogen, FJ; Vogel, WV; Wensing, BM | 1 |
| Masaoka, T; Sato, T; Shiono, S; Yanagawa, N | 1 |
| Everitt, C; Leong, T | 1 |
| Brkovich, VS; Hussey, DH; Karnad, AB; McGuff, HS; Miller, FR; Otto, RA | 1 |
| Andrade, RS; Avril, N; Branstetter, BF; Degirmenci, B; Ferris, RL; Filho, PA; Heron, DE; Seethala, RR | 1 |
| Plukker, JT; Sloof, GW; Van Lanschot, JJ; Van Westreenen, HL; Westerterp, M | 1 |
| Chao, KS; Chen, S; Fu, Z; Guo, H; Liu, T; Yang, G; Yang, X; Yin, Y; Yu, J; Yu, Y; Yuan, S | 1 |
| Waldron, JN | 1 |
| Chan, SC; Chang, JT; Kang, CJ; Ko, SF; Lee, LY; Liao, CT; Ng, SH; Wang, HM; Wong, AM; Yen, TC | 1 |
| Ho, L; Jadvar, H; Seto, J | 1 |
| Sloof, GW | 1 |
| Grierson, JR; Krohn, KA; Ng, P; O'Sullivan, J; Peterson, LM; Rajendran, JG; Scharnhorst, J; Schwartz, DL | 1 |
| Choi, JY; Kim, BT; Lee, KS; Shim, YM; Sung, YM; Yi, CA | 1 |
| Gangarosa, LM; Khandani, AH; Socinski, MA; Stinchcombe, TE | 1 |
| Endoh, K; Gotoh, M; Hasegawa, T; Higuchi, M; Kanno, R; Suzuki, H; Teranishi, Y | 1 |
| Barberet, M; Cammilleri, S; Fakhry, N; Giovanni, A; Lussato, D; Mundler, O; Zanaret, M | 1 |
| Barberet, M; Deveze, A; Fakhry, N; Giovanni, A; Jacob, T; Mundler, O; Paris, J; Zanaret, M | 1 |
| Döbert, N; Kovács, AF; Landes, CA; Walendzik, H; Zaplatnikov, K | 1 |
| Baek, CH; Jeong, HS; Ki Chung, M; Kim, BT; Kim, HJ; Kyung Lee, D; Son, YI; Young Choi, J | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JS; Nam, SY; Roh, JL; Ryu, CH | 1 |
| Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JC; Lee, JH; Lee, SW; Nam, SY | 1 |
| Bao, A; Goins, B; McGuff, HS; Miller, FR; Natarajan, M; Otto, RA; Phillips, WT; Santoyo, C; Woolley, FR; Zheng, X | 1 |
| Bartenstein, P; Brochhausen, C; Buchmann, I; Hansen, T; Junginger, T; Kneist, W; Oberholzer, K; Schreckenberger, M | 1 |
| Clément, P; Conessa, C; Foehrenbach, H; Poncet, JL | 1 |
| Fischbein, NJ; Kaplan, MJ; Le, QT; Loo, BW; McDougall, IR; Pinto, H; Quon, A | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yeo, NK | 1 |
| Gong, M; Li, CL; Yang, JG; Zou, LF | 1 |
| Allen, AM; Haddad, RI; Tishler, RB | 1 |
| Dijkstra, PU; Gravendeel, JP; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF; van der Wal, JE | 1 |
| Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, S; Nam, SY; Pae, KH; Roh, JL | 1 |
| Nguyen, BD; Ram, PC; Roarke, MC | 2 |
| Ahn, MI; Je, SK; Kim, CH; Park, YH | 1 |
| Hirai, T; Katsuragawa, S; Murakami, D; Murakami, R; Nishimura, R; Ota, K; Oya, N; Shiraishi, S; Tomiguchi, S; Uozumi, H; Yamashita, Y | 1 |
| Bar-Shalom, R; Daitzchman, M; Golz, A; Gordin, A; Israel, O; Keidar, Z; Kuten, A | 1 |
| Ahn, SD; Choi, EK; Im, KC; Kim, JH; Kim, JS; Kim, SY; Lee, SW; Nam, SY; Oh, SJ; Shin, SS | 1 |
| Brown, R; Feiglin, D; Hsu, J; Koniarczyk, M; Newman, N; Pohar, S | 1 |
| Kaanders, JH; Oyen, WJ; Schinagl, DA; Van Dalen, JA; Vogel, WV | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, MR; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Choi, SH; Kim, JS; Kim, MR; Kim, SB; Kim, SY; Lee, SW; Nam, SY; Roh, JL | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, CH | 1 |
| Baumann, M; Bergmann, R; Beuthien-Baumann, B; Hessel, F; Kotzerke, J; Schütze, C; Steinbach, J; Yaromina, A | 1 |
| Ahn, JH; Cho, KJ; Choi, KD; Jung, HY; Kim, JH; Kim, MK; Kim, SB; Kim, SY; Kim, YH; Lee, GH; Park, SI; Ryu, JS; Shin, JH; Song, HY | 1 |
| Adelstein, DJ; Carroll, MA; Esclamado, RM; Lorenz, RR; Rybicki, LA; Saxton, JP; Strome, M; Tan, A; Wood, BG | 1 |
| Bong, JS; Cheng, V; Chundru, S; Fink-Bennett, D; Gaskill, M; Grills, I; Kestin, L; Martinez, AA; Schmidt, J; Wong, CY; Yan, D | 1 |
| Cheng, JD; Cohen, SJ; Freedman, G; Goldberg, M; Haluszka, O; Konski, AA; Li, T; Maurer, A; Meropol, NJ; Scott, W; Weiner, LM; Yu, JQ | 1 |
| Buatti, JM; Chang, K; Graham, MM; Hoffman, HT; Luo, P; Menda, Y; Tan, H; Yao, M | 1 |
| Coche, E; Cosnard, G; Duprez, T; Geets, X; Grégoire, V; Lee, JA; Lonneux, M; Tomsej, M | 1 |
| Connell, CA; Corry, J; Hicks, RJ; Hogg, A; Milner, AD; Peters, LJ; Rischin, D | 1 |
| Chen, XX; Fu, Z; Mu, DB; Sun, XR; Wang, SP; Yang, WF; Yu, JM | 1 |
| Asadpour, B; Coenen, HH; Demirel, C; DiMartino, E; Eble, MJ; Gagel, B; Hamacher, K; Kaiser, HJ; Maneschi, P; Pinkawa, M; Piroth, M; Reinartz, P; Scholbach, T; Stanzel, S; Zimny, M | 1 |
| Bar-Shalom, R; Daitzchman, M; Golz, A; Gordin, A; Israel, O; Keidar, Z | 1 |
| Al-Nahhas, A; Ambrosini, V; D'Errico, A; Fabbri, M; Fanti, S; Fini, M; Franchi, R; Nanni, C; Pettinato, C; Rubello, D; Spinelli, A; Trepidi, S; Zompatori, M | 1 |
| Chen, Y; Cui, NJ; Ma, J; Sun, Y; Tang, LL; Wang, Y; Wu, HB; Zong, JF | 1 |
| Hofmeyr, A; Lau, WF; Slavin, MA | 1 |
| Chambers, J; Damani, N; Katsoulis, IE; Livingstone, JI; Mattheou, AK; Wong, WL | 1 |
| Fu, Z; Guo, H; Huang, Y; Li, L; Xi, Y; Yang, G; Yu, J; Yuan, S; Zhang, B; Zhang, J; Zhu, H | 1 |
| Barberet, M; Fakhry, N; Giovanni, A; Lussato, D; Mundler, O; Zanaret, M | 1 |
| Abgral, R; Bizais, Y; Couturier, O; Kraeber-Bodéré, F; Querellou, S; Salaun, PY; Valette, G | 1 |
| Dietl, B; Kölbl, O; Marienhagen, J; Murthum, T | 1 |
| Fu, Z; Guo, HB; Li, WW; Liu, TH; Yang, GR; Yang, XH; Yu, JM; Yu, YH; Yuan, SH | 1 |
| Mittra, E; Niederkohr, R; Rodriguez, C; Segall, G; Vasanawala, M | 1 |
| Brugières, P; Capacchione, D; Créange, A; Evangelista, E; Itti, E; Kallel, F; Lefaucheur, JP; Meignan, M; Ortonne, N; Paone, G | 1 |
| Basu, D; McDonald, DJ; Nussenbaum, B; Siegel, BA | 1 |
| Bybel, B | 1 |
| Abreu-E-Lima, P; Gerbaudo, VH; Mamede, M; Mamon, H; Nosé, V; Oliva, MR | 1 |
| Fukuda, H | 1 |
| Dehdashti, F; Grigsby, PW; Kidd, EA; Siegel, BA | 1 |
| Horiuchi, C; Inoue, T; Kawakami, M; Matsuda, H; Mikami, Y; Nishimura, G; Oka, T; Taguchi, T; Tanigaki, Y; Tsukuda, M; Yoshida, T | 1 |
| Dietl, B; Kölbl, O; Kühnel, T; Marienhagen, J; Schreyer, A | 1 |
| Gerbaudo, VH; Julius, B | 1 |
| Brown, PD; Foote, RL; Garces, YI; Kasperbauer, JL; Lowe, VJ; Shintani, SA | 1 |
| Balogova, S; Chater, PE; Grahek, D; Hugentobler, A; Kerrou, K; Montravers, F; Périé, S; St Guily, JL; Susini, B; Talbot, JN | 1 |
| Galysh, RL; Hernandez, A; Jones, DR; Kahaleh, M; McDonough, PB; Northup, PG; Shami, VM; Shen, KR; White, GE | 1 |
| Chang, TC; Chao, A; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
| Arima, S; Hasegawa, Y; Nakashima, T; Nishio, M; Ogawa, T; Ozawa, T; Suzuki, H; Suzuki, M; Tamaki, T; Terada, A | 1 |
| Buatti, JM; Dornfeld, K; Fath, MA; Graham, MM; Hichwa, RD; Mattson, DM; Simons, AL; Smith, BJ; Spitz, DR; Walsh, SA | 1 |
| Hoffmann, AL; Kaanders, JH; Oyen, WJ; Schinagl, DA; van Dalen, JA; Vogel, WV | 1 |
| Aigner, RM; Feichtinger, M; Kärcher, H | 1 |
| Chen, T; Guo, W; Huang, G; Li, SJ; Ren, GX; Song, SL | 1 |
| Buatti, J; Dornfeld, K; Dornfeld, M; Funk, G; Graham, M; Hopkins, S; Karnell, L; Karnell, M; Menda, Y; Simmons, J; Smith, R; Spitz, DR; Yao, M | 1 |
| Bilodeau, PA; Coleman, TA; Gourin, CG; Patel, VS; Watts, TL; Williams, HT | 1 |
| Chen, T; Huang, G; Liu, JJ; Song, SL; Song, YY; Sun, XG; Wang, ZH | 1 |
| Demeaux, H; Fernandez, P; Gindre, A; Guyot, M; Laurentjoye, M; Majoufre-Lefebvre, C; Ricard, AS; Siberchicot, F | 1 |
| Li, G; Zhang, Y; Zhuang, H | 1 |
| Brouwer, J; Castelijns, JA; de Bree, R; Hoekstra, OS; Hooft, L; Leemans, CR; Riphagen, II | 1 |
| Campbell, BH; Maheshwari, M; Massey, BL; Michel, MA; Schultz, CJ; Vernon, MR; Wang, D; Wilson, JF; Wong, SJ | 1 |
| Doki, Y; Fujiwara, Y; Higuchi, I; Hirao, T; Makari, Y; Matsuyama, J; Miyata, H; Monden, M; Takiguchi, S; Yamasaki, M; Yasuda, T | 1 |
| Bae, DS; Huh, SJ; Lee, JA; Oh, D | 1 |
| Damrose, EJ | 1 |
| Friedrich, G; Gugatschka, M; Schwarz, T | 1 |
| Ikeda, K; Katahira, K; Kawanaka, K; Mori, T; Nomori, H; Shiraishi, S; Yamashita, Y | 1 |
| Cicone, F; Deron, P; Loose, D; Scopinaro, F; Signore, A; Van de Vyvere, F; Van de Wiele, C; Vermeersch, H | 1 |
| de Bree, R; Golding, RP; Hoekstra, OS; Kuik, DJ; Leemans, CR; Oyen, WJ; Pruim, J; Roodenburg, JL; Senft, A; van den Hoogen, FJ | 1 |
| Chao, M; Feigen, M; Joon, DL; Joon, ML; Kai, C; Khoo, V; Nguyen, BT; Quong, G; Rykers, K; Scott, A; See, A; Wada, M; Zupan, E | 1 |
| Bartenstein, P; Brochhausen, C; Buchholz, HG; Buchmann, I; Haberkorn, U; Hansen, T; Schmidtmann, I | 1 |
| Bisdas, S; Rumboldt, Z; Spicer, K | 1 |
| Chan, SC; Chang, JT; Chin, SC; Fan, KH; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Boughanim, M; Duvillard, P; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Pham, CT; Rey, A; Schlumberger, M; Zafrani, Y | 1 |
| El-Haddad, G; Lilien, DL; Patterson, JC; Takalkar, AM | 1 |
| Inubushi, M; Kanegae, K; Kitagawa, Y; Notani, K; Saitoh, M; Takinami, S; Tamaki, N; Tei, K; Totsuka, Y; Yamazaki, Y | 1 |
| Precht, LM; Vallières, E | 1 |
| Chao, A; Cheng, HH; Ho, KC; Lai, CH; Lin, G; Wang, CC; Yen, TC | 1 |
| Abe, Y; Endo, S; Fukuda, H; Hatazawa, J; Ido, T; Ito, M; Iwata, R; Kubota, K; Matsuzawa, T; Sato, T; Takahashi, T; Yamada, K | 1 |
| Arnold, W; Avril, N; Herz, M; Kau, RJ; Kruschke, C; Laubenbacher, C; Saumweber, D; Schwaiger, M; Wagner-Manslau, C; Ziegler, S | 1 |
| Austin, JR; Kim, EE; Wong, FC | 1 |
| Alavi, A; Buchpiguel, C; Chin, BB; Zukerberg, BW | 1 |
| Bishop, J; Frank, A; Gobar, L; Gupta, N; Jaeger, S; Lefkowitz, D; Lynch, H; Mailliard, J; Scott, W; Sunderland, J | 1 |
| Hubner, KF; Raja, S; Yasuda, S | 1 |
| Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Boering, G; Braams, JW; Freling, NJ; Nikkels, PG; Pruim, J; Roodenburg, JL; Vaalburg, W; Vermey, A | 1 |
| Clavo, AC; Grénman, R; Minn, H; Wahl, RL | 1 |
| Drane, WE; Landau, S; Mancuso, AA; Mukherji, SK; Tart, RP | 1 |
| Dimitrakopoulou-Strauss, A; Haberkorn, U; Reisser, C; Seifert, E; Strauss, LG | 1 |
| Black, M; Gjedde, A; Yamamoto, YL; Zeitouni, AG | 1 |
| Drane, WE; Mancuso, AA; Mukherji, SK | 1 |
| Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Raben, M; Randall, ME; Watson, NE; Williams, DW | 1 |
| Aitasalo, K; Happonen, RP; Minn, H | 1 |
| Haberkorn, U; Reisser, C; Strauss, LG | 2 |
| Anzai, Y; Chaiken, L; Choi, Y; Hawkins, RA; Hoh, CK; Juillard, G; Lufkin, R; Maddahi, J; Phelps, ME; Rege, SD | 1 |
| Couson, F; Donath, A; Junod, AF; Lemoine, R; Louis, O; Nicod, L; Slosman, DO; Spiliopoulos, A | 1 |
| Aberle, DR; Dahlbom, M; Glaspy, JA; Hawkins, RA; Hoh, CK; Phelps, ME; Razavi, MK; Rege, SD | 1 |
| Bergman, J; Joensuu, H; Leskinen-Kallio, S; Lindholm, P; Minn, H; Ruotsalainen, U | 1 |
| Eades, CG; Fahey, FH; Gage, HD; Harkness, BA; Keyes, JW; Pelizzari, CA; Yu, JN | 1 |
| Blahd, W; Brown, C; Khonsary, A; Mandelkern, M; Santiago, SM; Sazon, DA; Soo Hoo, GW; Williams, AJ | 1 |
| Drane, WE; Mancuso, AA; Mendenhall, WM; Mukherji, SK; Parsons, JT; Stringer, S | 1 |
| Becker, M; Benchaou, M; Donath, A; Lehmann, W; Lemoine, R; Rufenacht, D; Slosman, DO | 1 |
| Akashi, Y; Fukumura, T; Ichiya, Y; Kawashima, A; Kuwabara, Y; Masuda, K; Omagari, J; Sasaki, M; Yoshida, T | 1 |
| Chevretton, EB; Hemingway, R; McGurk, M; Wong, W | 1 |
| Clavo, AC; Minn, H; Wahl, RL | 1 |
| Cooper, JD; Dehdashti, F; Flanagan, FL; Patterson, GA; Siegel, BA; Sundaresan, SR; Trask, DD | 1 |
| Nakai, Y; Ochi, H; Ohashi, Y; Okamura, T; Sakamoto, H | 1 |
| Bazzicalupo, L; Fiore, F; Gravina, A; Mainolfi, C; Maurea, S; Panico, MR; Salvatore, M; Wang, H | 1 |
| Deloar, HM; Fujiwara, T; Hayashi, Y; Itoh, M; Kanamaru, R; Miyake, M; Nakamura, T; Takahashi, H; Watabe, H; Yoshioka, T | 1 |
| Baddeley, H; Beaney, R; Chevretton, EB; Davis, J; Hussain, K; Maisey, M; McGurk, M; Tierney, P; Wong, WL | 1 |
| Belani, CP; Ferson, PF; Keenan, RJ; Landreneau, RJ; Luketich, JD; Meltzer, CC; Schauer, PR; Townsend, DW; Urso, GK | 1 |
| Bailey, MS; Block, MI; Cooper, JD; Dehdashti, F; Flanagan, FL; Patterson, GA; Siegel, BA; Sundaresan, RS | 1 |
| Bergman, J; Eronen, E; Grénman, R; Haaparanta, M; Joensuu, H; Klemi, PJ; Lapela, M; Leskinen, S; Lindholm, P; Minn, H | 1 |
| Higashi, K; Nambu, Y; Nishikawa, T; Oguchi, M; Okimura, T; Seki, H; Tonami, H; Ueda, Y; Yamamoto, I; Yuasa, K | 1 |
| Lamonica, D; Myers, LL; Nabi, H; Simpson, GT; Wax, MK | 1 |
| Brun, E; Erlandsson, K; Kjellén, E; Ohlsson, T; Sandell, A; Strand, SE; Tennvall, J; Wennerberg, J | 1 |
| Cheon, EM; Han, J; Kim, BT; Kim, Y; Kwon, OJ; Lee, KS; Rhee, CH; Shin, MH; Yoon, SB | 1 |
| Hayashi, N; Ishii, Y; Nakaumra, S; Sadato, N; Takahashi, N; Tsuchida, T; Uematsu, H; Waki, A; Yonekura, Y | 1 |
| Kapucu, LO; Keenan, RJ; Luketich, JD; Meltzer, CC; Townsend, DW | 1 |
| Adamietz, IA; Adams, S; Baum, RP; Bormeth, SB; Böttcher, HD; Hör, G; Mose, S; Rahn, AN; Sengupta, S | 1 |
| Braams, JW; Nikkels, PG; Nooren, CA; Roodenburg, JL; Vaalburg, W; Vermey, A; Witjes, MJ | 1 |
| Adams, S; Baum, RP; Bitter, K; Hör, G; Stuckensen, T | 1 |
| AAssar, OS; Caputo, GR; Dillon, WP; Fischbein, NJ; Hawkins, RA; Kaplan, MJ; Price, DC; Singer, MI | 2 |
| Benz, P; Grötz, KA; Kuffner, HD; Kunkel, M; Spitz, J; Wagner, W; Wahlmann, U | 1 |
| Bruchhaus, H; Hillinger, S; Schmid, RA; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Collignon, J; Deneufbourg, JM; Hustinx, R; Moreau, P; Paulus, P; Rigo, P; Sambon, A; Vivegnis, D | 1 |
| Couper, GW; McAteer, D; Nicolson, M; Norton, M; Park, KG; Wallis, F; Welch, A | 1 |
| Bishop, H; Gill, H; Graeber, G; Gupta, N; Hurst, J; Stephens, T | 1 |
| Boyd, J; Dunphy, F; Kim, HJ; Lowe, V | 1 |
| Myers, LL; Wax, MK | 1 |
| Fukuchi, K; Hamada, S; Hayashida, K; Ishida, Y; Nakanishi, N; Nishimura, T; Satoh, T; Shimotsu, Y; Takamiya, M; Toba, M | 1 |
| Kawabe, J; Kitayama, H; Matsuda, M; Nakai, Y; Nasako, Y; Ochi, H; Ohashi, Y; Okamura, T; Sakamoto, H; Sakashita, T | 1 |
| Ali, A; Cai, J; Chu, JC; Nguyen, C; Recine, D; Rodebaugh, R; Saxena, VA; Sharma, M | 1 |
| Johkoh, T; Kusuoka, H; Miyoshi, S; Nakamura, H; Nishimura, T; Tatsumi, M; Tomiyama, N; Watanabe, Y; Yutani, K | 1 |
| Hanasono, MM; Ku, GH; Kunda, LD; Segall, GM; Terris, DJ | 1 |
| Alavi, A; Benard, F; Chalian, AA; Farber, LA; Machtay, M; Rosenthal, DI; Smith, RJ; Weber, RS; Weinstein, GS | 1 |
| Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Greven, KM; Joyce, WT; Keyes, JW; McGuirt, WF; Williams, DW | 1 |
| Eisbruch, A; Kison, PV; Kosuda, S; Recker, BE; Sugawara, Y; Wahl, RL | 1 |
| Azuma, H; Ishii, Y; Kitagawa, Y; Ogasawara, T; Sadato, N; Yonekura, Y; Yoshida, M | 1 |
| Bohuslavizki, KH; Clausen, M; Klutmann, S; Kröger, S; Mester, J; Sonnemann, U; Thoms, J; Werner, JA | 1 |
| Aloj, L; Caracó, C; Eckelman, WC; Jagoda, E; Neumann, RD | 1 |
| Damgaard, K; Daugaard, G; Eigtved, A; Friberg, L; Lassen, U | 1 |
| Alexiou, C; Arnold, W; Kau, RJ; Laubenbacher, C; Schwaiger, M; Werner, M | 1 |
| Birzgalis, AR; Collins, CD; Cowan, RA; Farrington, WT; Hastings, DL; Johnson, RJ; Slevin, NJ; Swindell, R; Waller, ML | 1 |
| Hoekstra, A; Stokkel, MP; van Rijk, PP | 1 |
| Hordijk, GJ; Koole, R; Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Chen, MY; Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Meyer, MA; Nathan, CO | 1 |
| Smith, TA; Titley, J | 1 |
| Allal, A; Bang, P; Becker, M; Dulguerov, P; Guyot, JP; Haenggeli, CA; Lehmann, W; Slosman, D | 1 |
| Choi, JY; Kim, BT; Kim, JJ; Kim, SE; Lee, KH; Lee, KS; Shim, YM | 1 |
| Büll, U; Cremerius, U; Di Martino, E; Hausmann, R; Krombach, GA; Nowak, B; Sellhaus, B; Westhofen, M | 1 |
| Benz, P; Förster, GJ; Kuffner, HD; Kunkel, M; Reichert, TE; Wagner, W | 1 |
| Clavo, AC; Fisher, SJ; Minn, H; Wahl, RL | 1 |
| Beyer, T; Brun, T; Byars, L; Charron, M; Jerin, J; Kinahan, PE; Nutt, R; Roddy, R; Townsend, DW; Young, J | 1 |
| Grahek, D; Kerrou, K; Monceaux, G; Montravers, F; Périé, S; St Guily, JL; Talbot, JN | 1 |
| Damm, M; Eckel, H; Jungehülsing, M; Pietrzyk, U; Scheidhauer, K; Schicha, H; Stennert, E | 1 |
| Bormans, G; Coosemans, W; De Leyn, P; De Wever, W; Dupont, P; Ectors, N; Flamen, P; Haustermans, K; Hiele, M; Lerut, A; Mortelmans, L; Peeters, M; Stroobants, S; Van Cutsem, E; Van Raemdonck, D | 1 |
| Chisin, R; Macapinlac, HA | 1 |
| Chu, J; Delaney, G; Kiat, H; Lin, P; Pocock, N | 1 |
| Charron, M; Dachille, MA; Friedman, D; Luketich, JD; Meehan, M; Meltzer, CC; Strollo, D; Townsend, DW; Urso, GK | 1 |
| Futatsubashi, M; Kanno, T; Kasamatsu, N; Momiki, S; Nobezawa, S; Okada, H; Ouchi, Y; Torizuka, T; Yoshikawa, E | 1 |
| Cambier, JP; De Leyn, P; De Wever, W; Flamen, P; Lerut, A; Maes, A; Mortelmans, L; Peeters, M; Van Cutsem, E; Van Raemdonck, D | 1 |
| Fujibayashi, Y; Itoh, H; Sadato, N; Sugimoto, K; Takahashi, N; Tsuchida, T; Waki, A; Welch, MJ; Yonekura, Y | 1 |
| Aigner, RM; Karpf, E; Schwarz, T; Wurzinger, G | 1 |
| Benard, F; Boileau, R; Mongeau, CJ; Turcotte, E; Verreault, J | 1 |
| Albrecht, SR; Allal, AS; Allaoua, M; Becker, M; Dulguerov, P; Goerres, GW; Haenggeli, CA; Lehmann, W; Slosman, DO | 1 |
| Akiyama, Y; Hara, T; Inagaki, K; Kudo, K; Morita, T; Soma, T; Suzuki, T; Takeda, Y; Tnabe, M; Yano, M | 1 |
| de Klerk, JM; Hordijk, GJ; Stokkel, MP | 1 |
| Alavi, A; Denittis, A; Li, P; Machtay, M; Mozley, PD; Smith, R; Yeh, D; Zhuang, H | 1 |
| D'Costa, I; Fisher, R; Hart, R; Hicks, R; Hughes, P; Peters, L; Rischin, D; Sexton, M; von Roemeling, R | 1 |
| Kim, BT; Kim, K; Lee, KS; Park, SJ; Shim, YM | 1 |
| Avril, N; Bauer, M; Brücher, BL; Fink, U; Schwaiger, M; Siewert, JR; Stein, HJ; Weber, W; Werner, M; Zimmerman, F | 1 |
| Benz, P; Förster, GJ; Grötz, KA; Kunkel, M; Kutzner, J; Rippins, G; Wagner, W; Wahlmann, U | 1 |
| Bhola, R; Lin, EC | 1 |
| Ackermann, R; Börner, AR; Coenen, HH; Hamacher, K; Herzog, H; Langen, KJ; Müller-Mattheis, V | 1 |
| Borges-Neto, S; Ravizzini, GC; Wagner, M | 1 |
| Al Suhaibani, H; Bakheet, S; Kerr, IG; Manji, MF; Powe, J; Subhi, J | 1 |
| Brink, I; Hasse, J; Imdahl, A; Jenkner, S; Moser, E; Nitzsche, E; Stoelben, E | 1 |
| Adams, S; Baum, RP; Kovács, AF; Stuckensen, T | 1 |
| Higashi, K; Katsuda, S; Oguchi, M; Sakuma, T; Seki, H; Taki, S; Taniguchi, M; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Balon, H; Bohdiewicz, P; Chmielewski, GW; Dickinson, C; Dworkin, HJ; Fink-Bennett, D; Hill, JC; Nuñez, R; Pursel, SE; Ravikrishnan, KP; Welsh, RJ; Wong, CY | 1 |
| Hollenbeak, CS; Lowe, VJ; Stack, BC | 1 |
| Lee, D; Marn, CS; Rosenthal, EL; Taylor, R; Teknos, TN | 1 |
| Achtyes, ED; Eisbruch, A; Johnston, CM; Nakamoto, Y; Reynolds, KR; Sugawara, Y; Wahl, RL | 1 |
| Endo, K; Inoue, T; Mogi, K; Nakasone, Y; Negishi, A; Oriuchi, N; Takeuchi, K | 1 |
| Kitagawa, Y; Maruta, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Biassoni, L; Hain, SF; Halfpenny, W; Maisey, MN; McGurk, M; Sherman, JA | 1 |
| Brun, E; Kjellén, E; Ohlsson, T; Perfekt, R; Sandell, A; Strand, SE; Tennvall, J; Wennerberg, J | 1 |
| Choufani, G; Goldman, S; Hassid, S; Sheikholeslam-zadeh, R | 1 |
| Bohuslavizki, KH; Dose, J; Hemminger, GE | 1 |
| Conessa, C; Foehrenbach, H; Gaillard, JF; Kossowski, M; Maszelin, P; Poncet, JL | 1 |
| Cohn, DE; Dehdashti, F; Gibb, RK; Herzog, TJ; Mutch, DG; Rader, JS; Siegel, BA | 1 |
| Pfaltz, M; Schmid, S; Steinert, H; Stoeckli, SJ | 1 |
| Bormans, G; Cambier, JP; De Leyn, P; De Wever, W; Ectors, N; Flamen, P; Haustermans, K; Lerut, A; Maes, A; Mortelmans, L; Van Cutsem, E; Van Raemdonck, D | 1 |
| Grigsby, PW; Miller, TR | 1 |
| Gabalski, EC; Gona, JM; Husain, S; Myers, LL; Nabi, H; Wax, MK | 1 |
| Alavi, A; Cuchiara, A; Hickeson, M; Matthies, A | 1 |
| Bender, D; Bentzen, L; Kaarstad, K; Keiding, S; Munk, OL | 1 |
| Haberkorn, U; Schadel, A; Seifert, E; Strauss, LG | 1 |
| Haberkorn, U; Reisser, C; Strauss, LG; van Kaick, G | 1 |
| Dimitrakopoulou, A; Haag, D; Haberkorn, U; Oberdorfer, F; Reisser, C; Rudat, V; Strauss, LG; van Kaick, G; Ziegler, S | 1 |
| Abe, Y; Fujiwara, T; Fukuda, H; Hatazawa, J; Ido, T; Itoh, M; Kubota, K; Matsuzawa, T; Tada, M; Yamaguchi, K | 1 |
| Abe, Y; Fujiwara, T; Fukuda, H; Itoh, M; Kawai, H; Kubota, K; Matsuzawa, T; Miyazawa, H; Yamaguchi, K; Yamaguchi, T | 1 |
81 review(s) available for fluorodeoxyglucose f18 and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Diagnostic efficacy of combined CT and MRI in detecting nodal metastasis in patients with oral cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mouth Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2022 |
Clinical Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; COVID-19; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2022 |
Diagnostic value of imaging modalities in primary squamous cell carcinoma of the liver.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Liver; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2023 |
Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Expert Testimony; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology | 2023 |
Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer.
Topics: Carcinoma, Squamous Cell; Female; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms | 2023 |
Prognostic and predictive values of baseline and mid-treatment FDG-PET in oropharyngeal carcinoma treated with primary definitive (chemo)radiation and impact of HPV status: Review of current literature and emerging roles.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Pre- and post-treatment FDG PET-CT as a predictor of patient outcomes in anal squamous cell carcinoma: A systematic review and meta-analysis.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma-a review.
Topics: Biopsy; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Larynx; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2021 |
Squamous cell carcinoma of the tongue with cardiac metastasis on 18F-FDG PET/CT: A case report and literature review.
Topics: Adult; Carcinoma, Squamous Cell; Fatal Outcome; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymph Nodes; Medical Illustration; Neck Dissection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tongue; Tongue Neoplasms | 2021 |
Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2017 |
Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.
Topics: Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiopharmaceuticals | 2017 |
Molecular Imaging-Guided Radiotherapy for the Treatment of Head-and-Neck Squamous Cell Carcinoma: Does it Fulfill the Promises?
Topics: Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Molecular Imaging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided | 2018 |
Cervical metastasis of gingival carcinoma misdiagnosed as branchiogenic carcinoma, a rare entity - report of a case and review of literature.
Topics: Branchioma; Carcinoma, Squamous Cell; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Lymphatic Metastasis; Middle Aged; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Survival Analysis; Tumor Burden | 2018 |
Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Endosonography; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2013 |
Evaluation and staging of squamous cell carcinoma of the oral cavity and oropharynx: limitations despite technological breakthroughs.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Sentinel Lymph Node Biopsy | 2013 |
Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Frontal meningioma incidentally detected in the routine preoperative assessment of tongue cancer: a case report and literature review.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Frontal Bone; Humans; Incidental Findings; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Neoplasms, Multiple Primary; Positron-Emission Tomography; Preoperative Care; Tongue Neoplasms; Treatment Outcome | 2013 |
Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2014 |
Meta-analysis of (18) fluorodeoxyglucose positron emission tomography-CT for diagnosis of lung malignancies in patients with head and neck squamous cell carcinomas.
Topics: Carcinoma, Squamous Cell; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Sensitivity and Specificity | 2015 |
18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
[Metabolic tailoring in radiotherapy for head and neck cancer].
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Clinical Trials as Topic; Diffusion Magnetic Resonance Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Misonidazole; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tumor Burden | 2014 |
¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Incidence; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2015 |
The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Tumor Burden | 2015 |
Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[Role of positron emission tomography and CT with 18F-FDG PET-CT in follow-up of patients treated for head and neck squamous cell carcinoma].
Topics: Carcinoma, Squamous Cell; Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Use of 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography for Patient Management and Outcome in Oropharyngeal Squamous Cell Carcinoma: A Review.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
(18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2016 |
Effectiveness of FDG-PET/CT for evaluating early response to induction chemotherapy in head and neck squamous cell carcinoma: A systematic review.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2016 |
The predictive value of 18F-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after neoadjuvant chemoradiotherapy: a meta-analysis.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Databases, Factual; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Odds Ratio; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2016 |
Novel imaging approaches to head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Diagnostic Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Misonidazole; Oxygen; Positron-Emission Tomography | 2008 |
Surgical salvage of cancer of the oropharynx after chemoradiation.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Quality of Life; Salvage Therapy; Treatment Failure | 2009 |
PET monitoring of therapy response in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Advances in imaging in the work-up of head and neck cancer patients.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
[Positron emission tomography in the management of cervix cancer patients].
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms; Uterine Neoplasms | 2009 |
Standardized uptake value is of prognostic value for outcome in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2010 |
Neck dissection after chemoradiation for carcinoma of the upper aerodigestive tract: indications and complications.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Fibrosis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Postoperative Complications; Prognosis; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Treatment options for squamous cell cancer of the esophagus: a systematic review of the literature.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Neoadjuvant Therapy; Outcome and Process Assessment, Health Care; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
[Squamous cell carcinoma of the esophagus].
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Humans; Jejunum; Lymph Node Excision; Male; Microsurgery; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Survival Rate | 2011 |
Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2011 |
New tracers beyond FDG in head and neck oncology.
Topics: Amino Acids; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals | 2011 |
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.
Topics: Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers--an audit and review of published studies.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies.
Topics: Carcinoma, Squamous Cell; Clinical Protocols; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Patient Positioning; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Accuracy of 18F-FDG PET/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Genetic Heterogeneity; Humans; Inguinal Canal; Lymph Nodes; Male; Multimodal Imaging; Penile Neoplasms; Positron-Emission Tomography; Publication Bias; Quality Assurance, Health Care; ROC Curve; Tomography, X-Ray Computed | 2012 |
The role of FDG PET-CT in the therapeutic evaluation for HNSCC patients.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2013 |
Head and neck cancer.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Alternative PET tracers in head and neck cancer. A review.
Topics: Amino Acids; Antibodies, Monoclonal; Carbon Radioisotopes; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Misonidazole; Nitroimidazoles; Nucleosides; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Nuclear Medicine; Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.
Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2004 |
False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient.
Topics: Adult; Carcinoma, Squamous Cell; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Middle Aged; Nasopharyngeal Neoplasms; Osteoradionecrosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Positron emission tomography in gastric and esophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed | 2004 |
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Irinotecan; Life Tables; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Functional imaging in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis | 2005 |
Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2006 |
Imaging of cervical lymph nodes in head and neck cancer: the basics.
Topics: Adult; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neck; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palpation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2005 |
The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Synchronous bilateral tonsillar carcinoma: role of fluoro-deoxyglucose positron emission tomography scanning in detecting occult primary tumours in metastatic nodal disease of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Neck Dissection; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tonsillar Neoplasms; Tonsillectomy | 2006 |
Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
[Positron emission tomography in head and neck squamous cell carcinomas].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2006 |
Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Subtraction Technique; Systems Integration; Thyroid Neoplasms; Tomography, X-Ray Computed; United States; Whole Body Imaging | 2007 |
Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy.
Topics: Carcinoma, Squamous Cell; Confidence Intervals; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Probability; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Thallium-201 uptake in lung cancer.
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Octreotide; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Role of PET FDG in the management of head and neck squamous cell cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
The indications of FDG-PET in neck oncology.
Topics: Carcinoma, Squamous Cell; Equipment Design; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Positron emission tomography (PET) in the evaluation of tumor proliferation and follow-up of therapy in ear, nose and throat tumors].
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Otorhinolaryngologic Neoplasms; Tomography, Emission-Computed | 1992 |
108 trial(s) available for fluorodeoxyglucose f18 and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma.
Topics: Alphapapillomavirus; Biomarkers; Carcinoma, Squamous Cell; Circulating Tumor DNA; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kinetics; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
Topics: Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Immunotherapy; Mouth Neoplasms; Nivolumab; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Development and Testing of a Machine Learning Model Using
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Machine Learning; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Quality of Life; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Single-Blind Method | 2017 |
Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Research Design; Squamous Cell Carcinoma of Head and Neck | 2017 |
Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Long-term outcome of
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Treatment Outcome | 2017 |
Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Roles of posttherapy
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Failure; Uterine Cervical Neoplasms | 2018 |
A feasibility study on adaptive
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cetuximab; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated | 2018 |
Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2019 |
Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study.
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Nadroparin; Neoplasm Recurrence, Local; Neoplasm Staging; Pemetrexed; Pneumonectomy; Positron-Emission Tomography | 2019 |
Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma.
Topics: Age Factors; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sex Factors; Time Factors; Tomography, X-Ray Computed | 2013 |
Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; ErbB Receptors; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2013 |
The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3).
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2013 |
Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Systemic control and evaluation of the response to neoadjuvant chemotherapy in resectable thoracic esophageal squamous cell carcinoma with ¹⁸F-fluorodeoxyglucose positron emission tomography-positive lymph nodes.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Young Adult | 2015 |
A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Sorafenib; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung; Male; Middle Aged; Multimodal Imaging; Organs at Risk; Positron-Emission Tomography; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Spinal Cord; Time Factors; Tomography, X-Ray Computed | 2015 |
Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDG-PET/CT for esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Lesion regression rate based on RECIST: prediction of treatment outcome in patients with head and neck cancer treated with chemoradiotherapy compared with FDG PET-CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Pelvis; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiation-Protective Agents; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2015 |
Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Comparison of characteristics of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET during staging of esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography | 2015 |
Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Staging; Non-Randomized Controlled Trials as Topic; Outcome Assessment, Health Care; Positron-Emission Tomography; Prospective Studies; Remission Induction; Time Factors; Tomography, X-Ray Computed | 2015 |
Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Squamous Cell Carcinoma of Head and Neck | 2016 |
Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with high-risk cutaneous squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Skin Neoplasms | 2016 |
Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Uterine Neoplasms | 2016 |
Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Treatment Outcome | 2008 |
Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Fiber Optic Technology; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Patient Selection; Positron-Emission Tomography; Radiation Dosage; Research Design; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
Topics: Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngoscopy; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms.
Topics: Aged; Carcinoma, Squamous Cell; DNA, Antisense; ErbB Receptors; Female; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor | 2009 |
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2009 |
Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Quality of Life; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Remission Induction; Retreatment; Tomography, X-Ray Computed; Tumor Burden | 2009 |
A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
Topics: Adult; Aged; Aorta; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2010 |
Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Mouth; Mouth Neoplasms; Multivariate Analysis; Neck; Patient Selection; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Risk Factors; Salvage Therapy; Survival Analysis; Time Factors | 2009 |
Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.
Topics: Carcinoma, Squamous Cell; Contrast Media; Diffusion Magnetic Resonance Imaging; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Computer-Assisted; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2009 |
Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with (18)F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tyrosine | 2010 |
Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Coordination Complexes; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Regression Analysis; Thiosemicarbazones | 2009 |
18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Recurrence; Time Factors | 2009 |
Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Squamous Cell; Disease Progression; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Prognosis; Survival Analysis; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
The role of ¹⁸fluoro-deoxy glucose combined position emission and computed tomography in the clinical management of anal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2011 |
Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cost-Benefit Analysis; Costs and Cost Analysis; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study.
Topics: Aged; Aged, 80 and over; Bone Marrow Cells; Carcinoma, Squamous Cell; Cell Proliferation; Diagnosis, Differential; Dideoxynucleosides; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prospective Studies; Tyrosine | 2010 |
Clinical Phase I study with an Insulin-like Growth Factor-1 receptor inhibitor: experiences in patients with squamous non-small cell lung carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Protein Kinase Inhibitors; Receptor, IGF Type 1; Treatment Outcome | 2011 |
Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tumor Burden | 2010 |
Evaluation of ¹⁸F-FDG PET/CT in early-stage cervical carcinoma.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
Whole body 18F-FDG PET predicts progression free and overall survival in squamous cell carcinoma of the esophagus: results of a prospective trial.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Whole Body Imaging | 2010 |
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; ROC Curve; Treatment Outcome | 2011 |
Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thoracotomy; Tomography, X-Ray Computed | 2011 |
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Contrast Media; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; ROC Curve; Sample Size; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Topics: Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Esophageal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Prospective evaluation of (18)F-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Penile Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2012 |
Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Delayed Diagnosis; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for ¹⁸F-FDG-PET-guided dose escalation in oropharyngeal cancer: a planning study.
Topics: Aged; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Treatment Outcome | 2013 |
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma.
Topics: Adult; Aged; Aorta, Abdominal; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Uterine Cervical Neoplasms | 2013 |
18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cystectomy; Fluorodeoxyglucose F18; Lymph Node Excision; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mediastinal Neoplasms; Mediastinoscopy; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Sensitivity and Specificity; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, Spiral Computed | 2003 |
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sarcoma, Clear Cell; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Neoplasms; Whole-Body Counting | 2003 |
Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 2; Humans; Male; Middle Aged; Monosaccharide Transport Proteins; Mouth Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed | 2004 |
Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2003 |
18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Uterine Cervical Neoplasms | 2004 |
[Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
Topics: Aged; Blood Glucose; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Laryngeal Neoplasms; Laryngectomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Salvage Therapy; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Detection of distant metastases in esophageal cancer with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Usefulness of FDG-PET to detect recurrent cervical cancer based on asymptomatically elevated tumor marker serum levels--a preliminary report.
Topics: Adult; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2004 |
pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Misonidazole; Oximetry; Oxygen; Oxygen Consumption; Polarography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Korea; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2004 |
The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Whole-Body Counting | 2005 |
FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2005 |
Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
Topics: Adult; Carcinoma, Squamous Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Hexokinase; Humans; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2005 |
Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies.
Topics: Body Burden; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiation Protection; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Relative Biological Effectiveness; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage | 2006 |
Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Thoracic Neoplasms; Tomography, X-Ray Computed | 2006 |
Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Korea; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Treatment Outcome | 2007 |
Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Survival Analysis | 2007 |
Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucous Membrane; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Tomography, Emission-Computed | 1996 |
Performance study of a miniature gamma ray scintillation vivo probe for tumor localization.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Citrates; Deoxyglucose; Endoscopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Tomography, Emission-Computed | 1997 |
FDG PET evaluation of head and neck cancer: value of imaging the thorax.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed | 2000 |
Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Prospective Studies; Radionuclide Imaging | 2000 |
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography.
Topics: Algorithms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Hypoxia; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Misonidazole; Radiation-Sensitizing Agents; Radiopharmaceuticals; Survival Analysis; Tirapazamine; Tomography, Emission-Computed; Triazines | 2001 |
Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2002 |
Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Groin; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Vulvar Neoplasms | 2002 |
1158 other study(ies) available for fluorodeoxyglucose f18 and Carcinoma, Epidermoid
| Article | Year |
|---|---|
The usefulness of [18F]FDG-PET/CT in detecting and managing cancers with unknown primary site depends on histological subtype.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Young Adult | 2021 |
Immunotherapy (Cemiplimab)-Induced Bullous Pemphigoid: A Possible Pitfall in 18F-FDG PET/CT.
Topics: Aged; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Immunotherapy; Male; Pemphigoid, Bullous; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Total lesion glycolysis as a predictor of clinical T3-4a laryngeal cancer with laryngectomy or nonlaryngectomy.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2021 |
The CT and PET/CT findings in primary pulmonary lymphoepithelioma-like carcinoma with pathological correlation: a study of 215 cases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; RNA, Small Interfering; Tomography, X-Ray Computed | 2022 |
Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2022 |
PET/CT versus triple endoscopy in initial workup of HPV+ oropharyngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Endoscopy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Radiomics analysis of [
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tongue; Tongue Neoplasms | 2023 |
Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Epithelial Cells; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Survival benefit associated with postoperative PET-CT before adjuvant radiotherapy or chemoradiotherapy in patients with oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Detecting Interval Distant Metastases With 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
Topics: Alphapapillomavirus; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Glycolysis; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Histogram analysis of
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2022 |
Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
Topics: Carcinoma, Squamous Cell; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Mouth Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2022 |
18F-FDG PET/CT in Primary Intraosseous Squamous Cell Carcinoma.
Topics: Adult; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Mandible; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Clinical Effects of PET-CT Before Definite Concurrent Chemoradiotherapy in Patients With Unresectable Stage IIIA-IIIB Squamous Cell Carcinoma of the Lungs.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2022 |
eIF6 is potential diagnostic and prognostic biomarker that associated with
Topics: Biomarkers; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Peptide Initiation Factors; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Tumor Microenvironment | 2022 |
Prognostic role of baseline
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Paranasal Sinuses; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Prognostic factors associated with
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2022 |
[Solitary Mixed Squamous and Glandular Papilloma of the Peripheral Lung:Report of a Case].
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Papilloma; Positron-Emission Tomography | 2022 |
Maximum standardised uptake value is prognostic in patients with early-stage squamous cell carcinoma of the tongue.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tongue | 2022 |
Frequency and malignancy rate of incidental focal salivary gland lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Mouth Neoplasms; Parotid Gland; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
FDG PET/CT in Isolated Nasal Cavity Metastasis From Squamous Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Nasal Cavity; Positron Emission Tomography Computed Tomography | 2022 |
Post-Treatment Neck Dissection of Tonsillar and Base of Tongue Squamous Cell Carcinoma in the Era of PET-CT, HPV, and p16.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tongue; Tongue Neoplasms; Tonsillar Neoplasms | 2022 |
Contribution of F-18 fluorodeoxyglucose PET/CT and contrast-enhanced thoracic CT texture analyses to the differentiation of benign and malignant mediastinal lymph nodes.
Topics: Adenocarcinoma; Bayes Theorem; Carcinoma, Squamous Cell; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2023 |
The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
Topics: Adult; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Oropharyngeal Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Robotic Surgical Procedures; Squamous Cell Carcinoma of Head and Neck | 2022 |
Hyoepiglottic Rheumatoid Nodule Mimicking Head and Neck Malignancy on 18 F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rheumatoid Nodule | 2023 |
[Metabolic Tumor Imaging in Head and Neck Oncology].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Incidental Finding of a Tongue Schwannoma Mimicking Local Recurrence of Squamous Cell Carcinoma on a Systematic Follow-up 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Incidental Findings; Neurilemmoma; Positron Emission Tomography Computed Tomography; Tongue | 2023 |
Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
Inflammation after catheterisation mimicking tumour with squamous cell lung carcinoma in positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Humans; Inflammation; Lung; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Head and Neck Neoplasms; Humans; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2023 |
Focal
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies | 2023 |
The potential value of thallium-201 scintigraphy in the diagnosis of squamous cell carcinoma arising from extensive pyoderma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2023 |
A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables.
Topics: Carcinoma, Squamous Cell; China; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Synchronous Squamous Cell Carcinoma of Rectum and Anal Canal Detected by FDG PET/CT-A Rare Entity.
Topics: Aged; Anal Canal; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectum | 2023 |
Outcomes of solitary postoperative recurrence of esophageal squamous cell carcinoma diagnosed with FDG-PET/CT and treated with definitive radiation therapy.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Recurrence; Retrospective Studies | 2023 |
Volume-based 18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters correlate with delayed neck metastasis in clinical early-stage oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Sialadenitis; Squamous Cell Carcinoma of Head and Neck | 2023 |
Differential diagnosis of lung cancer and tuberculosis based on 18 F-fluorodeoxyglucose PET/CT multi-time points imaging.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tuberculosis | 2023 |
Post-treatment 18F-fludeoxyglocuse-positron emission tomography in human papillomavirus-associated oropharyngeal cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Retrospective Studies | 2023 |
Association Between 18F-Fluorodeoxyglucose Uptake and Mutation Status of Epidermal Growth Factor Receptor in Sinonasal Tract Cancer.
Topics: Carcinoma, Squamous Cell; ErbB Receptors; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mutation; Paranasal Sinuses; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2023 |
Prognostic significance of the harmonized maximum standardized uptake value of 18F-FDG-PET/CT in patients with resectable oral tongue squamous cell carcinoma: a multicenter study.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2023 |
Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prevalence; Retrospective Studies; Risk Factors | 2023 |
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Human Papillomavirus Viruses; Humans; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Uterine Cervical Neoplasms | 2023 |
A case of synchronous double cancers consisting of maxillary gingival carcinoma and intraductal papillary mucinous carcinoma, invasive: case report.
Topics: Adenocarcinoma, Mucinous; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Gingiva; Gingival Neoplasms; Humans | 2023 |
Contribution of FDG-PET in the diagnostic assessment of cervical lymph node metastasis in Oral Cavity Squamous Cell Carcinoma (OCSCC).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Unusual Case of Primary Hepatic Squamous Carcinoma on 18F-FDG PET/CT.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Relationship between the maximum standardized uptake value of fluoro-2-deoxyglucose-positron emission tomography/computed tomography and clinicopathological characteristics in tongue squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tongue Neoplasms; Young Adult | 2019 |
Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Lymph Node Metastases Diagnosed by
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome | 2019 |
Restaging [
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2020 |
Nivolumab-induced Pancreatitis: An Immune-related Adverse Event.
Topics: Aged; Antineoplastic Agents, Immunological; Biomarkers, Tumor; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Nivolumab; Pancreatitis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Gastrointestinal: Anterior mediastinal colonic interposition on F-18 FDG PET/CT imaging.
Topics: Carcinoma, Squamous Cell; Colon; Digestive System Surgical Procedures; Epidermolysis Bullosa Dystrophica; Esophageal Diseases; Esophagectomy; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2020 |
Prognostic value of 18F-FDG PET parameters in patients with locally advanced non-small cell lung cancer treated with induction chemotherapy.
Topics: Adenocarcinoma of Lung; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2020 |
Added value of para-aortic surgical staging compared to
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Complications; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2020 |
Renal Metastases from a Nasal Cavity Mixed Squamous Cell and Adenoid Cystic Carcinoma: A Case Report.
Topics: Carboplatin; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Cetuximab; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Nasal Cavity; Nose Neoplasms; Paclitaxel; Palliative Care; Positron-Emission Tomography; Rare Diseases | 2020 |
Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Physicians; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2020 |
Commentary: Esophageal squamous cell carcinoma: A disease requiring more research.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography | 2020 |
Detection of extraoral primary cancers by positron emission tomography/computed tomography in patients with oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2020 |
Accuracy of
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Development and validation of a radiomics signature on differentially expressed features of
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Esophagus; Fluorodeoxyglucose F18; Humans; Reproducibility of Results; Retrospective Studies; ROC Curve | 2020 |
Isolated Pancreatic Metastasis From Squamous Cell Lung Cancer Mimicking Primary Pancreatic Ductal Adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
Prediction of the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma by FDG-PET imaging dataset using deep learning analysis: A hypothesis-generating study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Datasets as Topic; Deep Learning; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Oropharyngeal Neoplasms; Oropharynx; Papillomavirus Infections; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and
Topics: Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
PET/MRI and genetic intrapatient heterogeneity in head and neck cancers.
Topics: Aged; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genes, Neoplasm; Genes, p53; Genetic Heterogeneity; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Mutation; Neoplasms, Multiple Primary; Oropharyngeal Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptor, Notch1 | 2020 |
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2020 |
Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiation Dosage; Survival Analysis; Treatment Outcome | 2020 |
Radiomic feature analysis of pre-treatment FDG PET-CT for predicting outcome in anal squamous cell carcinoma.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
In reply to letter to the editor: radiomic feature analysis of pre-treatment FDG PET-CT for predicting outcome in anal squamous cell carcinoma.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-Involved neck only versus mucosal irradiation.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neoplasms, Unknown Primary; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Xerostomia | 2020 |
Investigating the Reliability of Fluorodeoxyglucose 18 Positive Emission Tomography-Computed Tomography Detection of Regional Lymph Node Metastasis in Head and Neck Malignancy.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
18F-Fluciclovine PET/MRI in a Patient With Squamous Cell Carcinoma of the Uterine Cervix Correlated With 18F-FDG PET/CT.
Topics: Adult; Carboxylic Acids; Carcinoma, Squamous Cell; Cyclobutanes; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2020 |
Total Lesion Glycolysis Ratio in Positron Emission Tomography/Computed Tomography Images During Neoadjuvant Chemotherapy Can Predict Pathological Tumor Regression Grade and Prognosis in Patients with Locally Advanced Squamous Cell Carcinoma of the Esophag
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Glycolysis; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2021 |
Adherence to pretreatment and intratreatment imaging of head and neck squamous cell carcinoma patients undergoing (chemo) radiotherapy in a research setting.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2021 |
Squamous Cell Carcinoma of Thymus Presenting as Constrictive Pericarditis Diagnosed With 18F-FDG PET/CT.
Topics: Aged; Carcinoma, Squamous Cell; Echocardiography; Fluorodeoxyglucose F18; Humans; Male; Pericarditis, Constrictive; Positron Emission Tomography Computed Tomography; Thymus Neoplasms | 2021 |
Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer.
Topics: Aged; Carcinoma, Squamous Cell; Elastic Tissue; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Neoplasm Staging; Neoplasms, Connective Tissue; Positron Emission Tomography Computed Tomography; Quinolines | 2021 |
Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome; Tumor Burden | 2020 |
Prediction of survival outcome based on clinical features and pretreatment
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunotherapy; Male; Middle Aged; Positron-Emission Tomography | 2020 |
Circulating tumor HPV DNA complements PET-CT in guiding management after radiotherapy in HPV-related squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Circulating Tumor DNA; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Papillomavirus Infections; Positron Emission Tomography Computed Tomography | 2021 |
The feasibility of
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2020 |
Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Hypopharynx; Laryngeal Neoplasms; Machine Learning; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2021 |
Primary hepatic squamous carcinoma concurrent with gastric signet ring cell carcinoma demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Carcinoma, Signet Ring Cell; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2021 |
Machine learning based on clinico-biological features integrated
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Machine Learning; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Novel 5-point 18-FDG-PET/CT visual scoring system for assessing treatment response in patients with oesophageal or gastro-oesophageal junction carcinoma.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms | 2021 |
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Topics: Biomarkers; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2021 |
Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic response.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Watchful Waiting | 2020 |
Texture Analysis Using Preoperative Positron Emission Tomography Images May Predict the Prognosis of Patients With Resectable Oral Squamous Cell Carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2021 |
Impact of PET/CT on management of patients with esophageal cancer - results from a PET/CT registry study.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Registries | 2021 |
DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Groin; Humans; Incidental Findings; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2021 |
Diagnostic performance of 18F-FDG PET/CT for the detection of occult primary tumors in squamous cell carcinoma of unknown primary in the head and neck: a single-center retrospective study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2021 |
False negative rate at
Topics: Adenocarcinoma; Adult; Aged; Aorta; Carcinoma, Squamous Cell; Chemoradiotherapy; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2021 |
Imaging findings of cutaneous angiosarcoma of the scalp: Comparison with cutaneous squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Magnetic Resonance Imaging; Retrospective Studies; Scalp; Skin Neoplasms | 2021 |
Herpes zoster reactivation during head and neck cancer therapy: interpreting post-treatment positron emission tomography/CT imaging.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Herpes Zoster; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Comparison of treatment response assessed by 18F-FDG PET/CT with the histopathological response using tumor regression grading on surgically resected specimen following neoadjuvant chemotherapy in squamous cell carcinoma of esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography | 2021 |
The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Ultrasonography | 2021 |
Lung cancer combined with diffuse peritoneal and mesenteric amyloidosis detected on 18F-FDG PET/CT: A case report.
Topics: Aged; Amyloidosis; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Mesentery; Omentum; Pneumonectomy; Positron Emission Tomography Computed Tomography | 2021 |
Squamous Cell Carcinoma of the Gingiva.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Gingiva; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Good prediction of treatment responses to neoadjuvant chemoradiotherapy for esophageal cancer based on preoperative inflammatory status and tumor glucose metabolism.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Biomarkers; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Leukocyte Count; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Neutrophils; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sex Factors; Survival Analysis; Treatment Outcome | 2021 |
Primary Intraosseous Squamous Cell Carcinoma of the Mandible Mimicking Inflammation on FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Male; Mandible; Middle Aged; Positron Emission Tomography Computed Tomography | 2022 |
Beyond the
Topics: Carcinoma, Squamous Cell; Electrons; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2022 |
Texture Indices of 18F-FDG PET/CT for Differentiating Squamous Cell Carcinoma and Non-Hodgkin's Lymphoma of the Oropharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies | 2021 |
Assessment of Apparent Diffusion Coefficients and SUVs as Predicators of Histological Differentiation in Anal Squamous Cell Carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Cell Differentiation; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Diffuse Linear Pattern of Pericardial FDG Activity in Pericardial Metastasis From Squamous Cell Lung Carcinoma.
Topics: Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Pericarditis, Tuberculous | 2022 |
68Ga-DOTATATE PET/CT in Primary Pulmonary Lymphoepithelioma-Like Carcinoma.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging | 2022 |
PET-Uptake Reduction into Lymph Nodes After Neoadjuvant Therapy is Highly Predictive of Prognosis for Patients Who have Thoracic Esophageal Squamous Cell Carcinoma Treated with Chemoradiotherapy Plus Esophagectomy.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoadjuvant Therapy; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2022 |
Value of [18F]FDG PET-CT in the follow-up of surgically treated oral tongue squamous cell carcinoma: single centre cohort analysis on 87 patients.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2021 |
Three-Dimensional Image Fusion of
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Maxillary Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Otorhinolaryngologic Surgical Procedures; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2017 |
Colonic Metastasis From Esophageal Squamous Cell Carcinoma Demonstrated With 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Colonic Neoplasms; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
Topics: Aged; Analysis of Variance; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Netherlands; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2017 |
18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Failure | 2017 |
FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of 18FDG-PET scans: A long follow-up results of phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Organoplatinum Compounds; Positron-Emission Tomography | 2017 |
Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Mass Screening; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies | 2017 |
Radiation-induced Angiosarcoma as a Cause of Pleural Effusion.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Pleural Effusion, Malignant; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracoscopy | 2017 |
Correlation analysis of [
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma | 2017 |
Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm, Residual; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2017 |
Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2017 |
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cohort Studies; Deoxyglucose; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Hydroxybenzoates; Lung; Lung Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Phenotype; Positron-Emission Tomography; Prognosis; Survival Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reference Values; Retrospective Studies; Treatment Outcome | 2017 |
GLUT-1 expression of pulmonary mixed squamous cell and glandular papilloma may be associated with high SUVmax on fluorodeoxyglucose-positron emission tomography.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Complex and Mixed; Papilloma; Positron-Emission Tomography | 2017 |
Preoperative
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2017 |
The maximum standardized uptake value increment calculated by dual-time-point
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Tongue Neoplasms | 2017 |
Comorbidity Assessment in Patients With Oral Squamous Cell Carcinoma: Can Imaging Techniques (Fludeoxyglucose Positron-Emission Tomographic Computed Tomography and Contrast-Enhanced Computed tomography) Provide Additional Information?
Topics: Carcinoma, Squamous Cell; Comorbidity; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2018 |
An amazing cause of false PET positivity: Diagnosed after a lung cancer surgery.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Uterine Cervical Neoplasms | 2017 |
Importance of positron emission tomography for assessing the response of primary and metastatic lesions to induction treatments in T4 esophageal cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2017 |
Oligometastatic Stomach Carcinoma From Lung Squamous Cell Carcinoma Detected by 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Topics: Adult; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Hypoxia | 2017 |
18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2017 |
Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2018 |
Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Hypoxia | 2017 |
Usefulness of esophagogastroduodenoscopy and
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Early Detection of Cancer; Endoscopy, Digestive System; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2017 |
FDG PET/CT in 2 Cases of Renal Metastasis From Esophageal Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers.
Topics: Adult; Aged; Area Under Curve; Biomarkers, Tumor; Carcinoma, Squamous Cell; DNA Mutational Analysis; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography; Regression Analysis; Retrospective Studies; Small Cell Lung Carcinoma | 2017 |
Spinal Metastasis Characterized on FDG PET/CT in Head and Neck Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Spinal Neoplasms | 2017 |
Port-Site Metastasis of Uterine Carcinosarcoma after Laparoscopy.
Topics: Abdominal Neoplasms; Carcinoma, Squamous Cell; Carcinosarcoma; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Keratin-5; Laparoscopy; Middle Aged; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2017 |
Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Japan; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Time Factors; Treatment Outcome | 2017 |
Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome; Young Adult | 2017 |
Hypoxic volume evaluated by
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Neck Dissection; Neoplasm Grading; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Treatment Outcome; Tumor Hypoxia | 2018 |
Prognostic value of volumetric FDG PET/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra-arterial chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tongue; Tongue Neoplasms; Treatment Outcome | 2017 |
Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature review.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Injuries; Retrospective Studies | 2018 |
Hypermetabolic Vocal Cord Focus With Recurrent Oral Cancer History.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Laryngitis; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Vocal Cords | 2018 |
Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Peripheral Nervous System Neoplasms; Pilot Projects; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Incorporating
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pelvic Bones; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results | 2017 |
Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Prognosis; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck | 2017 |
Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Decision Making; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Palliative Care; Patient Care Team; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2018 |
Multiple Hypermetabolic Subcutaneous Lesions From Hidradenitis Suppurativa Mimicking Metastases on 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Skin | 2018 |
Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2018 |
Optimal transformations leading to normal distributions of positron emission tomography standardized uptake values.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Normal Distribution; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Elevated 18F-NaF uptake in cricoid cartilage in a patient with laryngeal carcinoma: A case report and literature review.
Topics: Carcinoma, Squamous Cell; Cricoid Cartilage; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2017 |
Diagnostic accuracy of
Topics: Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Fluorodeoxyglucose activity associated with a cosmetic poly-L-lactide filler: a potential confounder on positron emission tomography and computed tomography.
Topics: Aged; Carcinoma, Squamous Cell; Dermal Fillers; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Polyesters; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tongue Neoplasms | 2018 |
Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in
Topics: B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Programmed Cell Death 1 Receptor; Reproducibility of Results; ROC Curve; Squamous Cell Carcinoma of Head and Neck | 2018 |
Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Dimensional Measurement Accuracy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iowa; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Surgical Procedures, Operative; Tomography, X-Ray Computed | 2018 |
Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2018 |
A SUV
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron Emission Tomography Computed Tomography; Prognosis; Propensity Score; Radiopharmaceuticals; Radiosurgery; Survival Rate | 2018 |
Concomitant cutaneous squamous cell carcinoma and chronic lymphocytic leukemia in a patient: The utility of
Topics: Abdominal Pain; Aged; Biopsy; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Ear Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Metastasis; Male; Neck Dissection; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2018 |
Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2018 |
Metaplastic Squamous Cell Carcinoma of Breast Demonstrated on 18F-FDG PET/CT.
Topics: Adult; Breast Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Heterogeneity and irregularity of pretreatment
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Genes, p16; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis | 2018 |
Tumour metabolic activity measured by fluorodeoxyglucose positron emission tomography for radiotherapy planning as a prognostic factor for locally advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy; Treatment Outcome | 2018 |
Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup.
Topics: Aged; Carcinoma, Squamous Cell; Cohort Studies; Diffusion Magnetic Resonance Imaging; Equipment Design; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Statistics as Topic | 2018 |
Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Male; Mandible; Mandibular Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2018 |
(
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Rate; Uterine Cervical Neoplasms | 2018 |
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.
Topics: Aged; Aged, 80 and over; B7-H1 Antigen; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Female; Fluorodeoxyglucose F18; Forkhead Transcription Factors; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunity; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; T-Lymphocytes, Regulatory | 2018 |
Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2018 |
Radiotherapy volume delineation using 18F-FDG-PET/CT modifies gross node volume in patients with oesophageal cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tumor Burden | 2018 |
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Retrospective Studies | 2018 |
Correlation of human papilloma virus status with quantitative perfusion/diffusion/metabolic imaging parameters in the oral cavity and oropharyngeal squamous cell carcinoma: comparison of primary tumour sites and metastatic lymph nodes.
Topics: Aged; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Organometallic Compounds; Oropharyngeal Neoplasms; Papillomaviridae; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2018 |
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018).
Topics: Ablation Techniques; Administration, Topical; Aftercare; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Biopsy; Carcinoma, Squamous Cell; Chemoradiotherapy; Colorectal Surgery; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Papanicolaou Test; Papillomavirus Infections; Papillomavirus Vaccines; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Societies, Medical; Survival Rate | 2018 |
In-vivo topical mucosal delivery of a fluorescent deoxy-glucose delineates neoplasia from normal in a preclinical model of oral epithelial neoplasia.
Topics: Animals; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Mouth Neoplasms; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography | 2018 |
Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2018 |
Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tumor Burden | 2018 |
Intra-tumoural heterogeneity characterization through texture and colour analysis for differentiation of non-small cell lung carcinoma subtypes.
Topics: Adenocarcinoma; Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Differentiation; Color; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Support Vector Machine | 2018 |
Is there a place for FDG-PET-CT in early oral cancer patients?
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2018 |
Correlation of quantified metabolic activity in nonsmall cell lung cancer with tumor size and tumor pathological characteristics.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Tumor Burden | 2018 |
Oropharyngeal Squamous Cell Carcinoma Metastasis to Distal Skeletal Muscle on FDG PET/CT.
Topics: Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography | 2018 |
Bone Sequestration as a Consequence of Esophageal Carcinoma Metastasis Detected by 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Osteolysis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2018 |
Accurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2018 |
Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection.
Topics: Adult; Age Factors; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; HIV; HIV Infections; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2018 |
Texture analysis of computed tomography data using morphologic and metabolic delineation of esophageal cancer-relation to tumor type and neoadjuvant therapy response.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2019 |
A Cardiac Metastasis of Follicular Thyroid Carcinoma With Partly Squamous Cell Differentiation: Detection in FDG-PET Preceded Visibility on Echocardiography and MRI by More Than a Year.
Topics: Adenocarcinoma, Follicular; Carcinoma, Squamous Cell; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
18F-FDG PET/CT of Squamous Cell Carcinoma in a Thyroglossal Duct Cyst.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroglossal Cyst; Thyroid Neoplasms | 2019 |
Head and Neck Cancer Soft Tissue Radiation Necrosis-Diagnostic Challenge.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Necrosis; Positron Emission Tomography Computed Tomography; Radiation Injuries; Salvage Therapy; Tongue Neoplasms | 2019 |
Amide proton transfer imaging to evaluate the grading of squamous cell carcinoma of the cervix: A comparative study using
Topics: Amides; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Observer Variation; Positron-Emission Tomography; Prospective Studies; Protons; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2019 |
Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography evaluation using metabolic tumor volume of the primary tumor and lymph nodes in advanced hypopharyngeal cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate; Tumor Burden | 2019 |
Volumetric
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Smoking; Survival Rate; Treatment Failure; Tumor Burden | 2019 |
Use of MRI and FDG-PET/CT to predict fixation of advanced hypopharyngeal squamous cell carcinoma to prevertebral space.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Spine | 2019 |
The Impact of a Stepwise Approach to Primary Tumor Detection in Squamous Cell Carcinoma of the Neck With Unknown Primary.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngoscopy; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Robotic Surgical Procedures; Survival Rate; Tonsillectomy | 2019 |
Is There a Role for an 18F-fluorodeoxyglucose-derived Biological Boost in Squamous Cell Anal Cancer?
Topics: Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2019 |
The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Male; Maxillary Sinus; Maxillary Sinus Neoplasms; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2018 |
Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
Early metabolic response to chemoradiotherapy by interim FDG PET/CT is associated with better overall survival and histological response in esophageal cancers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; France; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Young Adult | 2019 |
Clinical Significance of
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2019 |
Tumor Voxel Dose-Response Matrix and Dose Prescription Function Derived Using
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Dose-Response Relationship, Radiation; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy Dosage | 2019 |
Prospective evaluation of pretreatment and intratreatment FDG PET-CT SUV stability in primary head and neck cancer.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2019 |
Topics: alpha-Methyltyrosine; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Positron-Emission Tomography; Prognosis | 2019 |
Correlation analysis between the SUVmax of FDG-PET/CT and clinicopathological characteristics in oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2019 |
Anal cancer chemoradiotherapy outcome prediction using
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Papillomaviridae; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Tumor Burden | 2019 |
Incidentally Detected Oropharyngeal Squamous Cell Carcinoma on 18F-Fluciclovine PET/CT.
Topics: Aged; Carboxylic Acids; Carcinoma, Squamous Cell; Cyclobutanes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2019 |
Intratumoral heterogeneity as measured using the tumor-stroma ratio and PET texture analyses in females with lung adenocarcinomas differs from that of males with lung adenocarcinomas or squamous cell carcinomas.
Topics: Adenocarcinoma of Lung; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sex Factors | 2019 |
Xanthomatous Interstitial Pneumopathy: Chemotherapy- or Contrast Substance Related Change?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Xanthomatosis | 2020 |
Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Signal-To-Noise Ratio; Software | 2019 |
Workup of Suspected Chest Metastases on
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Patient Care Planning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thorax; Time-to-Treatment; United States | 2019 |
Gingival Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Male; Medical Illustration; Middle Aged; Positron Emission Tomography Computed Tomography | 2020 |
FDG PET based prediction of response in head and neck cancer treatment: Assessment of new quantitative imaging features.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2019 |
FDG PET/CT for metastatic squamous cell carcinoma of unknown primary of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
Topics: Adult; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skin Neoplasms | 2019 |
18F-FDG PET/CT Imaging of Trichoblastic Carcinoma With Nodal Metastasis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
PET/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue.
Topics: Adult; Aged; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Retrospective Studies; Tomography, X-Ray Computed; Tongue; Tongue Neoplasms; Tumor Burden | 2019 |
Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Alphapapillomavirus; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2019 |
18F-FDG PET/CT in Oral Cuniculatum Carcinoma.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2019 |
Diagnostic Performance of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/CT for Chronic Empyema-Associated Malignancy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Empyema; Female; Fistula; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2019 |
Staging and Response Evaluation to Neo-Adjuvant Chemoradiation in Esophageal Cancers Using 18FDG PET/ CT with Standardized Protocol.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2019 |
[Basaloid Squamous Cell Carcinoma;Report of a Case].
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 2019 |
FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial.
Topics: Adult; Aged; Anus Neoplasms; Australia; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated | 2019 |
18F-FDG-PET/CT for the assessment of the contralateral neck in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2013 |
Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Differentiation; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Observer Variation; Radionuclide Imaging; Recurrence; Reproducibility of Results; Retrospective Studies; Young Adult | 2013 |
Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Topics: Aged; Aged, 80 and over; Bone Marrow Neoplasms; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2013 |
Rare axillary metastasis from squamous cell carcinoma of the tonsil.
Topics: Axilla; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2013 |
Extracapsular spread in hypopharyngeal squamous cell carcinoma: diagnostic value of FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
In vitro chemoresponse to cisplatin and outcomes in cervical cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Drug Screening Assays, Antitumor; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Serendipitous discovery of non-sestamibi-avid squamous cell lung cancer invading the heart during myocardial perfusion imaging.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Multimodal Imaging; Myocardial Perfusion Imaging; Myocardium; Neoplasm Invasiveness; Radiography; Technetium Tc 99m Sestamibi | 2013 |
The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Variety and complexity of fluorine-18-labelled fluoro-2-deoxy-D-glucose accumulations in the oral cavity of patients with oral cancers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Facial Muscles; Female; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Mandible; Maxilla; Middle Aged; Mouth; Mouth Neoplasms; Multimodal Imaging; Palatine Tonsil; Positron-Emission Tomography; Radiopharmaceuticals; Sublingual Gland; Tomography, X-Ray Computed; Tongue; Tongue Neoplasms; Young Adult | 2013 |
Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 cases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Impact of positron emission tomography with the use of fluorodeoxyglucose on response to induction chemotherapy in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Male; Middle Aged; Oropharyngeal Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2013 |
Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
[Penile metastasis from esophageal cancer: a case report].
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Penile Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2013 |
Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Alphapapillomavirus; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2014 |
[Prognostic value of PET/CT in lung cancer: retrospective analysis of 47 patients].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2013 |
[Brown tumors: a pitfall in PET-CT diagnosis].
Topics: Biopsy; Carcinoma, Squamous Cell; Chronic Kidney Disease-Mineral and Bone Disorder; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Multimodal Imaging; Osteolysis; Positron-Emission Tomography; Rectal Neoplasms; Ribs; Sigmoidoscopy; Tomography, X-Ray Computed | 2013 |
Evaluation of 18F-FDG PET/CT as a diagnostic imaging and staging tool for feline oral squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cat Diseases; Cats; Female; Fluorodeoxyglucose F18; Lymph Nodes; Male; Mouth Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Clinicopathological determinants of positron emission tomography computed tomography fluorodeoxyglucose standardised uptake value in head and neck carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2013 |
Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2013 |
Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Large Neutral Amino Acid-Transporter 1; Male; Methyltyrosines; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult | 2013 |
A novel minimally invasive technique to create a rabbit VX2 lung tumor model for nano-sized image contrast and interventional studies.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Iohexol; Liposomes; Lung Neoplasms; Nanocapsules; Neoplasm Transplantation; Optical Imaging; Particle Size; Rabbits; Radionuclide Imaging; Tumor Burden; X-Ray Microtomography | 2013 |
Squamous cell carcinoma of the prostate with strong FDG uptake on PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2014 |
Diagnostic accuracy of ultrasound, ¹⁸F-FDG-PET/CT, and fused ¹⁸F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Prospective Studies; Radiography; Radionuclide Imaging; Ultrasonography | 2014 |
Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Standardized uptake value and resection margin involvement predict outcomes in pN0 head and neck cancer.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Time Factors | 2013 |
A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinoscopy; Middle Aged; Models, Statistical; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate | 2013 |
Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymph Nodes; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Multivariate Analysis; Neck; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2014 |
Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Prospective Studies; ROC Curve; Tomography, X-Ray Computed | 2013 |
Aggressive strategy for the treatment of synchronous metastatic anal squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Mitomycin; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Tomography, X-Ray Computed | 2013 |
The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Scotland; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
PET imaging of tumor hypoxia using 18F-labeled pimonidazole.
Topics: Animals; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Mice, Nude; Nitroimidazoles; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Cells, Cultured | 2013 |
Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2013 |
Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images.
Topics: Animals; Carcinoma, Squamous Cell; Computer Simulation; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mice; Microvessels; Misonidazole; Oxygen; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Cells, Cultured | 2013 |
Feasibility and incremental benefit of puffed-cheek 18F-FDG PET/CT on oral cancer patients.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Cheek; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Comparison of PET imaging with 64Cu-liposomes and 18F-FDG in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch model of oral dysplasia and squamous cell carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Brain; Carcinoma, Squamous Cell; Copper Radioisotopes; Cricetinae; Disease Models, Animal; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heart; Liposomes; Mouth Neoplasms; Positron-Emission Tomography | 2014 |
Relationship between extracapsular spread and FDG PET/CT in oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer.
Topics: Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2013 |
Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; ROC Curve; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Diagnostic value of ¹⁸F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Is FDG -PET-CT a valuable tool in prediction of persistent disease in head and neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2013 |
Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
A low molecular weight zinc2+-dipicolylamine-based probe detects apoptosis during tumour treatment better than an annexin V-based probe.
Topics: Amines; Angiogenesis Inhibitors; Animals; Annexin A5; Apoptosis; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Indoles; Mice; Mice, Nude; Molecular Probes; Molecular Weight; Neoplasms, Experimental; Organometallic Compounds; Picolinic Acids; Pyrroles; Skin Neoplasms; Sunitinib; Tumor Cells, Cultured; Zinc | 2014 |
(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2013 |
FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron-Emission Tomography; Smoking; Tomography, X-Ray Computed | 2014 |
Clinical impact of 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-positron emission tomography (PET) on treatment choice in recurrent cancer of the cervix uteri.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Choice Behavior; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Recurrence; Uterine Cervical Neoplasms | 2013 |
Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2014 |
Outcome analysis of (18)F-fluorodeoxyglucose positron-emission tomography in patients with lung cancer after partial volume correction.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Phantoms, Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2013 |
Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Patient Outcome Assessment; Pharynx; Positron-Emission Tomography; Recurrence; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2013 |
Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Treatment Outcome; Tumor Burden | 2014 |
Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Odds Ratio; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Treatment Failure; Treatment Outcome | 2014 |
[Determination of prognostic factors].
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Taiwan; Tomography, X-Ray Computed | 2013 |
[Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2013 |
[Evaluation of tumor heterogeneity for esophageal squamous cell cancer by dynamic FDG-PET].
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography | 2013 |
[Evaluation of false-negative lymph nodes diagnosed by fludeoxy glucose-positron emission tomography in cases of metastatic esophageal squamous cell carcinoma].
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography | 2013 |
Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
(18)F-FDG-PET/CT in assessing response to neoadjuvant chemoradiotherapy for potentially resectable locally advanced esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Liver; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iohexol; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2014 |
Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden | 2014 |
Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Computer Simulation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Induction Chemotherapy; Male; Middle Aged; Models, Biological; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2014 |
Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
Isolated nasal tip metastasis from esophageal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nose Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
Pre-treatment metabolic tumor volume and total lesion glycolysis are useful prognostic factors for esophageal squamous cell cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; ROC Curve; Tumor Burden | 2014 |
Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
IMRT with ¹⁸FDG-PET\\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2015 |
Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Squamous Cell; Endoscopy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Logistic Models; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Radiotherapy response in head and neck cancer - evaluation of the primary tumour site.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
FDG PET/MR for lymph node staging in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2014 |
Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Topics: Aged; Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
(18)F-FDG uptake predicts diagnostic yield of transbronchial biopsy in peripheral lung cancer.
Topics: Adenocarcinoma; Biopsy; Bronchioles; Bronchoscopy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies | 2014 |
The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Prognostic value of 18F-fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cohort Studies; Denmark; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hospitals, University; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome | 2015 |
Diagnosis of squamous cell carcinoma metastasis with 18F-FDG PET/CT in stoma after percutaneous endoscopic gastrostomy: a rare and poorly known iatrogenic cause of spread of head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gastrostomy; Head and Neck Neoplasms; Humans; Iatrogenic Disease; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Surgical Stomas; Tomography, X-Ray Computed | 2014 |
Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Positron-Emission Tomography; Preoperative Period; Treatment Outcome | 2014 |
Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cone-Beam Computed Tomography; Cyclin-Dependent Kinase Inhibitor p16; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tomography, X-Ray Computed; Tumor Suppressor Protein p53 | 2015 |
False-positive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases.
Topics: Adenocarcinoma; Aged, 80 and over; Bone Neoplasms; Carcinoma, Signet Ring Cell; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; False Positive Reactions; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Treatment Outcome | 2014 |
Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mouth Neoplasms; Multidetector Computed Tomography; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Tumor Burden | 2014 |
Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
Potential impact of atelectasis and primary tumor glycolysis on F-18 FDG PET/CT on survival in lung cancer patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Pulmonary Atelectasis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2014 |
Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2014 |
[18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2015 |
Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Proportional Hazards Models; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Should We Routinely Investigate Incidental Head and Neck Findings on 18-Fluorodeoxyglucose Positron Emission Tomography in Patients Being Staged for Non-small Cell Lung Cancer? A Retrospective Analysis.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2015 |
Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Prognostic significance of the intratumoral heterogeneity of (18) F-FDG uptake in oral cavity cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed | 2014 |
Metabolic parameters using ¹⁸F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2014 |
Generation of prescriptions robust against geometric uncertainties in dose painting by numbers.
Topics: Algorithms; Carcinoma, Squamous Cell; Confidence Intervals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasms; Normal Distribution; Positron-Emission Tomography; Prescriptions; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Uncertainty | 2015 |
Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Carcinoma, Squamous Cell; Contrast Media; Dental Implants; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Comparison of intratumoral FDG and Cu-ATSM distributions in cancer tissue originated spheroid (CTOS) xenografts, a tumor model retaining the original tumor properties.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Colonic Neoplasms; Coordination Complexes; Fluorodeoxyglucose F18; Mice; Organometallic Compounds; Spheroids, Cellular; Thiosemicarbazones | 2014 |
Adhesive capsulitis mimicking metastasis on 18F-FDG-PET/CT.
Topics: Aged; Bursitis; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Shoulder Joint; Tomography, X-Ray Computed | 2015 |
Primary squamous cell carcinoma of the thyroid on FDG PET/CT.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tumor Burden | 2014 |
Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Impact of initial FDG PET/CT in the management plan of patients with locally advanced head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease Management; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Delineation gross tumor volume based on positron emission tomography images by a numerical approximation method.
Topics: Animals; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Imaging, Three-Dimensional; Male; Models, Biological; Multimodal Imaging; Neoplasm Transplantation; Phantoms, Imaging; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2014 |
The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm, Residual; Oropharyngeal Neoplasms; Patient Care Planning; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2014 |
3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; ROC Curve; Tomography, X-Ray Computed; Young Adult | 2015 |
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2015 |
Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cell Hypoxia; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Monocarboxylic Acid Transporters; Muscle Proteins; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Symporters; Tumor Microenvironment | 2014 |
Clinical usefulness of [18F]FDG PET-CT and CT/MRI for detecting nodal metastasis in patients with hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2015 |
Efficiency of three-dimensional Doppler ultrasonography in assessing nodal metastasis of head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Comparative Effectiveness Research; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2015 |
Association between the standardized uptake value and high-risk HPV in hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Papillomavirus Infections; Positron-Emission Tomography; Preoperative Care; Proportional Hazards Models; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2014 |
Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hemoglobins; Humans; Male; Middle Aged; Multimodal Imaging; Pharyngeal Neoplasms; Pharynx; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2015 |
Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
Topics: Animals; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Disease Models, Animal; ErbB Receptors; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Immunoglobulin Fragments; Immunohistochemistry; Mice; Mice, Inbred BALB C; Multimodal Imaging; Neoplasm Transplantation; Positron-Emission Tomography; Radiotherapy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomaviridae; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tumor Burden | 2014 |
Heterogeneity in [18F]fluorodeoxyglucose positron emission tomography/computed tomography of non-small cell lung carcinoma and its relationship to metabolic parameters and pathologic staging.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2014 |
Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.
Topics: Aged; Algorithms; Artifacts; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Validity of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for pretreatment evaluation of patients with cervical carcinoma: a retrospective pathology-matched study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Contrast Media; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2014 |
Glucose metabolism gene expression patterns and tumor uptake of ¹⁸F-fluorodeoxyglucose after radiation treatment.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gene Expression; Glucose; Glucose Transporter Type 1; Head and Neck Neoplasms; Heterografts; Hexokinase; Immunohistochemistry; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; RNA, Messenger; Tumor Burden | 2014 |
Metabolic tumour volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study.
Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Coordination Complexes; Copper Radioisotopes; Dog Diseases; Dogs; Fluorodeoxyglucose F18; Glycolysis; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Sarcoma, Experimental; Thiosemicarbazones; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Efficacy of 18F-fluorodeoxyglucose positron emission tomography/CT imaging for extracapsular spread of laryngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2016 |
Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Squamous Cell Carcinoma of Head and Neck; Thionucleosides; Thymidine; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
Topics: Biomarkers; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Immunohistochemistry; Neoplasm Grading; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2014 |
[18F]-FDG PET-CT prediction of response to induction chemotherapy in head and neck squamous cell carcinoma: preliminary findings.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
[(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
The role of tonsillectomy in the initial diagnostic work-up of head and neck squamous cell carcinoma of unknown primary.
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Diseases; Male; Middle Aged; Neoplasm Invasiveness; Neoplasms, Unknown Primary; Palatine Tonsil; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tonsillectomy | 2014 |
Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Methyltyrosines; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy.
Topics: 4-1BB Ligand; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Immunohistochemistry; Immunotherapy; Longitudinal Studies; Magnetic Resonance Imaging; Mice; Mice, Inbred C3H; Mouth Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck | 2016 |
Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Conformal; Response Evaluation Criteria in Solid Tumors; Survival Rate; Tomography, X-Ray Computed | 2015 |
Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals | 2015 |
Positive clinical impact of an additional PET/CT scan before adjuvant radiotherapy or concurrent chemoradiotherapy in patients with advanced oral cavity squamous cell carcinoma.
Topics: Adult; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Solitary peritoneal lymph node metastasis of head and neck cancer diagnosed with FDG-PET/CT imaging.
Topics: Adult; Carcinoma, Squamous Cell; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Mouth Floor; Mouth Neoplasms; Multimodal Imaging; Peritoneum; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Is 18F-fluorodeoxyglucose positron emission tomography/computed tomography helpful in the decision-making process for neck dissection in patients with T1-T2 lingual cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tongue Neoplasms | 2015 |
Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Evaluation of ¹⁸F-fluorodeoxyglucose uptake in enlarged mediastinal lymph nodes in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2015 |
Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Differences in the prognostic significance of the SUVmax between patients with resected pulmonary Adenocarcinoma and squamous cell carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2014 |
Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma--a retrospective study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Perineural spreading along the trigeminal nerve in a squamous cell carcinoma of the tongue.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed; Tongue Neoplasms; Trigeminal Nerve; Trigeminal Nerve Diseases | 2015 |
Potential values of metabolic tumor volume and heterogeneity measured with ¹⁸F-FDG PET/CT pretreatment to evaluate local control for esophageal squamous cell carcinoma treated with nonsurgical therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiation Dosage; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
An unusual right ventricle metastasis from mandible squamous cell carcinoma detected on FDG PET/CT.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Male; Mandibular Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Oropharyngeal Neoplasms; Papillomaviridae; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Therapy; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Risk; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F-fluorodeoxyglucose uptake level-based lymph node staging in oropharyngeal squamous cell cancer--role of molecular marker expression on diagnostic outcome.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Molecular Diagnostic Techniques; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR.
Topics: Adult; Aged; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
Squamous cell carcinoma of the tongue with metastasis to the right ventricle.
Topics: Carcinoma, Squamous Cell; Disease Progression; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed; Tongue Neoplasms | 2015 |
Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospecti
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Inflammation; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Regression Analysis; Solitary Pulmonary Nodule; Statistics, Nonparametric; Time Factors; Tomography, X-Ray Computed | 2015 |
Predictive and prognostic value of metabolic tumor volume (MTV) in patients with laryngeal carcinoma treated by radiotherapy (RT) / concurrent chemoradiotherapy (CCRT).
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Therapeutics; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Radiation-Induced Esophagitis Masquerading as Disease Progression in Case of Esophageal Carcinoma: A Diagnostic Dilemma Solved on Follow-up FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagitis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2015 |
Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
Topics: Adult; Aged; Artifacts; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
[Usefulness of FDG-PET for superficial esophageal squamous cell carcinoma].
Topics: Carcinoma, Squamous Cell; Endoscopy, Gastrointestinal; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Retrospective Studies | 2015 |
(18)F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma.
Topics: Adult; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Statistics as Topic; Tongue Neoplasms | 2015 |
Value of FDG PET/CT in staging of oral cancer: four simultaneous primary malignancies.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Discovery of the primary site of esophageal squamous cell carcinoma based on axillary lymph nodes metastasis detected with fluorodeoxyglucose positron-emission tomography: report of a case.
Topics: Axilla; Carcinoma, Squamous Cell; Endoscopy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography | 2014 |
Molecular imaging biomarkers of resistance to radiation therapy for spontaneous nasal tumors in canines.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Chondrosarcoma; Coordination Complexes; Dog Diseases; Dogs; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Male; Molecular Imaging; Multimodal Imaging; Nose Neoplasms; Organometallic Compounds; Osteosarcoma; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Prognosis; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Regression Analysis; Thiosemicarbazones; Thymidine; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Safety and cost analysis of an (18)FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hospital Costs; Humans; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2015 |
Long-term results of survival analysis after a 5-year follow-up: Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2015 |
Detection of subclinical recurrence or second primary cancer using (18) F-FDG PET/CT in patients treated curatively for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2016 |
18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Mouth; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Proportional Hazards Models; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
Topics: Carcinoma, Squamous Cell; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Organs at Risk; Oropharyngeal Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Proton Therapy; Protons; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tomography, X-Ray Computed | 2015 |
[Positron emission tomography/computed tomography for lung cancer staging].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Cell Proliferation; Cohort Studies; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.
Topics: Adenocarcinoma; Aged; Bronchoscopy; Carcinoma, Squamous Cell; Databases, Factual; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2015 |
Monitoring response to gefitinib in nude mouse tumor xenografts by (18)F-FDG microPET-CT: correlation between (18)F-FDG uptake and pathological response.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; ROC Curve; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Tomography, X-Ray Computed | 2015 |
Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Failure; Young Adult | 2016 |
Extensive Tattoos Mimicking Lymphatic Metastasis on Positron Emission Tomography Scan in a Patient With Cervical Cancer.
Topics: Adult; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tattooing; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Positron emission tomography evaluation of sinonasal inverted papilloma and related conditions: a prospective clinical study.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nasal Polyps; Nose Neoplasms; Papilloma, Inverted; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-fluorodeoxyglucose positron emission tomography for predicting tumor response to radiochemotherapy in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiotherapy, Intensity-Modulated | 2015 |
Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Topics: Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neck; Oropharyngeal Neoplasms; Palpation; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Marked Hematopoiesis Masquerading Multiple Bone Metastasis in a Lung Cancer Patient With Myelodysplastic Syndrome.
Topics: Bone Marrow; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematopoiesis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Myelodysplastic Syndromes; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed | 2015 |
Intratumoral Heterogeneity of Subcutaneous Nodules in a Never-Smoker Woman of Lung Squamous Cell Carcinoma Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography: A Case Report.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
[Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
Topics: Adult; Aged; Aged, 80 and over; Cancer Care Facilities; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hungary; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2015 |
Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated | 2016 |
Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Prognostic role of metabolic parameters of (18)F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Staging of cervical cancer based on tumor heterogeneity characterized by texture features on (18)F-FDG PET images.
Topics: Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Support Vector Machine; Tissue Distribution; Tumor Burden; Uterine Cervical Neoplasms | 2015 |
The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Coloring Agents; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heterografts; Mice; Mice, Nude; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2015 |
FDG-PET nodal staging does not correlate with histopathological nodal stage for oesophageal cancers.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2015 |
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Face; Female; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
FDG PET/CT Findings of Recurrent Respiratory Papillomatosis With Malignant Degeneration in the Lung.
Topics: Adult; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Tract Infections; Tomography, X-Ray Computed | 2015 |
Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Imidazoles; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Triazoles | 2015 |
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
FDG PET/CT Manifestation of Rare Widespread Metastatic Chemoradiation-Refractory Thymic Squamous Cell Carcinoma.
Topics: Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, X-Ray Computed | 2015 |
Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; ErbB Receptors; Fluorodeoxyglucose F18; Glutathione Transferase; Head and Neck Neoplasms; Humans; Immunohistochemistry; Ki-67 Antigen; Multimodal Imaging; Multivariate Analysis; Neoplasm Proteins; Positron-Emission Tomography; Proto-Oncogene Proteins c-bcl-2; Radiopharmaceuticals; Tomography, X-Ray Computed; Tubulin; Tumor Suppressor Protein p53 | 2015 |
Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aorta; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Failure; Uterine Cervical Neoplasms; Young Adult | 2015 |
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2016 |
Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2016 |
The correlation between the metabolic tumor volume and hematological parameters in patients with esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Hematologic Tests; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; ErbB Receptors; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Squamous Cell Carcinoma of Head and Neck | 2016 |
Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2015 |
Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma.
Topics: Blood Vessels; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Lymphatic Vessels; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed; Tumor Burden | 2015 |
The association of (18)F-FDG PET and glucose metabolism biomarkers GLUT1 and HK2 in p16 positive and negative head and neck squamous cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Kinesins; Male; Middle Aged; Papillomavirus Infections; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2015 |
Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Spatio-temporal stability of pre-treatment 18F-Fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose painting.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed | 2015 |
Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.
Topics: Adult; Aged; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
Improving the Spatial Alignment in PET/CT Using Amplitude-Based Respiration-Gated PET and Respiration-Triggered CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Lung; Lung Neoplasms; Male; Middle Aged; Motion; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Mechanics; Tomography, Emission-Computed; Tomography, Spiral Computed | 2015 |
Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging; Young Adult | 2015 |
Correlation between pretreatment FDG-PET biological target volume and location of T-site failure after definitive radiation therapy for head and neck cancers.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2015 |
Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Squamous cell carcinoma arising from a Zenker's diverticulum: contribution of FDG-PET/CT to the diagnosis.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Zenker Diverticulum | 2016 |
High glucose uptake unexpectedly is accompanied by high levels of the mitochondrial ß-F1-ATPase subunit in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitochondria; Mitochondrial Proton-Translocating ATPases; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2015 |
Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Hyoid osteoradionecrosis accompanied by candida infection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Carcinoma, Squamous Cell; Chemoradiotherapy; Deglutition Disorders; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Hyoid Bone; Male; Middle Aged; Multimodal Imaging; Necrosis; Osteoradionecrosis; Pharyngeal Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2015 |
Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiographic Image Enhancement; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The prognostic value of total lesion glycolysis via 18F-fluorodeoxyglucose PET-CT in surgically treated esophageal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Frozen Sections; Glucose; Groin; Humans; Inguinal Canal; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Precision Medicine; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Turkey; Vulvar Neoplasms | 2016 |
Impact of number of [(18)F]fluorodeoxyglucose-PET-positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2016 |
The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Carcinoma, Squamous Cell; Cohort Studies; Dyrk Kinases; Female; Fluorodeoxyglucose F18; Gene Expression; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nuclear Proteins; Primary Cell Culture; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; RNA, Messenger; Ubiquitin-Protein Ligases | 2015 |
Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model.
Topics: Animals; Benzamides; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line; ErbB Receptors; Female; Fluorodeoxyglucose F18; HSP90 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Iodine Radioisotopes; Isoindoles; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Radioimmunotherapy; Radiopharmaceuticals | 2016 |
The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cross-Sectional Studies; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2015 |
A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2015 |
[(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Second Primary; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Topics: Carcinoma, Squamous Cell; Endoscopy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2016 |
Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagus; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Taxoids; Treatment Outcome | 2016 |
Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma.
Topics: Animals; Antibodies, Monoclonal; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Immunoglobulin Fab Fragments; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Recombinant Proteins; Tissue Distribution | 2016 |
Fluorodeoxyglucose-positron emission tomography/computed tomography imaging of squamous cell carcinoma arising in a meningomyelocele.
Topics: Adult; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Meningomyelocele; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Spinal Neoplasms | 2016 |
(18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Risk Assessment; Treatment Outcome | 2016 |
Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Young Adult | 2016 |
Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2015 |
[Prognostic value of the metabolically active tumour volume].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Prognostic value of 2-[(18) F]fluoro-2-deoxy-D-glucose positron emission tomography for patients with oral squamous cell carcinoma treated with retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2016 |
The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Comorbidity; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Maryland; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate | 2015 |
Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Pretreatment screening for distant metastases in the Dutch head and neck centers: 10 years later.
Topics: Attitude of Health Personnel; Carcinoma, Squamous Cell; Early Detection of Cancer; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Health Care Surveys; Humans; Neoplasm Metastasis; Netherlands; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Surgeons; Tomography, X-Ray Computed | 2016 |
Changes in Total Lesion Glycolysis Evaluated by Repeated F-18 FDG PET/CT as Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Preoperative Chemoradiotherapy.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2016 |
The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms; Whole Body Imaging; Young Adult | 2016 |
18F-FDG PET-CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Positron Emission Tomography Computed Tomography | 2016 |
Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Models, Theoretical; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2016 |
Unusual Presentation of Elastofibroma Dorsi on 18F-FDG-PET/CT: A Case Report.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Fibrous Tissue; Neoplasms, Second Primary; Pleural Effusion; Positron-Emission Tomography; Thoracic Neoplasms | 2016 |
Usefulness of 18f-Fluorodeoxyglucose Positron Emission Tomography for Predicting the Pathological Response of Neoadjuvant Chemoradiotherapy for T4 Esophageal Squamous Cell Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagus; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Taxoids; Treatment Outcome | 2015 |
Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2016 |
Positive (18)Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Predicts Preinvasive Endobronchial Lesion Progression to Invasive Cancer.
Topics: Aged; Aged, 80 and over; Bronchial Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Different Prognostic Implications of 18F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2016 |
Silicone Granuloma in the Buttocks Incidentally Detected by 18F-FDG PET/CT 30 Years After Free Liquid Silicone Injections.
Topics: Buttocks; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Granuloma; Head and Neck Neoplasms; Humans; Incidental Findings; Injections, Intramuscular; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Silicones; Squamous Cell Carcinoma of Head and Neck; Transgender Persons | 2016 |
FDG PET/CT in Patients With Head and Neck Squamous Cell Carcinoma After Primary Surgical Resection With or Without Chemoradiation Therapy.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Bronchoscopy; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Thoracotomy | 2016 |
Intensity modulated arc therapy implementation in a three phase adaptive (18)F-FDG-PET voxel intensity-based planning strategy for head-and-neck cancer.
Topics: Adult; Aged; Algorithms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Middle Aged; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Reproducibility of Results | 2016 |
Prognostic value of FDG-PET volumetric parameters in patients with p16-positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiotherapy; Retrospective Studies; Tumor Burden | 2016 |
PET/CT findings within the contralateral tonsil following unilateral tonsillectomy.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Palatine Tonsil; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tonsillar Neoplasms; Tonsillectomy; Victoria | 2016 |
[Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with
Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2016 |
PET/CT in the evaluation of treatment response to neoadjuvant chemoradiotherapy and prognostication in patients with locally advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Modern Radiology in the Management of Head and Neck Cancer.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Disease Management; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
FDG PET/CT Imaging of Prostate Carcinosarcoma.
Topics: Carcinoma, Squamous Cell; Carcinosarcoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Transurethral Resection of Prostate; Urinary Retention | 2016 |
Validation of metabolic tumor volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Molecular biological correlation of fluorine-18 fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Biomarkers, Tumor; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Neoplasm Staging; Retrospective Studies | 2016 |
Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2016 |
Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Topics: Aged; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2016 |
Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2016 |
Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; ROC Curve; Survival Rate; Treatment Outcome | 2016 |
[Primary Squamous Cell Carcinoma of the Prostate in which Docetaxel Therapy was Effective : A Case Report].
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Taxoids | 2016 |
Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Comorbidity; Disease Management; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; United States | 2018 |
Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2016 |
Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
Topics: Aged; Area Under Curve; Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate | 2016 |
The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; DNA Damage; DNA Repair; Docetaxel; Down-Regulation; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Radiotherapy Dosage; Squamous Cell Carcinoma of Head and Neck; Taxoids; Up-Regulation | 2017 |
Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Grading; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
Should (18)F FDG PET/CT Really Be Indicated in Routine Clinical Practice for Detecting Contralateral Neck Node Metastasis in Head and Neck Squamous Cell Carcinoma?
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neoplastic Cells, Circulating; Positron Emission Tomography Computed Tomography; Recurrence | 2016 |
Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Republic of Korea; Retrospective Studies; Uterine Cervical Neoplasms | 2016 |
Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: a diagnostic and management dilemma.
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography | 2016 |
Synchronous presentation of nasopharyngeal carcinoma and abdominal paraganglioma with avid 18F-FDG and 68Ga-DOTA-TOC uptake in PET/CT by both tumours.
Topics: Abdominal Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms, Multiple Primary; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution | 2016 |
Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; France; Humans; Longitudinal Studies; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
Topics: Animals; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Mice, Nude; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy Dosage; Xenograft Model Antitumor Assays | 2016 |
Prognostic significance of clinical and
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Young Adult | 2016 |
Utility of
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Survival Rate | 2017 |
Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy.
Topics: Adult; Aged; Biomarkers, Tumor; Carbonic Anhydrase IX; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Immunohistochemistry; Ku Autoantigen; Male; Middle Aged; Misonidazole; Papillomavirus Infections; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Hypoxia | 2016 |
Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2016 |
Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Dose painting by numbers based on retrospectively determined recurrence probabilities.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Probability; Radiotherapy Dosage; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2017 |
The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients.
Topics: Adult; Aftercare; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2017 |
Glucose Metabolism and Its Complicated Relationship with Tumor Growth and Perfusion in Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Spin Labels; Squamous Cell Carcinoma of Head and Neck | 2016 |
Prognostic significance of venous invasion and maximum standardized uptake value of
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Treatment Outcome; Vascular Neoplasms | 2017 |
Heterogeneity of Glucose Metabolism in Esophageal Cancer Measured by Fractal Analysis of Fluorodeoxyglucose Positron Emission Tomography Image: Correlation between Metabolic Heterogeneity and Survival.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fractals; Glucose; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
FDG PET/CT in Carcinoma of the Tongue With Bilateral Adrenal Metastases.
Topics: Adrenal Gland Neoplasms; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tongue Neoplasms | 2017 |
Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Treatment Outcome | 2017 |
The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: preliminary findings.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2017 |
The predictive value of
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulva.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Vulvar Neoplasms | 2017 |
Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2017 |
Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
Topics: Adult; Aged; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Positron Emission Tomography Computed Tomography; Tumor Burden; Uterine Cervical Neoplasms | 2017 |
The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Complications; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden | 2017 |
Answer to Photo Quiz: An old male with multiple hotspots on
Topics: Adipose Tissue, Brown; Carcinoma, Squamous Cell; Deglutition Disorders; Diagnosis, Differential; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagus; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe 18F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Electron Transport Complex I; Fluorodeoxyglucose F18; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Positron-Emission Tomography; Pyridazines; Pyridines; Radiopharmaceuticals | 2017 |
PET/CT for Head and Neck Squamous Cell Carcinoma: Should We Routinely Include the Head and Abdomen?
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Pennsylvania; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Skull Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2017 |
Role of
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis | 2017 |
FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2017 |
Nasal-Tip Metastasis on 18F-FDG PET/CT Scan in a Patient With Squamous Lung Carcinoma.
Topics: Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nose Neoplasms; Positron Emission Tomography Computed Tomography | 2017 |
Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2017 |
Case report of primary renal pelvis squamous cell carcinoma coexisting with long-standing calculi in left kidney on 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Kidney Calculi; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2008 |
Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma: intermethod and interobserver variations.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Larynx; Male; Middle Aged; Mouth; Observer Variation; Pharynx; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2008 |
F-18 FDG PET/CT imaging of submandibular gland oncocytoma.
Topics: Adenoma, Oxyphilic; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lip Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Submandibular Gland Neoplasms; Tomography, X-Ray Computed | 2008 |
Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms | 2009 |
FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiography, Thoracic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2009 |
Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome | 2009 |
Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Computer Simulation; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2009 |
A case of two synchronous primary lung tumors demonstrated by FDG positron emission tomography.
Topics: Adenocarcinoma; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Urinary Bladder Neoplasms; Whole Body Imaging | 2008 |
Port site and distant metastases of gallbladder cancer after laparoscopic cholecystectomy diagnosed by positron emission tomography.
Topics: Aged; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cholecystectomy, Laparoscopic; Cholecystitis; Cholelithiasis; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Incidental Findings; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Seeding; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Cross-Sectional Studies; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2009 |
Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endoscopy, Digestive System; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Squamous cell carcinoma of the right kidney on FDG PET-CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
Topics: Acetates; Adenocarcinoma; Carbon; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Use of single MRI and 18F-FDG PET-CT scans in both diagnosis and radiotherapy treatment planning in patients with head and neck cancer: advantage on target volume and critical organ delineation.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Parotid Gland; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2008 |
False-positive positron emission tomography appearance with 18F-fluorodeoxyglucose after definitive radiotherapy for cancer of the mobile tongue.
Topics: Adult; Brachytherapy; Carcinoma, Squamous Cell; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tongue Neoplasms; Young Adult | 2009 |
Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; ROC Curve; Treatment Outcome | 2009 |
The limitation of PET imaging for biological adaptive-IMRT assessed in animal models.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Disease Models, Animal; Fibrosarcoma; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Mice; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated | 2009 |
Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Survival Rate | 2009 |
Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2009 |
Effect of 18F-fluorodeoxyglucose positron emission tomography on the management of patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Radiotherapy, Adjuvant; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2008 |
Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections.
Topics: Carcinoma, Squamous Cell; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Portal Vein; Positron-Emission Tomography; Preoperative Care; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Yttrium Radioisotopes | 2009 |
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Evaluation of D-18F-FMT, 18F-FDG, L-11C-MET, and 18F-FLT for monitoring the response of tumors to radiotherapy in mice.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Squamous Cell; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Methionine; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Positron-Emission Tomography; Tyrosine | 2009 |
[Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antigens, CD34; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Lung Neoplasms; Lymphatic Metastasis; Male; Microvessels; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2008 |
[(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
[The role of (18)F-FDG DHC SPECT-CT in the diagnosis and staging for lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Role of PET/CT in maxillo-facial surgery.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromosome Banding; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorodeoxyglucose F18; Gene Expression; Genes, p53; Head and Neck Neoplasms; Humans; Mutation; Radiopharmaceuticals | 2009 |
The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2009 |
The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography | 2009 |
Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals | 2009 |
Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiotherapy, Conformal; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radioisotopes; Tomography, X-Ray Computed; Video-Assisted Surgery | 2009 |
The identification of a tumor of the cervix on PET/CT with bladder filling and emptying.
Topics: Carcinoma, Squamous Cell; Diuresis; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder; Uterine Cervical Neoplasms; Whole Body Imaging | 2009 |
Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas.
Topics: Adult; Aged; beta Catenin; Cadherins; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins c-bcl-2; Radiopharmaceuticals; Survival Analysis; Vascular Endothelial Growth Factor A | 2009 |
Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2009 |
Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Monitoring; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Radionuclide Imaging; Xenograft Model Antitumor Assays | 2009 |
Mandibular lesion differential diagnoses in a patient with a previous history of locally advanced head and neck carcinoma.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mandible; Middle Aged; Neoplasm Recurrence, Local; Osteoradionecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2009 |
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome; Tumor Burden; Young Adult | 2009 |
Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome?
Topics: Adenoma, Pleomorphic; Adult; Aged; Aged, 80 and over; Apoptosis; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitosis; Neoplasm Staging; Pharynx; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Young Adult | 2009 |
(18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2010 |
The utility of FDG-PET for detecting multiple primary cancers in hypopharyngeal cancer patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2009 |
Biological correlates of the maximum 18-fluoro-2-deoxy-glucose uptake on positron emission tomography in non-small cell lung carcinoma after induction chemotherapy.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction | 2009 |
Comparison of [18F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation.
Topics: Animals; Autoradiography; Biological Transport; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Mice; Mice, Nude; Positron-Emission Tomography; Radiation Dosage; Time Factors; Transplantation, Heterologous | 2009 |
(18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Remission Induction; Tomography, X-Ray Computed; Tumor Burden | 2010 |
High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis | 2009 |
GTV spatial conformity between different delineation methods by 18FDG PET/CT and pathology in esophageal cancer.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
[Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphography; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Three synchronous tumours identified by FDG-PET/CT.
Topics: Adenoma, Villous; Aged; Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Tongue Neoplasms | 2009 |
Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2009 |
[Potential place of FDG-PET for the GTV delineation in head and neck and lung cancers].
Topics: Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2009 |
A suspected [18F]fluorodeoxyglucose positron emission tomography-negative metastatic lymph node successfully diagnosed by laparoscopic staging in esophageal cancer: report of two cases.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings.
Topics: Aged; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Additional diagnostic value of (18)F-FDG PET-CT in detecting retropharyngeal nodal metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retroperitoneal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
Detection and prediction of local recurrence of maxillary sinus cancer using F-18 FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Maxillary Sinus Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2010 |
Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Tumor Suppressor Protein p53 | 2009 |
Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
Topics: Carcinoma, Squamous Cell; Dideoxynucleosides; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Heart; Humans; Lung; Lymph Node Excision; Male; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Spinal Cord; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
Topics: Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2010 |
[Correlation between PET-CT 18FDG uptake in primary lesions and clinicopathological parameters in esophageal carcinoma patients].
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Chemoradiotherapy in the management of primary squamous-cell carcinoma of the rectum.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Mitomycin; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy, Adjuvant; Rectal Neoplasms; Retrospective Studies; Treatment Outcome | 2011 |
18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.
Topics: Carboplatin; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Nuclear Medicine; Observer Variation; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Polyostotic fibrous dysplasia mimicking bone metastases in a patient with advanced-stage cervical cancer.
Topics: Adult; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2010 |
Role of pretreatment 18FDG-PET/CT in surgical decision-making for head and neck cancers.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Decision Making; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Retrospective Studies; Sensitivity and Specificity | 2010 |
[Evaluation of fluorodeoxyglucose-position-emission tomography-computer tomography imaging on head and neck squamous cell carcinomas including primary tumors and lymph node metastases].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2010 |
Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Humans; Laryngeal Neoplasms; Male; Middle Aged; Multivariate Analysis; Pharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Early monitoring of radiotherapeutic effects of nasopharyngeal carcinoma xenografts in nude mice using 18F-FDG PET-CT imaging.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Positron-Emission Tomography; Random Allocation; Tomography, X-Ray Computed; Tumor Burden | 2010 |
[Prognostic value of pretherapeutic 18F-FDG PET/CT in cancer of the uterine cervix: a retrospective study of 53 patients].
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2010 |
SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Cisplatin; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Inhibitory Concentration 50; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Vascular Endothelial Growth Factor A | 2010 |
Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Carcinoma, Squamous Cell; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Palatine Tonsil; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Spiral Computed; Tonsillar Neoplasms; Triiodobenzoic Acids | 2010 |
Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography; Retrospective Studies | 2010 |
Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Tumor Burden; Young Adult | 2011 |
An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Kinetics; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Muscles; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Tomography, X-Ray Computed | 2010 |
FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; DNA-(Apurinic or Apyrimidinic Site) Lyase; DNA, Neoplasm; Female; Fluorodeoxyglucose F18; Genotype; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2010 |
Sequential FDG-PET/CT after neoadjuvant chemotherapy is a predictor of histopathologic response in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2011 |
18f-fdg pet for routine posttreatment surveillance in oral and oropharyngeal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Monitoring, Physiologic; Mouth Neoplasms; Oropharyngeal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results | 2010 |
The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Serpins; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
Topics: Aged; Carcinoma, Squamous Cell; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Injections, Intravenous; Iohexol; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed | 2010 |
[18F]Fluorodeoxyglucose positron emission tomography in the initial staging of squamous cell carcinoma of the head and neck: promise, evidence, and reality.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Survival Analysis | 2010 |
Pretreatment positron emission tomography with [18F]fluorodeoxyglucose for head and neck squamous cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multicenter Studies as Topic; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Two coincident squamous cell carcinomas of the esophagus in a patient with achalasia: evidence by F-18 FDG PET/CT.
Topics: Adult; Carcinoma, Squamous Cell; Esophageal Achalasia; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2011 |
Contrast-enhanced ¹⁸F-FDG-PET/CT for the assessment of necrotic lymph node metastases.
Topics: Aged; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiographic Image Enhancement; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2011 |
Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Oxonic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Remission Induction; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tegafur; Treatment Outcome | 2011 |
Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Stomach Neoplasms | 2010 |
Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Japan; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2010 |
PET-CT staging of the neck in cancers of the oropharynx: patterns of regional and retropharyngeal nodal metastasis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2010 |
Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Oropharyngeal Neoplasms; Polymerase Chain Reaction; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate | 2010 |
The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnostic Imaging; Endoscopy; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Uvula | 2010 |
18F-FET PET/CT in advanced head and neck squamous cell carcinoma: an intra-individual comparison with 18F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
CT, MR, (18)F-FDG PET/CT, and their combined use for the assessment of mandibular invasion by squamous cell carcinomas of the oral cavity.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Iohexol; Magnetic Resonance Imaging; Male; Mandible; Mandibular Neoplasms; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Four-dimensional positron emission tomography: implications for dose painting of high-uptake regions.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Neoplasm Invasiveness; Netherlands; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Regression Analysis; Risk Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organ Size; Parotid Gland; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2012 |
FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis.
Topics: Adolescent; Adult; Apoptosis; Carcinoma, Squamous Cell; Child; Female; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Head and Neck Neoplasms; Hexokinase; Humans; Male; Middle Aged; Neoplasm Invasiveness; Radionuclide Imaging; Up-Regulation; Young Adult | 2011 |
Sarcoid-like reaction mimics progression of disease after induction chemotherapy for lung cancer.
Topics: Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Disease Progression; Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2010 |
Diagnostic significance of characteristic findings on ultrasonography for the stitch abscess after surgery in patients with oral squamous cell carcinoma.
Topics: Abscess; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Surgical Wound Infection; Sutures; Tomography, X-Ray Computed; Ultrasonography | 2011 |
The potential role of non-FDG-PET in the management of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Warthin tumor: a potential source of diagnostic error.
Topics: Adenolymphoma; Aged; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Maxillary Neoplasms; Neoplasms, Multiple Primary; Paraproteinemias; Parotid Diseases; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Mimicry of physiological urinary FDG excretion: squamous cell carcinoma of esophagus metastasizing to psoas muscle.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Psoas Muscles; Tomography, X-Ray Computed | 2011 |
Squamous cell carcinoma of the bulbar conjunctiva seen on F-18 FDG PET/CT.
Topics: Aged; Carcinoma, Squamous Cell; Conjunctiva; Eye Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planning.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urothelium | 2011 |
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Squamous Cell; Chemoradiotherapy; Choline; Cisplatin; Contrast Media; Diagnostic Imaging; Extracellular Space; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Gadolinium DTPA; Glucose; Glycolysis; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric; Tongue Neoplasms; Tonsillar Neoplasms | 2012 |
Imaging tumor perfusion and oxidative metabolism in patients with head-and-neck cancer using 1- [11C]-acetate PET during radiotherapy: preliminary results.
Topics: Acetic Acid; Adolescent; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oxygen; Positron-Emission Tomography; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy Dosage; Regional Blood Flow; Remission Induction | 2012 |
Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Amoebic abscess diagnosed on fluorodeoxyglucose positron emission tomography scan in patient with recurrent oropharyngeal squamous cell carcinoma.
Topics: Aged; Amebiasis; Carcinoma, Squamous Cell; Colonic Diseases; Fluorodeoxyglucose F18; Humans; Male; Oropharyngeal Neoplasms; Positron-Emission Tomography | 2011 |
Hounsfield units upon PET/CT are useful in evaluating metastatic regional lymph nodes in patients with oesophageal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
Synchronous malignancies in patients with squamous cell carcinomas of the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2011 |
The appearance of cardiac metastasis from squamous cell carcinoma of the lung on F-18 FDG PET/CT and post hoc PET/MRI.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Movement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Respiration; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.
Topics: Adenocarcinoma; Aged; Anthracosis; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Coal; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Turkey | 2012 |
[Experience with combined treatment of invasive squamous cell cancer of the penis].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Salvage Therapy; Tomography, X-Ray Computed | 2011 |
Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Tumor Microenvironment | 2012 |
Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Pulmonary FDG uptake without a CT counterpart - a pitfall in interpreting PET/CT images.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Pneumonia; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed; Tongue Neoplasms; Whole Body Imaging | 2011 |
Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2011 |
False-positive positron emission tomography in patients with history of malignancy.
Topics: Adult; Anus Neoplasms; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma, Lobular; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Metabolic response of pelvic and para-aortic lymph nodes during radiotherapy for carcinoma of the uterine cervix: using positron emission tomography/computed tomography.
Topics: Aorta; Brachytherapy; Carcinoma, Squamous Cell; Cervix Uteri; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Pelvis; Positron-Emission Tomography; Prognosis; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Preoperative Period; Prospective Studies; Radiopharmaceuticals | 2016 |
Fluorodeoxyglucose-positive Warthin tumor in a neck node mimicking metastasis in primary intraosseous left posterior mandibular cancer staging with positron emission tomography/computed tomography.
Topics: Adenolymphoma; Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Neoplasms, Multiple Primary; Parotid Neoplasms; Positron-Emission Tomography; Radiography, Panoramic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Increased glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Male; Middle Aged; Mouth Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric | 2012 |
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Survival Rate; Treatment Outcome | 2011 |
Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Cohort Studies; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma.
Topics: Aged; Analysis of Variance; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Hepatic macronodular tuberculoma mimics liver metastasis in a patient with locoregional advanced tongue cancer.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mycobacterium tuberculosis; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tongue Neoplasms; Tuberculoma; Tuberculosis, Hepatic; Tuberculosis, Pulmonary | 2011 |
Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2011 |
A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Demography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-FDG uptake in primary lung cancer as a predictor of intratumoral vessel invasion.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Prognosis; Radionuclide Imaging; Retrospective Studies | 2011 |
The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2011 |
Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Tomography, X-Ray Computed; Tongue Neoplasms | 2011 |
Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Correlation of 18F-FDG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Cell Differentiation; Diffusion; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies | 2011 |
Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cinnamates; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Head and Neck Neoplasms; Immunoenzyme Techniques; Lactates; Linear Models; Luminescent Measurements; Mice; Mice, Nude; Monocarboxylic Acid Transporters; Nitroimidazoles; Oxidation-Reduction; Symporters; Tumor Microenvironment; Uterine Cervical Neoplasms | 2011 |
Linear correlation between patient survival and decreased percentage of tumor [(18)F]fluorodeoxyglucose uptake for late-course accelerated hyperfractionated radiotherapy for esophageal cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; China; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Linear Models; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2012 |
Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Collision lung cancer on F-18 FDG PET/CT.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomogr
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2011 |
Comparison of clinical and surgical-pathological staging in IIIA non-small cell lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mediastinoscopy; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Thoracic Neoplasms | 2012 |
18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2011 |
FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Australia; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Confounding Factors, Epidemiologic; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome | 2011 |
Bronchogenic squamous cell carcinoma mass with central photopenia on FDG-PET scan.
Topics: Aged; Bronchial Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2012 |
Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Differentiating osteoradionecrosis from nasopharyngeal carcinoma tumour recurrence using ⁹⁹Tcm-sestamibi SPECT/CT.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Osteoradionecrosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Matched cohort analysis of the effect of pretreatment positron emission tomography on clinical outcomes of patients with head and neck cancer treated with definitive chemoradiotherapy.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Treatment Outcome | 2012 |
Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Tumor Burden | 2011 |
Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma; Survival Rate | 2011 |
Spontaneous regression of primary lung cancer arising from an emphysematous bulla.
Topics: Blister; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Frozen Sections; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Regression, Spontaneous; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Pulmonary Emphysema; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2011 |
¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2011 |
F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Proliferation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Prediction of the outcome of definitive chemoradiation by decrease in F-18 FDG uptake in nonsurgical esophageal squamous cell cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Proportional Hazards Models; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Prediction of local failures with a combination of pretreatment tumor volume and apparent diffusion coefficient in patients treated with definitive radiotherapy for hypopharyngeal or oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hemoglobins; Humans; Male; Middle Aged; Multivariate Analysis; Oropharyngeal Neoplasms; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy; Recurrence; Retrospective Studies; Treatment Outcome | 2011 |
Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2011 |
The role of integrated F-18-FDG-PET scanning in the detection of M1 disease in oesophageal adenocarcinoma and impact on clinical management.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Colonic Neoplasms; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity | 2011 |
Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cervix Uteri; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Failure; Uterine Cervical Neoplasms; Uterus; Young Adult | 2012 |
Improved treatment outcomes with (18) F-FDG PET/CT for patients with advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Case-Control Studies; Chemoradiotherapy; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Biopsy, Needle; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neck Dissection; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Proportional Hazards Models; Receptors, Erythropoietin; Registries; Retrospective Studies; Risk Assessment; Survival Analysis; Tongue Neoplasms; Treatment Outcome | 2012 |
The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Serpins; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2012 |
The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Disease-Free Survival; DNA, Viral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Incidence; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Papillomavirus Infections; Pennsylvania; Population Surveillance; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tomography, X-Ray Computed | 2011 |
Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2011 |
The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Prevalence of esophageal cancer during the pretreatment of hypopharyngeal cancer patients: routinely performed esophagogastroduodenoscopy and FDG-PET/CT findings.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Endoscopy, Digestive System; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
The value of PET/CT to assess clinically negative necks.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neck; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Fluorodeoxyglucose-induced allergic reaction: a case report.
Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Diphenhydramine; Drug Hypersensitivity; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Pyriform Sinus; Radiopharmaceuticals; Secondary Prevention; Squamous Cell Carcinoma of Head and Neck; Terfenadine; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Bone Marrow; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Hematologic Diseases; Humans; Leukocyte Count; Linear Models; Middle Aged; Neutrophils; Platelet Count; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2012 |
Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; Female; Fluorodeoxyglucose F18; Humans; Karnofsky Performance Status; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2012 |
Comparative methods for PET image segmentation in pharyngolaryngeal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Laryngeal Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tumor Burden | 2012 |
Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Palatine Tonsil; Positron-Emission Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2013 |
Different distribution of (62) Cu ATSM and (18)F-FDG in head and neck cancers.
Topics: Adenocarcinoma; Aged; Analysis of Variance; Biopsy; Carcinoma, Squamous Cell; Coordination Complexes; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Thiosemicarbazones; Tomography, X-Ray Computed | 2012 |
Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging.
Topics: Animals; Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Mice; Mice, Nude; Multimodal Imaging; Necrosis; Neoplasm Transplantation; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; ROC Curve; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tomography, X-Ray Computed; Transplantation, Heterologous; Tumor Burden | 2012 |
Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Tumor Burden | 2012 |
Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Hexokinase; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiography; Survival Rate | 2013 |
Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2012 |
Cost-effectiveness of positron emission tomography/computed tomography in the management of advanced head and neck cancer.
Topics: Aged; Alberta; Carcinoma, Squamous Cell; Cohort Studies; Contrast Media; Cost-Benefit Analysis; Disease Progression; Female; Fluorodeoxyglucose F18; Hospital Costs; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Palliative Care; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Predictive value of metabolic tumor volume measured by 18F-FDG PET for regional lymph node status in patients with esophageal cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; ROC Curve; Tumor Burden | 2012 |
The relationship between GLUT-1 and vascular endothelial growth factor expression and 18F-FDG uptake in esophageal squamous cell cancer patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Tumor Burden; Vascular Endothelial Growth Factor A | 2012 |
FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diffusion; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Docetaxel; Drug Administration Schedule; Fluorodeoxyglucose F18; Humans; Male; Penile Neoplasms; Positron-Emission Tomography; Taxoids; Treatment Outcome | 2012 |
Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2012 |
Feasibility of shrinking field radiation therapy through 18F-FDG PET/CT after 40 Gy for stage III non-small cell lung cancers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2012 |
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms | 2012 |
Changes in cervical cancer FDG uptake during chemoradiation and association with response.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Function Tests; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
¹⁸F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Role of positron emission tomography-computed tomography in the management of anal cancer.
Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Digital Rectal Examination; False Positive Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proctoscopy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2012 |
Early recurrence or submucosal residual of laryngeal squamous cell carcinoma: diagnosis by CT-guided endolaryngeal core biopsy on a transcutaneous approach.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
18-fluoro-deoxy-glucose positron emission tomography with computed tomography-based gross tumor volume estimation and validation with magnetic resonance imaging for locally advanced cervical cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Metabolic imaging biomarkers of postradiotherapy xerostomia.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Organs at Risk; Oropharyngeal Neoplasms; Parotid Gland; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Xerostomia | 2012 |
The value of ¹⁸F-FDG PET/CT in assessment of metabolic response in esophageal cancer for prediction of histopathological response and survival after preoperative chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2012 |
PET/CT significance for planning radiotherapy of head and neck cancer.
Topics: Adult; Aged; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Young Adult | 2012 |
Preoperative predictive model of cervical lymph node metastasis combining fluorine-18 fluorodeoxyglucose positron-emission tomography/computerized tomography findings and clinical factors in patients with oral or oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anatomy, Regional; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2012 |
18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose-6-Phosphatase; Hexokinase; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Mouth Floor; Mouth Mucosa; Mouth Neoplasms; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Statistics, Nonparametric; Tongue | 2012 |
F-18 FDG PET/CT and Tc-99m sulfur colloid SPECT imaging in the diagnosis and treatment of a case of dual solitary fibrous tumors of the retroperitoneum and pancreas.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Solitary Fibrous Tumors; Technetium Tc 99m Sulfur Colloid; Tomography, X-Ray Computed; Tongue Neoplasms | 2012 |
Positron emission tomography in the detection of occult primary head and neck carcinoma: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2012 |
The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Topics: Carcinoma, Squamous Cell; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Forecasting; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neck Dissection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
Topics: Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2012 |
Positron-emission tomography pitfalls related to oral prosthesis.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Maxillary Neoplasms; Middle Aged; Multimodal Imaging; Palatal Obturators; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging.
Topics: Adenocarcinoma; Adult; Aged; Aorta, Abdominal; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Middle Aged; Neoplasm Grading; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2012 |
Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2012 |
Oesophageal squamous cell carcinoma: relationship between fluorine-18 fludeoxyglucose positron emission tomography CT maximum standardised uptake value, metabolic tumour volume, and tumour, node and metastasis classification.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Young Adult | 2012 |
Metastatic gastric cancer from squamous cell lung carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Japan; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Salvage Therapy; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.
Topics: Adult; Aged; Automation; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Image Processing, Computer-Assisted; Male; Medical Oncology; Middle Aged; Positron-Emission Tomography; Radiotherapy; Respiration; Tumor Burden | 2012 |
Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Human Papillomavirus DNA Tests; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts.
Topics: Animals; Annexin A5; Apoptosis; Biomarkers, Tumor; Carbon Isotopes; Carcinoma, Squamous Cell; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Mice; Mice, SCID; Neoplasm Transplantation; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Transplantation, Heterologous | 2012 |
Usefulness of 3'-deoxy-3'-18F-fluorothymidine PET for predicting early response to chemoradiotherapy in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
[Serial (18)F-FDG PET-CT imaging during radiotherapy for nasopharyngeal carcinoma: a prospective clinical study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, High-Energy; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.
Topics: Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Metastasis; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Parotid gland metastasis from squamous cell carcinoma of esophagus detected by FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Parotid Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Endosonography; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Preoperative evaluation of patients with squamous cell carcinoma of the oral cavity: fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography and ultrasonography versus histopathology.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2012 |
Use of routine ultrasound-guided fine-needle aspiration cytology to assess the neck in patients with head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Neoplasm Staging | 2012 |
Orthotopic VX rabbit tongue cancer model with FDG-PET and histologic characterization.
Topics: Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Neoplasm Transplantation; Organothiophosphorus Compounds; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Tongue Neoplasms | 2013 |
Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2013 |
Use of pretreatment metabolic tumor volumes on PET-CT to predict the survival of patients with squamous cell carcinoma of esophagus treated by curative surgery.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Sarcoidlike reaction of neoplasia causing hypermetabolic thoracic adenopathy in setting of extrathoracic malignancy: report of two cases and a review of the differential diagnostic considerations.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Sacrum; Sarcoidosis; Thorax; Tomography, X-Ray Computed | 2012 |
18F-fluorodeoxythymidine micro-positron-emission tomography versus 18F-fluorodeoxyglucose micro-positron-emission tomography for in vivo minimal residual disease imaging.
Topics: Animals; Carcinoma, Squamous Cell; Dideoxynucleosides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Luminescent Measurements; Mice; Mice, Nude; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2013 |
Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed | 2012 |
Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
PET/MRI in head and neck cancer: initial experience.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Whole Body Imaging | 2013 |
A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT.
Topics: Algorithms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gels; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Models, Anatomic; Models, Biological; Multimodal Imaging; Neoplasms; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Three-dimensional positron emission tomography image texture analysis of esophageal squamous cell carcinoma: relationship between tumor 18F-fluorodeoxyglucose uptake heterogeneity, maximum standardized uptake value, and tumor stage.
Topics: Adult; Aged; Biological Transport; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2013 |
Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cell Proliferation; Choline; Choline Kinase; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2013 |
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.
Topics: Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Glycolysis; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Medical Oncology; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Treatment Outcome; Tumor Burden | 2013 |
Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck Dissection; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Salivary Gland Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2013 |
Commentary on: Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Utility of quantitative 18 F-fluorodeoxyglucose uptake measurement to identify occult tonsillar carcinoma in patients with cervical metastasis of unknown primary tumours: a retrospective case-control study.
Topics: Carcinoma, Squamous Cell; Case-Control Studies; Chi-Square Distribution; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2013 |
Role of 18F-FDG PET/CT in the diagnosis of clinically suspected Marjolin ulcer.
Topics: Adult; Aged; Burns; Carcinoma, Squamous Cell; Chronic Disease; Contracture; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Skin Diseases; Skin Neoplasms; Skin Ulcer; Tomography, X-Ray Computed | 2012 |
Technical note: 9-month repositioning accuracy for functional response assessment in head and neck chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Device Removal; Diffusion Magnetic Resonance Imaging; Equipment Design; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immobilization; Masks; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Time Factors | 2012 |
Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Spatio-Temporal Analysis; Tomography, X-Ray Computed | 2013 |
Extracapsular spread and FDG PET/CT correlations in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Floor; Mouth Neoplasms; Neck; Neoplasm Invasiveness; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; ROC Curve; Statistics, Nonparametric; Tomography, X-Ray Computed; Tongue Neoplasms; Young Adult | 2013 |
Clinical significance of ¹⁸F-fluorodeoxyglucose positron emission tomography in superficial esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Lymphatic Vessels; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals | 2013 |
[Esophageal cancer: outcome according to therapeutic strategy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2013 |
The role of positron emission tomography with 18F-fluorodeoxyglucose in nodal staging of clinical and radiological N₀ head and neck cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Computer Simulation; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: a biological modeling study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cell Hypoxia; Cohort Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Models, Biological; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated | 2013 |
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aorta; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vena Cava, Inferior | 2013 |
An 18FDG-PET/CT finding of a mediastinal abscess.
Topics: Abscess; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Serpins | 2013 |
Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Remission Induction; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The potential of FDG-PET in the detection of occult lymph node metastasis: importance of patient selection and reference standard.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Tomography, X-Ray Computed | 2013 |
Fluorodeoxyglucose imaging using a coincidence gamma camera to detect head and neck squamous cell carcinoma and response to chemotherapy.
Topics: Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Early changes in [18F]FLT uptake after chemotherapy: an experimental study.
Topics: Antineoplastic Agents; Artifacts; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Deoxycytidine; Dideoxynucleosides; Dose-Response Relationship, Drug; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Humans; Methotrexate; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tumor Cells, Cultured | 2002 |
Evaluation of esophageal cancer by positron emission tomography.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
Topics: Actuarial Analysis; Bayes Theorem; Carcinoma, Squamous Cell; Cohort Studies; Denmark; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Detection of residue of nasopharyngeal carcinoma with FDG PET].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
Topics: Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Leiomyosarcoma; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2002 |
Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Multivariate Analysis; Neoadjuvant Therapy; Odds Ratio; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2003 |
The heart or a tumor? Lung cancer in the lower left thorax can mimic myocardial FDG uptake on PET imaging.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart; Humans; Lung; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Thorax; Tomography, Emission-Computed | 2003 |
Detection of response to neoadjuvant therapy of esophageal squamous cell carcinoma by positron emission tomography (PET).
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Radiopharmaceuticals; Remission Induction; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Male; Monosaccharide Transport Proteins; Mouth Neoplasms; Prognosis; Retrospective Studies; Survival Analysis; Tomography, Emission-Computed | 2003 |
A needle free system for cervical lymphatic mapping and sentinel node biopsy in oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tongue Neoplasms | 2002 |
Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Observer Variation; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multivariate Analysis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
[Diagnostic imaging--recent progress].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Hiatal hernia mimics centrally necrotic cancer in the lung on FDG positron emission tomographic imaging.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hernia, Hiatal; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Necrosis; Radiography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2003 |
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Hypoxia; Combined Modality Therapy; Coordination Complexes; Copper Radioisotopes; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Life Tables; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organometallic Compounds; Prospective Studies; Radiation Tolerance; Radiopharmaceuticals; Survival Rate; Thiosemicarbazones; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Feasibility Studies; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Multiple Primary; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Mice; Mice, SCID; Radioisotope Dilution Technique; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed; Verapamil | 2003 |
Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
PET imaging of Sertoli cell tumor in androgen insensitivity syndrome.
Topics: Aged; Androgen-Insensitivity Syndrome; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Sertoli Cell Tumor; Testicular Neoplasms; Tomography, Emission-Computed | 2003 |
Evaluation of head and neck squamous cell carcinoma after treatment.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2003 |
[Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Esophagus; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Staging of head and neck squamous cell cancer with extended-field FDG-PET.
Topics: Carcinoma, Squamous Cell; Digestive System Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Neoplasms, Multiple Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Surveillance of basaloid oral squamous cell carcinoma: the value of [18F]FDG-PET.
Topics: Adult; Aged; Carcinoma, Basosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Positron-Emission Tomography; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
The impact of FDG PET on the management of occult primary head and neck tumours.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Diagnostic significance of FDG-PET and argyrophilic nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm, Residual; Nucleolus Organizer Region; Prognosis; Radiopharmaceuticals; Silver Staining; Tomography, Emission-Computed | 2004 |
[Preliminary research of the relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung squamous cell carcinoma].
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins | 2003 |
18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Dideoxynucleosides; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neck Dissection; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[Study on glucose metabolic rate in non-small cell lung cancer patients with blood stasis syndrome and non-blood stasis syndrome].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Medicine, Chinese Traditional; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.
Topics: Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Male; Middle Aged; Muscle, Skeletal; Patient Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carcinosarcoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Do hardware artefacts influence the performance of head and neck PET scans in patients with oral cavity squamous cell cancer?
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Carcinoma, Squamous Cell; Dental Alloys; Dental Prosthesis; Female; Fluorodeoxyglucose F18; Germanium; Head and Neck Neoplasms; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Middle Aged; Orthopedic Fixation Devices; Phantoms, Imaging; Radioisotopes; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Penile Neoplasms; Penis; Remission Induction; Survival Analysis; Tomography, Emission-Computed | 2004 |
Lymph node staging in lung cancer using [18F]FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Carcinoid Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
Topics: Carcinoma, Squamous Cell; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Methionine; Pharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Software; Tissue Distribution; Treatment Outcome | 2004 |
The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2004 |
Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Laryngeal Neoplasms; Laryngectomy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Radiopharmaceuticals; Retrospective Studies; Single-Blind Method; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Oropharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2004 |
Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neck; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity; Treatment Outcome | 2004 |
Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck.
Topics: Aged; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Confidence Intervals; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2004 |
Perineural spread of skin carcinoma to the base of the skull: detection with FDG PET and CT fusion.
Topics: Aged; Carcinoma, Squamous Cell; Cranial Nerve Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Skull Base Neoplasms; Tomography, X-Ray Computed; Trigeminal Nerve | 2004 |
Pleomorphic adenoma simulating metastatic squamous cell carcinoma on f-18 fluorodeoxyglucose positron emission tomography.
Topics: Adenoma, Pleomorphic; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
[18F-FDG positron emission tomography for mediastinal staging of lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2004 |
DNA ploidy, S-phase fraction and associations with 2-18F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; DNA, Neoplasm; Feasibility Studies; Flow Cytometry; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Cytometry; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Ploidies; Prospective Studies; Radiopharmaceuticals; S Phase; Tomography, Emission-Computed | 2004 |
Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies | 2004 |
Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2004 |
Idiopathic pulmonary fibrosis on F-18 FDG positron emission tomography.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals; Tongue Neoplasms | 2005 |
Peritoneal carcinomatosis from cervical cancer detected by F-18 FDG positron emission tomography.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2005 |
Positron emission tomography in cancer of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage | 2005 |
FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? In regard to Rogers et al. (Int J Radiat Oncol Biol Phys 2004;58:694-697).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2005 |
Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Mice; Mice, SCID; Neoplasm Invasiveness; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Treatment Outcome | 2005 |
Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Proportional Hazards Models; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals; Registries; Survival Analysis; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2005 |
A case of small cell carcinoma of the esophagus detected incidentally by FDG-PET.
Topics: Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Positron emission tomography (PET) in the management of oro-pharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Ultrasonography | 2005 |
F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2005 |
Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance.
Topics: Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2005 |
Positron-emission tomography for surveillance of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2005 |
Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Computer Simulation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2005 |
Fluorodeoxyglucose positron emission tomography in cutaneous squamous cell carcinoma: retrospective analysis of 12 patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2005 |
False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2005 |
The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2005 |
Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2005 |
Perineural invasion of squamous cell carcinoma of the lip with occult involvement of the infra-orbital nerve detected by PET-CT and treated with MRI-based IMRT: a case report.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lip Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Oxygen Consumption; Partial Pressure; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals | 2005 |
18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Case report: Gluteal injection site granulomas: false positive finding on FDG-PET in patients with non-small cell lung cancer.
Topics: Adipose Tissue; Aged; Buttocks; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Injections, Intramuscular; Lung Neoplasms; Male; Middle Aged; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography | 2005 |
The role of gamma-PET in the evaluation of patients with recurrent squamous cell cancer of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tongue Neoplasms | 2005 |
Comparison of CT- and FDG-PET-defined GT: in regard to Paulino et al. (Int J Radiat Oncol Biol Phys 2005;61:1385-1392).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2005 |
[A case of high FDG-uptake into the myocardium after radiotherapy for esophageal cancer].
Topics: Aged; Carcinoma, Squamous Cell; Cardiomyopathies; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Myocardium; Positron-Emission Tomography; Radiation Injuries | 2005 |
Response monitoring by positron emission tomography during radiotherapy of a squamous cell skin carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Computer-Assisted; Skin Neoplasms; Treatment Outcome | 2005 |
Ovulation and increased FDG uptake on PET: potential for a false-positive result.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Ovulation; Positron-Emission Tomography; Radiopharmaceuticals; Urethral Neoplasms | 2005 |
[18-FDG positon emission tomography and distal metastasis from lung cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Femur; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tibia; Whole Body Imaging | 2005 |
Topographic metabolic map of head and neck squamous cell carcinoma using 18F-FDG PET and CT image fusion.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Nasal Cavity; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
FDG-PET in carcinoma of the uterine cervix with endometrial extension.
Topics: Adenocarcinoma; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cervix Uteri; Combined Modality Therapy; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Survival Analysis | 2006 |
Two cases of maxillary cancer with a similar clinical course and imaging findings but markedly different levels of FDG uptake.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Maxillary Sinus Neoplasms; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2005 |
False-positive FDG-PET scan due to brown tumours.
Topics: Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Laryngeal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors.
Topics: Animals; Carcinoma, Squamous Cell; Equipment Design; Equipment Failure Analysis; Fluorodeoxyglucose F18; Humans; Male; Misonidazole; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Reproducibility of Results; Restraint, Physical; Sensitivity and Specificity; Species Specificity; Subtraction Technique | 2006 |
Controversies: is there a role for positron-emission tomographic CT in the initial staging of head and neck squamous cell carcinoma?
Topics: Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
FDG-PET in radiotherapy treatment planning of advanced head and neck cancer--a prospective clinical analysis.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Palliative Care; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals | 2006 |
FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2006 |
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Topics: Aged; Antibodies, Monoclonal; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Isotope Labeling; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Radioisotopes; Sensitivity and Specificity; Zirconium | 2006 |
Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sepsis; Tomography, X-Ray Computed; Upper Extremity; Venous Thrombosis | 2006 |
PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?
Topics: Adult; Aged; Carcinoma, Squamous Cell; Contrast Media; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neck; Neoplasm, Residual; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
FDG-PET in the clinically negative neck in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Squamous Cell; Cytodiagnosis; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity | 2006 |
[Positron emission tomography (PET)-computed tomography (CT) suggesting small intestinal metastasis from lung cancer; report of a case].
Topics: Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Ileus; Intestinal Neoplasms; Intestine, Small; Lung Neoplasms; Lymph Node Excision; Male; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Influence of F-fluorodeoxyglucose-positron emission tomography on computed tomography-based radiation treatment planning for oesophageal cancer.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2006 |
The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2006 |
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Fluorodeoxyglucose positron emission tomography for the preoperative staging of oral cavity cancers: only one piece of the puzzle.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Actinomycosis mimicking anastomotic recurrent esophageal cancer on PET-CT.
Topics: Actinomycosis; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Cell Hypoxia; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Middle Aged; Misonidazole; Multivariate Analysis; Positron-Emission Tomography; Survival Analysis | 2006 |
18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Mucoepidermoid; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed | 2006 |
Lung cancer presenting with a solitary colon metastasis detected on positron emission tomography scan.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Usefulness of [18F] fluoro-2-deoxyglucose-positron emission tomography-computed tomography (FDG-PET-CT) in the detection of lung cancer recurrence with paraneoplastic neurological syndrome.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
[Role of [18F]-FDG PET-CT in the management of the head and neck cancers].
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2006 |
[Contribution of 18FDG PET/CT post treatment surveillance of head and neck squamous cell carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Clinical Protocols; Data Interpretation, Statistical; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2006 |
The diagnostic role of radioactivity in sentinel nodes in oral and oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2006 |
Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Middle Aged; Neck; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2007 |
Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Rats; Rats, Nude; Transplantation, Heterologous | 2006 |
FDG-PET in the initial staging of squamous cell oesophageal carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radioisotopes | 2006 |
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Case-Control Studies; Cell Line, Tumor; Clinical Protocols; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
[The diagnostic value of FDG coincidence imaging combined with serum tumor marker assays for pulmonary lesions].
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Keratin-19; Keratins; Lung Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Plasma Cell Granuloma, Pulmonary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2006 |
Retropharyngeal nodes in hypopharynx cancer on positron emission tomography.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Male; Neoplasm Staging; Pharynx; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Salvage Therapy; Survival Rate; Treatment Outcome | 2007 |
F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Detection of a small lung cancer hidden in pneumoconiosis with progressive massive fibrosis using F-18 fluorodeoxyglucose PET/CT.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pneumoconiosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Child; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
The Feasibility of 18F-FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
What does PET imaging add to conventional staging of head and neck cancer patients?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Validated image fusion of dedicated PET and CT for external beam radiation and therapy in the head and neck area.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2008 |
Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Xenograft Model Antitumor Assays | 2007 |
Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neck Dissection; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2007 |
Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Theoretical; Positron-Emission Tomography; Radiotherapy; Reproducibility of Results; Small Cell Lung Carcinoma; Time Factors; Tomography, X-Ray Computed | 2007 |
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Analysis of Variance; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Tomography, Emission-Computed | 2007 |
Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, Spiral Computed | 2007 |
[Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cell Differentiation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed | 2007 |
pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle o
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Misonidazole; Oxygen Consumption; Polarography; Positron-Emission Tomography; Prognosis; Ultrasonography, Doppler, Color | 2007 |
The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Patient Care Planning; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET.
Topics: Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Feasibility Studies; Female; Fluorodeoxyglucose F18; Lung Neoplasms; Mice; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
[The values of MRI, CT, and PET-CT in detecting retropharyngeal lymph node metastasis of nasopharyngeal carcinoma].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Pharynx; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2007 |
Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Mediastinal Diseases; Middle Aged; Mycobacterium tuberculosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis, Lymph Node; Uterine Cervical Neoplasms | 2007 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Thoracic Cavity | 2007 |
Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
[Role of [18]-FDG PET/CT in the initial staging of head and neck cancers].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Endoscopy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging | 2007 |
[FDG-PET-CT based imaging of retropharyngeal lymph nodes with its impact on radiotherapy].
Topics: Antineoplastic Agents; Blood Glucose; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Lymphatic Irradiation; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2008 |
[FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
A case of three synchronous primary tumors demonstrated by F-18 FDG PET.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tonsillar Neoplasms | 2007 |
Image of the month. Diagnosis of endoneural sciatic nerve invasion by uterine cervical epidermoid cancer using [18F]FDG-PET/CT.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sciatic Neuropathy; Subtraction Technique; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Topics: Biopsy; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
F-18 FDG PET/CT following dental extraction in a patient with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cervical Vertebrae; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Peritonitis; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Tooth Extraction | 2007 |
FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2007 |
[Clinical significance of integrated PET/CT in the diagnosis of thoracic cancers].
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2007 |
Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Blood Glucose; Carcinoma, Squamous Cell; Cell Survival; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Prognosis; Radiotherapy Dosage; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
Topics: Carcinoma, Squamous Cell; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Medical Staff, Hospital; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Atelectasis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Biopsy; Carcinoma, Squamous Cell; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Time Factors; Tomography, X-Ray Computed | 2008 |
Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Decision Making; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagoscopy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer.
Topics: Adult; Aged; Aorta; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Taiwan; Uterine Cervical Neoplasms | 2008 |
[Detection of FDG-PET and FDG-PET/CT in head and neck squamous cell carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Enhanced response of human head and neck cancer xenograft tumors to cisplatin combined with 2-deoxy-D-glucose correlates with increased 18F-FDG uptake as determined by PET imaging.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glutathione; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Oxidative Stress; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Transplantation, Heterologous | 2007 |
Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
F-18 positron emission tomography and computed tomography image-fusion for image-guided detection of local recurrence in patients with head and neck cancer using a 3-dimensional navigation system: a preliminary report.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Jaw Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2008 |
Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals | 2008 |
Posttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with decreased quality of life after chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Diet; Eating; Female; Fluorodeoxyglucose F18; Glottis; Glucose; Head and Neck Neoplasms; Health Status; Humans; Larynx; Male; Middle Aged; Positron-Emission Tomography; Quality of Life; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome | 2008 |
Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2008 |
Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Fluorodeoxyglucose F18; Image Enhancement; Injections, Intravenous; Male; Metabolic Clearance Rate; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Time Factors; Tissue Distribution | 2008 |
[Role of PET-CT with 18-FDG in the management of UADT squamous-cell carcinomas: a retrospective study of 43 cases].
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Unsuspected synchronous lung cancer unveiled on FDG PET after chemotherapy for non-Hodgkin lymphoma.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Time Factors; Tomography, X-Ray Computed | 2008 |
Evaluation of clinical significance of 18F-fluorodeoxyglucose positron emission tomography in superficial squamous cell carcinomas of the thoracic esophagus.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Osteoradionecrosis after three-dimensional conformal radiotherapy for recurrent cervical cancer presenting as a progressive osteolytic lesion.
Topics: Bone Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Ilium; Middle Aged; Neoplasm Recurrence, Local; Osteolysis; Osteoradionecrosis; Positron-Emission Tomography; Radiotherapy, Conformal; Salvage Therapy; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2008 |
Radiographic properties of injected calcium hydroxylapatite: potential false positive findings on positron emission tomography.
Topics: Aged; Biocompatible Materials; Carcinoma, Squamous Cell; Durapatite; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngectomy; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2008 |
Positron emission tomography/computed tomography as a method for detection and monitoring of laryngeal chondritis.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cartilage Diseases; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Diseases; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck.
Topics: Belgium; Bone Marrow; Carcinoma, Squamous Cell; Comorbidity; Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival; Survival Rate | 2008 |
Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiography, Thoracic; Radiopharmaceuticals; Risk Factors; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Endotracheal metastasis from squamous cell cancer of the head and neck: PET/CT imaging.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tracheal Neoplasms | 2008 |
Assessing the impact of FDG-PET in the management of anal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Influence of cell proportions and proliferation rates on FDG uptake in squamous-cell esophageal carcinoma: a PET study.
Topics: Aged; Carcinoma, Squamous Cell; Cell Proliferation; Cell Size; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography | 2008 |
Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Blood Volume; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Otorhinolaryngologic Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Regional Blood Flow; Statistics as Topic; Tomography, X-Ray Computed | 2008 |
Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Whole Body Imaging | 2009 |
Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Para-Aortic Bodies; Pelvic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Simultaneous demonstration of metabolic lesions consistent with Alzheimer disease and brain metastases on FDG-PET imaging.
Topics: Alzheimer Disease; Brain Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Clinical Protocols; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Bronchial obstruction due to Teflon pledgets migration 13 years after lobectomy.
Topics: Aged; Bronchi; Bronchial Diseases; Bronchoscopy; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Foreign-Body Migration; Humans; Lung Neoplasms; Male; Pneumonectomy; Polytetrafluoroethylene; Positron-Emission Tomography; Postoperative Complications; Stents; Sutures; Tomography, X-Ray Computed | 2008 |
Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Deoxy Sugars; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Rabbits; Radioisotopes; Rats; Rhamnose; Tissue Distribution; Tomography, Emission-Computed | 1982 |
Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Endoscopy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Positron emission tomography in the detection of residual laryngeal carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxyglucose; Edema; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Laryngeal Diseases; Laryngeal Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiotherapy Dosage; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; False Positive Reactions; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Recurrence; Reproducibility of Results; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case.
Topics: Aged; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Neck; Neoplasm Staging; Pharyngeal Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Radionuclide Imaging | 1995 |
In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck.
Topics: Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Methionine; Radionuclide Imaging; Tumor Cells, Cultured | 1995 |
Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck.
Topics: Biopsy; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1994 |
Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Oropharyngeal Neoplasms; Tomography, Emission-Computed | 1995 |
Functional imaging of head and neck tumors using positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cerebellum; Cicatrix; Deoxyglucose; Female; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Pituitary Neoplasms; Tomography, Emission-Computed; Tonsillar Neoplasms | 1994 |
The promise FDG in diagnosis and surveillance of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Population Surveillance; Tomography, Emission-Computed | 1994 |
Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
Topics: Carcinoma; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Paranasal Sinus Neoplasms; Prognosis; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Detection of cancer recurrence in irradiated mandible using positron emission tomography.
Topics: Adult; Carcinoma, Squamous Cell; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mandibular Diseases; Mandibular Neoplasms; Osteoradionecrosis; Radiography; Tomography, Emission-Computed; Tongue Neoplasms | 1993 |
The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Tomography, Emission-Computed | 1993 |
Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET.
Topics: Adenoids; Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gingiva; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth; Oropharynx; Palatine Tonsil; Salivary Glands; Tomography, Emission-Computed | 1993 |
Satellite PET and lung cancer: a prospective study in surgical patients.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorodeoxyglucose F18; Hospitals, Satellite; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infant; Lung Neoplasms; Male; Middle Aged; Thoracic Neoplasms; Tomography, Emission-Computed | 1993 |
Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.
Topics: Aged; Blood Glucose; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Insulin; Male; Middle Aged; Tomography, Emission-Computed | 1993 |
Intermodality, retrospective image registration in the thorax.
Topics: Aged; Algorithms; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Phantoms, Imaging; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Topics: Adenocarcinoma; Aged; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Radiography, Thoracic; Tomography, Emission-Computed | 1996 |
Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
Topics: Biopsy; Carcinoma, Squamous Cell; Contrast Media; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1996 |
The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cervical Vertebrae; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Oropharynx; Retrospective Studies; Spinal Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
The use of positron emission tomography in the evaluation of orofacial malignancy and disease.
Topics: Ameloblastoma; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mandibular Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 1996 |
Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: in vitro evaluation for PET imaging.
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Cell Survival; Deoxyglucose; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Leucine; Methionine; Oxygen; Tomography, Emission-Computed; Tritium; Tumor Cells, Cultured | 1996 |
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; Esophagus; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Positron emission tomographic imaging of head and neck lesions.
Topics: Absorption; Adenoma; Aspergillosis; Carcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Head and Neck Neoplasms; Histiocytoma, Benign Fibrous; Humans; Magnetic Resonance Imaging; Maxillary Sinus; Maxillary Sinus Neoplasms; Maxillary Sinusitis; Nasopharyngeal Neoplasms; Papilloma; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 1997 |
Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |
A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Role of positron emission tomography in staging esophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparoscopy; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Video Recording | 1997 |
Improvement in staging of esophageal cancer with the addition of positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Contrast Media; Deoxyglucose; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Selection; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk Factors; Survival Analysis; Survival Rate; Time Factors; Tomography, Emission-Computed | 1997 |
Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Positron emission tomography in the evaluation of the N0 neck.
Topics: Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidence; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET.
Topics: Adult; Aged; Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 1997 |
Localized form of bronchioloalveolar carcinoma: FDG PET findings.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Fluorine-18-fluorodeoxyglucose uptake in pneumonia.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pneumonia, Bacterial; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
[Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed | 1998 |
Detection of oral dysplasia in animals with fluorine-18-FDG and carbon-11-tyrosine.
Topics: 4-Nitroquinoline-1-oxide; Animals; Carbon Radioisotopes; Carcinogens; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Mouth Mucosa; Mouth Neoplasms; Radiopharmaceuticals; Rats; Rats, Wistar; Tomography, Emission-Computed; Tyrosine | 1998 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 1998 |
[Value of (F18)-2-fluorodeoxyglucose PET scanning in staging mouth cavity carcinoma. Comparative evaluation of PET findings before and after preoperative radiochemotherapy with histological and computerized tomography findings].
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1998 |
Detection of extrathoracic metastases by positron emission tomography in lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.
Topics: Adenocarcinoma; Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Lung Diseases; Lung Neoplasms; Mediastinal Diseases; Mediastinal Neoplasms; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1998 |
Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Fluorine-18-fluorodeoxyglucose PET identification of cardiac metastasis arising from uterine cervical carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Neoplasms; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Uterine Cervical Neoplasms | 1998 |
Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
CT and PET lung image registration and fusion in radiotherapy treatment planning using the chamfer-matching method.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Physical Phenomena; Physics; Radiographic Image Enhancement; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Pilot Projects; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Evaluation of FDG PET in patients with cervical cancer.
Topics: Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1999 |
FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Radiotherapy, High-Energy; Tomography, Emission-Computed | 1999 |
[F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Topics: Biological Transport; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Membrane; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Enzymologic; Glucose Transporter Type 1; Hexokinase; Humans; Isoenzymes; Kinetics; Liver Neoplasms; Monosaccharide Transport Proteins; Radiopharmaceuticals; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tongue Neoplasms; Uterine Cervical Neoplasms | 1999 |
Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting.
Topics: Academic Medical Centers; Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Nose Neoplasms; Pilot Projects; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tonsillar Neoplasms | 1999 |
The detection of small carcinoma with 18F-FDG using a dual head coincidence camera.
Topics: Adult; Aged; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Neoplasm Recurrence, Local; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Reduced F-18 fluorodeoxyglucose uptake within marrow after external beam radiation.
Topics: Adult; Bone Marrow; Carcinoma, Squamous Cell; Cervical Vertebrae; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasm, Residual; Radiopharmaceuticals; Radiotherapy, High-Energy; Tomography, Emission-Computed | 2000 |
Deoxyglucose uptake by a head and neck squamous carcinoma: influence of changes in proliferative fraction.
Topics: Biomarkers; Carcinoma, Squamous Cell; Cell Count; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lactic Acid; Radiobiology; Radiopharmaceuticals; S Phase; Tumor Cells, Cultured | 2000 |
[Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma].
Topics: Biopsy; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Oropharyngeal Neoplasms; Predictive Value of Tests; Tomography, Emission-Computed | 2000 |
Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.
Topics: Aged; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
[Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Palpation; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
[(18F)-2-fluorodeoxyglucose PET. Prospects for secondary prevention of mouth cavity carcinoma].
Topics: Blood Glucose; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Mouth Neoplasms; Neoplasm Recurrence, Local; Predictive Value of Tests; Tomography, Emission-Computed | 2000 |
Effect of nitroimidazole sensitizers on in vitro glycolytic metabolism of hypoxic squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Death; Cell Hypoxia; Fluorodeoxyglucose F18; Humans; Misonidazole; Nimorazole; Radiation-Sensitizing Agents; Tomography, Emission-Computed; Tritium; Tumor Cells, Cultured | 2000 |
A combined PET/CT scanner for clinical oncology.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Data Interpretation, Statistical; Duodenal Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Polyps; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Fluorine-18 FDG dual-head gamma camera coincidence imaging of radiation pneumonitis.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung; Lung Neoplasms; Male; Radiation Pneumonitis; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Short dynamic FDG-PET imaging protocol for patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagectomy; Esophagostomy; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Gastrostomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Squamous Cell; Coordination Complexes; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; Free Radical Scavengers; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Radiopharmaceuticals; Reference Values; Regional Blood Flow; Thiosemicarbazones; Tissue Distribution; Tomography, Emission-Computed | 2000 |
Detection of unsuspected gastric MALT-lymphoma with F-18-FDG-PET.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasms, Second Primary; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2000 |
Extensive F-18 FDG uptake in metastatic spindle cell carcinoma of the lung.
Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Soft Tissue Neoplasms; Thoracic Neoplasms; Tomography, Emission-Computed | 2001 |
Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 2000 |
[Diagnostic efficacy of 18F-fluorodeoxy glucose-positron emission tomography in multiple solitary pulmonary nodules].
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Lethal Midline; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Fluorodeoxyglucose positron emission tomography, a new technique for increasing the detection rate of coincident thyroid cancer in head and neck oncology.
Topics: Adult; Aged; Blood Glucose; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography.
Topics: Adult; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome | 2001 |
[Therapy monitoring with 2-(18F)-FDG positron emission tomography after neoadjuvant radiation treatment of mouth carcinoma].
Topics: Adult; Aged; Blood Glucose; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2001 |
Unilateral diaphragmatic crus uptake on FDG positron emission tomographic imaging.
Topics: Aged; Carcinoma, Squamous Cell; Diaphragm; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pleural Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Work of Breathing | 2001 |
Uptake of cis-4-[18F]fluoro-L-proline in urologic tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Pilot Projects; Proline; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography detection of metastatic penile squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Penis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Positron emission tomography for the evaluation of metastases in patients with carcinoma of the cervix: a retrospective review.
Topics: Adult; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neoplasms, Second Primary; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET.
Topics: Adenocarcinoma; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cost-Benefit Analysis; Decision Trees; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Life Expectancy; Lymphatic Metastasis; Middle Aged; Models, Econometric; Morbidity; Neck Dissection; Neoplasm Staging; Quality-Adjusted Life Years; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Carcinoma, Verrucous; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2001 |
FDG-PET. A possible prognostic factor in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2002 |
FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Therapy monitoring using FDG-PET in metastatic cervical cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2000 |
[Positron emission tomography in head and neck oncology].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, Emission-Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2001 |
Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2002 |
Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2002 |
Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.
Topics: Adult; Aged; Bronchoscopy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Time Factors; Tomography, Emission-Computed | 2002 |
Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Female; Fluorodeoxyglucose F18; Liver; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 2002 |
[Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Carcinoma; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Tomography, Emission-Computed | 1992 |
[Diagnosis of energy metabolism in ENT tumors--a PET study].
Topics: Blood Glucose; Carcinoma, Squamous Cell; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Follow-Up Studies; Hemangiopericytoma; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Survival Rate; Tomography, Emission-Computed | 1992 |
Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; DNA, Neoplasm; Flow Cytometry; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Tomography, Emission-Computed | 1991 |
Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1990 |
[Positron emission tomography of lung cancer using 18F-2-fluoro-2-deoxy-D-glucose and L-[11C-methyl]-methionine].
Topics: Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxy Sugars; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Radioisotopes; Radionuclide Imaging | 1987 |